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Abstract 
 
The organic solid state appears in a complex number of forms. The design, synthesis 
and application of solid state organic materials have a big impact upon society, e.g. 
pharmaceuticals. Traditionally, the process of selecting active pharmaceutical 
ingredients (APIs) was limited to free drug or accepted salt formulations. The 
cocrystallisation of APIs with a former molecule significantly increases the 
developmental options for APIs. Many pharmaceutical solids are prepared as 
polycrystalline materials in order to deliver favourable physical properties, i.e. 
solubility, bioavailability and stability. In such cases, the development and application 
of structure solution techniques via powder X-ray diffraction (pxrd) has played an 
ever increasing pivotal role. In this thesis a number of new multi-component 
materials; oxamic acid:nicotinamide, oxamic acid:isonicotinamide, fumaric 
acid:nicotinamide, maleic acid:nicotinamide and maleic acid:isonicotinamide, will be 
synthesised, via a number of synthetic methods, and fully structurally characterised. A 
direct comparison of structures solved by powder and single crystal diffraction, have 
been made in order to evaluate the reliability of structure solution from pxrd in these 
types of materials. The thermal behaviour of molecular materials will be presented as 
significant structural information can be extracted from the anisotropic expansion of 
molecular materials. In conjunction with the research into new multi-component 
materials, the structure solution of oxamic acid via pxrd, single X-ray diffraction and 
neutron diffraction will be investigated. Small organic molecular materials like 
oxamic acid provide a challenge to the crystallographer due to the similarities in the 
electron density surrounding each functional group in the molecule.   
 
  
 
 
Acknowledgements 
 
The past four years or so would not have been as enjoyable an experience if it wasn’t 
for the people who I have shared my time with. Firstly, I would like to thank my 
supervisor Dr Maryjane Tremayne for allowing me the opportunity to study a PhD 
and for her vital guidance and input into the project. I will be ever in debt to Dr Sam 
Chong whose expertise and professionalism at the start of my PhD was vital to putting 
me on the right track to crystallographic happiness, and also an excellent drinking 
partner on conferences. I would like to extend my acknowledgements to both Dr 
Louise Male and Dr Benson Kariuki for their insight and single crystal diffraction 
knowledge.  I would like to thank past and present members of Team Tremayne, 
Liana, Duncan, Raja and Laura (especially for printing the thesis) for their help, 
guidance and general good-natured chitchat. 
I would also like to acknowledge the wider structural, theoretical and physical 
chemist community living on the second floor of the Haworth building including; Dr 
Dan Binks, Dr Tom Penfold, Dr Andy Bennett, Dr Oliver Borbon, Dr Emma 
Chapman, Loggy, Jan, Jon, Professor Johnston, Dr Britton and may others that I am 
sure I have missed.  
I would like to acknowledge my grandad and nan, Richard and Olive Hasson. If it 
wasn’t for their help during my undergraduate studies I wouldn’t be in this position 
now, both of whom sadly passed away during my PhD. Finally, I would like to thank 
my wife Nicola, and thank her again and again, just for being ace.   
__________________________________________________________________________________
Contents 
 
Contents  
 
1.0  Introduction................................................................................ ..1 
1.1  The fundamentals of crystalline state..............................................2 
1.2  Space groups............................................................................... ..5 
1.3  X-ray diffraction from crystalline solids................................... ..5 
1.4  The crystallographic phase problem............................................. ..7 
1.5  Single crystal vs. powder diffraction......................................... ..8 
1.6  Preferred orientation.................................................................. 11 
1.7  Structure prediction................................................................ 12 
1.7.1  Indexing................................................................................... 14 
1.7.2  Space group assignment............................. ............................. 14 
1.7.3  Pattern decomposition.................................................................. 15 
1.7.4  Structure solution.......... ........................................................... 16 
1.7.5  Differential evolution............................................................... 17 
1.7.6  Rietveld refinement.................................................................... 19 
1.8  Polymorphism......................................................................... 20 
1.9  Structure prediction................................................................ 22 
1.10  Thermal behaviour...................................................................... 24 
1.11  Forms of organic solids................................................................ 26 
1.11.1 Cocrystals vs. Salts...................................................................... 27 
1.11.2 Cocrystals applications................................................................. 30 
1.11.3 Cocrystal synthesis...................................................................... 32 
1.11.4 Reduced solvent methods for cocrystallisation synthesis.............34 
1.11.5 Cocrystal design............................................................................35 
__________________________________________________________________________________
Contents 
 
1.12  Aims.........................................................................................38 
 
2  Methodology.......................................................................... 47  
2.1  Variable temperature x-ray diffraction ...................................... 47 
2.1.1  Software and data handling..................................................... 47 
2.2  Structure solution from X-ray powder diffraction....................... 47 
 
3  Experimental.......................................................................... 56 
3.1  Instrumentation....................................................................... 56 
3.1.1  Bruker AXS D5000 high-resolution X-ray powder  
Diffractometer......................................................................... 56 
3.1.2  Bruker AXS D5005 high-resolution X-ray powder     
Diffractometer............................................................................. 56 
3.1.3  Sample effects using the Bruker AXS D5005  
high-resolution X-ray powder diffractometer..........................57 
3.1.4  Bruker AXS D5000 high-resolution X-ray powder 
   diffractometer fitted with Oxford Cryostream  
and capillary stage.................................................................. 59 
3.1.5  Bruker APEXII CCD Single Crystal diffractometer................... 60 
3.1.6  Perkin Elmer Pyris 1 DSC (differential scanning calorimeter).60 
3.1.7  Solid state NMR (nuclear magnetic resonance)....................... 61 
3.1.8  Solution NMR (nuclear magnetic resonance) .............................. 61 
3.1.9  Solid state Infra-red................................................................... 61 
3.1.10 High pressure liquid chromatography (HPLC)............................. 62 
3.2  Synthetic technique for cocrystal/salt synthesis......................... 62 
3.2.1  Solvent mediated crystallsation ................................................... 62 
__________________________________________________________________________________
Contents 
 
3.2.2  Incubator controlled solvent-mediated crystallisation.................. 62 
3.2.3  Liquid assisted grinding........................................................... 63 
3.2.4  Slurry sonication...................................................................... 63 
3.2.5  Dry grinding.......................................................... .................... 63 
3.3  Preparation and characterisation of system under investigation... 63 
3.3.1  Oxamic acid:isonicotinamide................................................... 63 
3.3.2  Synthesis......................................................................... .......... 63 
3.3.3  NMR analysis....................................................... ...................64 
3.3.4  HPLC results........................................................................... 65 
3.3.5  DSC analysis........................................................... ...................65 
3.3.6  Preparation of sample for single crystal diffraction..................... 65 
3.3.7  Stoichiometric diversity........................................................... 66 
3.4   Oxamic acid:nicotinamide........................................................ 66 
3.4.1  Synthesis........................................................................ .......... 66 
3.4.2  NMR analysis.......................... ................................................. 67 
3.4.3  HPLC result............................................................................. 68 
3.4.4  DSC analysis........................................................................... 68 
3.4.5  Preparation of sample for single crystal diffraction........ .......... 68 
3.5  Fumaric acid:nicotinamide....................................................... 68 
3.5.1  Synthesis.................................................................................. 68 
3.5.2  NMR analysis.................................... ....................................... 69 
3.5.3  Melting point analysis ............................................................ 70 
3.5.4  Preparation of sample for single crystal.................................. 70 
3.5.5  Stoichiometric diversity.......................................................... 70 
3.6  Maleic acid:nicotinamide........................................................... 70 
3.6.1  Synthesis (product A) ...................................... ....................70 
__________________________________________________________________________________
Contents 
 
3.6.2  NMR analysis (product A)............................................... .......... 71 
3.6.3  DSC analysis (product A)........................................................ 72 
3.6.4 Preparation of sample for single crystal diffraction 
(product)................................................................................. 72 
3.6.5 Synthesis (product B).................................................... .......... 72 
3.6.6 NMR analysis (product B)...................................................... 73 
3.6.7 DSC analysis (product B)....................................................... 73 
3.6.8 Preparation of sample (product B) for single crystal 
diffraction.................................................... ............................. 74 
3.7 Maleic acid:isonicotinamide..................................................... 74 
3.7.1 Synthesis.................................................... ............................. 75 
3.7.2 NMR analysis.......................................................................... 75 
3.7.3 Preparation of sample for single crystal diffraction.................. 75 
3.8 Succinic acid:nicotinamide....................................................... 75 
3.8.1 Synthesis............................................................................. .......... 75 
3.9 Adipic acid:nicotinamide.................................................... .......... 76 
3.9.1 Synthesis.................................................... ............................. 76 
3.10 Oxamic acid............................................................................. 76 
3.10.1 Solvent mediated recrystallisation...................................... .......... 76 
3.10.2 Neutron powder diffraction....................................................... 76
  
 
4.0 Crystal structure determination of Oxamic 
acid:isonicotinamide and oxamic  
acid:nicotinamide........................................................................ 78 
4.1  Characterisation of oxamic acid and isonicotinamide................. 80 
4.2  Structure solution and refinement from laboratory pxrd data. .84 
4.3  Rietveld refinement.................................................................. 86 
__________________________________________________________________________________
Contents 
 
4.4  Oxamic acid isonicotinamide: structure...................................91 
4.5  Comparison of the Single crystal vs. Powder structure .......... 95 
4.6  The efficiency of the DE algorithm........................................... 98 
4.7  Thermal behaviour of oxamic acid:isonicotinamide.................102  
4.8  Characterisation of oxamic acid:nicotinamide................. .........107 
4.9  Structure solution and refinement from laboratory pxrd data...111 
4.10  Rietveld refinement......................................................... .........113 
4.11  Oxamic acid:nicotinamide structure............................... .........116 
4.12  Single crystal vs. Powder structure................................ .........122 
4.13  The efficiency of the DE algorithm................................. .........128 
4.14  Thermal behaviour of oxamic acid:nicotinamide....................129 
 
5.0 Crystal structure determination of Fumaric acid:nicotinamide 
and maleic acid:nicotinamide and maleic 
acid:isonicotinamide..................................................................136 
5.1  Characterisation of fumaric acid and nicotinamide ...................137 
5.2  Structure solution and refinement from laboratory pxrd data....141 
5.3  Rietveld refinement...................................................................143 
5.4  Fumaric acid:nicotinamide structure..........................................146 
5.5 Comparison of the single crystal vs. Powder structure...........150 
5.6  Efficiency of the DE algorithm...............................................151  
5.7  Thermal behaviour of fumaric acid:nicotinamide....................154 
5.8  Cocrystallisation of maleic acid:nicotinamide................... .........158 
5.9  Characterisation of maleic acid:nicotinamide..........................159 
5.10  Structure solution of maleic acid:nicotinamide product A......165 
5.11  Describing the structure of maleic acid:nicotinamide.................170 
5.12  Thermal behaviour of maleic acid:nicotinamide product A.........170 
__________________________________________________________________________________
Contents 
 
5.13  Cocrystallisation of maleic acid:isonicotinamide........................173 
5.14  Characterisation of maleic acid:isonicotinamide........................177 
5.15  Maleic acid:isonicotinamide structure......................................177 
 
6.0  Polymorphism of oxamic acid..................................................186 
6.1  Oxamic acid.................................................................................186 
6.2  Polymorph screen........................................................................187 
6.3  Liquid assisted grinding...........................................................190 
6.4  DSC results.............................................................................191 
6.5  Solution 
1
H NMR results.........................................................192 
6.6  Solid-state NMR result...........................................................192 
6.7  Structure prediction results....................................................193 
6.8  Structure solution of oxamic acid form I from pxrd...............195 
6.9  Rietveld refinement.................................................................197 
6.10  Oxamic acid form I powder structure.....................................200 
6.11  Single crystal vs. Powder structure of oxamic acid form I......201 
6.12  The attempted structure solution of oxamic acid form II from 
pxrd.............................................................................................205 
6.13  Neutron diffraction data............................................................206 
6.14  Hydrogenated neutron data....................................................207 
6.14.1 Model A results.......................................................................208 
6.14.2 Model B results.........................................................................209 
6.14.3 Model C results.........................................................................209 
6.15  Thermal behaviour of oxamic acid............................................210 
 
7.0  Conclusion ...............................................................................213 
__________________________________________________________________________________
Contents 
 
8.0  Appendices A-X..................................................................216-267  
 
 
    
 
 
 
 
 
 
 
 
__________________________________________________________________________________ 
List of figures 
 
List of figures 
 
1.1 Unit cell parallelepiped. 
1.2 Lattice types, i) Body centred (I), ii) Primitive (P), iii) C centred and iv) F centred. 
1.3 The geometric conditions required for Bragg diffraction. 
1.4 Diffraction from an oriented single crystal. 
1.5 Diffraction cones of scattered X-rays, diffracted from a powder sample. 
1.6 A flow diagram outlining the processes involved in structure solution from pxrd.  
1.7 A symmetric vibronic harmonic oscillator. 
1.8 The classification of organic solids. 
1.9 Classification of a cocrystal (left) and a salt (right). 
1.10 Frequency of occurrence of organic molecular co-crystals in the Cambridge Structural 
Database from 1988 to 2007. For the purposes of this graph, co-crystals are distinct 
from solvates, hydrates, and simple salts.   
1.11 Schematic representations of isothermal ternary phase diagrams with (A) showing 
similar solubilities between starting components 1 and 2 in solvent S and (B) showing 
a system with a difference between solubilities of the starting components 1 and 2 in 
solvent S. Region A represents component 1 and solvent, B represents component 1 
and cocrystal, C represents cocrystal, D represents component 2 and cocrystal, E 
represents component 2 and cocrystal and finally F represents solution.  
1.12 Potential synthons found in acid-amides cocrystals.   
 
2.1 An example of local minimum and the global minimum on an energy hypersurface 
2.2 Production of an offspring trial structure using a combination of variables of the 
parent (P) and randomly selected individuals (R1, R2 and R3) 
2.3 Flow diagram of the DE calculation process 
__________________________________________________________________________________ 
List of figures 
 
2.4 Evolutionary progress plot for the successful solution of oxamic acid:nicotinamide 
showing the best Rwp (blue) and the mean Rwp (pink) for each generation. 
 
3.1 Diagram showing the techniques used to mount the sample onto the sample holder for 
collection of low-temperature data on D5005. 
3.2 
1
H NMR of oxamic acid:isonicotinamide product (from 1:1 starting ratio) using 
DMSO as solvent. 
1
H NMR 300MHz (DMSO-d6):  δ = 8.90 ppm (dd, 2H), 8.4 ppm 
(s, 1H), 8.21 ppm (s, 1H), 7.8 ppm (d, 4H) 
3.3 
1
H NMR of oxamic acid:nicotinamide multi-component crystal (from 1:1 starting 
ratio) using DMSO as solvent. 
1
H NMR 300MHz (DMSO-d6):  δ = 9.10 ppm (dd, 
1H), 8.7 ppm (d, 1H), 8.21 ppm (dt, 3H), 7.8 ppm (d, 1H) 7.7 (d, 1H), 7.5 (d, 1H). 
3.4 NMR of fumaric acid:nicotinamide product (from 1:1 starting ratio) using DMSO as 
solvent. 
1
H NMR 300MHz (DMSO-d6):  δ = 13.2 ppm (s, 2H), 9.10 ppm (dd, 1H), 8.7 
ppm (d, 1H), 8.21 ppm (dt, 1H), 8.19 ppm (s, 1H) 7.8 ppm (d, 1H) 7.6 (d, 1H), 6.6 (d, 
2H). 
3.5 
1
H NMR of maleic acid and nicotinamide product A multi-component crystal (from 
1:1 starting ratio) using DMSO as solvent. 1H NMR 300MHz (DMSO-d6):  δ = 9.10 
ppm (dd, 1H), 8.7 ppm (dd, 1H), 8.21 ppm (dt, 2H), 7.8 ppm (d, 1H) 7.6 (d, 1H), 6.2 
(d, 2H). 
 
3.6 
1
H
 
NMR of maleic acid and nicotinamide product B (from 1:1 starting ratio) using 
DMSO as solvent. 
1
H NMR 300MHz (DMSO-d6):  δ = 13.2 (s, 2H), 9.10 ppm (dd, 
1H), 8.7 ppm (dd, 1H), 8.21 ppm (dt, 2H), 7.8 ppm (d, 1H) 7.6 (d, 1H), 6.2 (d, 2H). 
 
3.7 
1
H NMR of oxamic acid and isonicotinamide multi-component crystal (from 1:1 
starting ratio) using DMSO as solvent. 
1
H NMR 300MHz (DMSO-d6):  δ = 8.90 ppm 
(dd, 2H), 8.4 ppm (s, 1H), 8.21 ppm (s, 1H), 6.2 ppm (d, 2H). 
 
__________________________________________________________________________________ 
List of figures 
 
4.1 Molecular diagrams of (i) oxamic acid, (ii) isonicotinamide and (iii) nicotinamide 
4.2 Potential dimeric synthons for the oxamate unit. 
4.3 Powder X-ray diffraction patterns of starting materials, oxamic acid (orange) and 
isonicotinamide (red) and the oxamic acid:isonicotinamide multi-component material 
(black) 
4.4 Solid state IR spectra of the oxamic acid and isonicotinamide mix (red) and the new 
multi-component crystal (blue) 
 
4.5 Powder X-ray diffraction data of the starting materials oxamic acid (orange) and 
isonicotinamide (red). Oxamic acid:isonicotinamide crystallised from solution 
mediated crystallisation (black), oxamic acid:isonicotinamide ground for 5 
minutes(purple), oxamic acid:isonicotinamide ground for 15 minutes (blue), oxamic 
acid: isonicotinamide ground for 20 minutes (green) and oxamic acid:isonicotinamide 
from sonic slurry(dark red). 
4.6 Molecular structures used in the DE structure solution, torsion angles are indicated by arrows, 
excluded hydrogen atoms are shown in brackets.  
4.7 Differential evolution progress plot for the successful structure solution of oxamic 
acid:isonicotinamide showing the Rwp of the best individual in blue and the mean % 
Rwp of the population in pink.  
 
4.8 The final Rietveld profile for oxamic acid:isonicotinamide. The experimental 
diffraction pattern is shown by red circles, the calculated diffraction pattern is shown 
by a solid green line, and the difference plot as a solid pink line. Reflection positions 
are marked by black dots. 
 
4.9 The molecular structure of oxamic acid:isonicotinamide. Showing the atom 
numbering scheme and the hard intermolecular hydrogen bonds within the 
asymmetric unit (dashed lines). Displacement ellipsoids are drawn at the 50% 
probability level and H atoms are shown as small spheres of arbitrary radii. 
 
4.10 A view along the a axis showing an infinitely hydrogen bonded sheet in the (105) 
plane. Hydrogen bonds are shown by a dotted green line 
__________________________________________________________________________________ 
List of figures 
 
4.11 A view of the hydrogen-bonded crystal structure of oxamic acid:isonicotinamide 
shown in projection down the a-axis. All six intermolecular hydrogen bonds are 
indicated as dashed lines; five interactions within a sheet (green) and one between 
sheets (black). The intramolecular hydrogen bond within the oxamate ion is not 
shown and H atoms not involved in hydrogen bonding have been omitted for clarity. 
 
4.12 A section of the hydrogen bonded sheet of oxamic acid:isonicotinamide. From single 
crystal data (left) and from pxrd data (right). 
 
4.13 Isonicotinamide molecule from oxamic acid: isonicotinamide. The green molecule 
represent single crystal positions, red molecule represent DE solution 20.53 and the 
blue molecule represents final refined positions. 
 
4.14 Oxamic acid molecule from oxamic acid:isonicotinamide. The green molecule 
represents single crystal positions, red molecule represent atoms from DE solution 
20.53 and the blue molecule represents the final refined atom positions. 
 
4.15 Variation of mutation rate F with constant population size. F = 0.3, 0.4 and 0.5 are 
shown by green, orange and blue lines respectively. Dotted lines represent the best 
Rwp of the population with the corresponding solid line representing the mean Rwp of 
the population. 
 
4.16 Two diffraction peaks of oxamate:isonicotinamide over the temperature range 
investigated, 295 K(blue), 250 K (pink), 200 K (orange), 150 K (sky blue) and 100 
K(purple). 
 
4.17 The fractional variation of lattice parameters obtained from the LeBail refinement, 
plotted against temperature; Unit cell volume (purple spots), a (blue line), b (pink 
line), c ( orange line) and β ( sky blue dashed line). 
4.18 The fractional variation of lattice parameters obtained from Rietveld refinement, 
plotted against temperature; Unit cell volume (purple spots), a (blue line), b (pink 
line), c (orange line) and β (sky blue dashed line). 
__________________________________________________________________________________ 
List of figures 
 
4.19 Powder X-ray diffraction patterns of the starting materials, oxamic acid (orange), 
nicotinamide (red) and oxamic acid:nicotinamide multi-component material (black). 
4.20 Solid state IR spectra of oxamic acid:nicotinamide mix (black) and the new multi-
component crystal (blue). 
4.21 Powder X-ray diffraction data of the starting materials oxamic acid (orange) and 
nicotinamide (red). Oxamic acid:nicotinamide crystallised from solution mediated 
crystallisation (black), oxamic acid:nicotinamide ground for 5 minutes (green), for 15 
minutes (purple), for 20 minutes (blue) and oxamic acid:nicotinamide from sonic 
slurry (dark red). 
4.22 Molecular structures used in the DE structure solution, torsion angles are indicated by 
arrows. Hydrogen atoms excluded from the calculation are shown in brackets. 
4.23 Evolutionary progress plot for the successful solution of oxamic acid:nicotinamide 
showing the best  Rwp (blue) and the mean Rwp (pink) for each generation. 
 
4.24 The final Rietveld profile for oxamic acid:nicotinamide. The experimental diffraction 
pattern is shown by red circles, the calculated diffraction pattern by a solid green line 
and the difference plot as a solid pink line. Reflection positions are marked by black 
dots.  
4.25 ORTEP diagram of the two asymmetric molecules in the multi-component crystal 
4.26 The tetrameric unit formed in the crystal structure oxamic acid:nicotinamide.  
Hydrogen bonds are indicated as dashed lines. 
4.27 The plannar oxamate acid sheet as viewed along the a axis. Hydrogen bonds are 
shown by the dotted green line. 
4.28 The nicotinamide sheet, viewed along the a axis 
4.29 View along the b axis showing the layered structure of oxamic acid and nicotinamide 
co-crystal adduct. 
4.30 Nicotinamide layer from the single crystal structure of oxamate:nicotinamide. 
4.31 Nicotinamide layer from the DE solution (Rwp = 10.38%) of oxamate: nicotinamide. 
4.32 Oxamate layer from the single crystal structure of oxamate:nicotinamide 
4.33 Oxamate layer from the DE solution (Rwp = 10.38 %) of oxamate acid:nicotinamide. 
__________________________________________________________________________________ 
List of figures 
 
4.34 The cis (left) and  trans nicotinamide molecule configuration(right) 
4.35 Oxamate ion molecule from oxamate: nicotinamide. The green molecule represents 
single crystal positions, the red molecule represents atoms from the DE solution 
(10.38) and the blue molecule represents the final refined atomic positions. 
4.36 The nicotinamide molecule from oxamate acid: nicotinamide. The green molecule 
represents single crystal positions, the red molecule represents atom positions from 
the DE solution (10.38) and the blue molecule represents final refined positions. 
4.37 Two diffraction peaks of oxamic acid:nicotinamide over the temperature range 
investigated, 295 K(blue), 250 K (pink), 200 K(orange), 150 K(sky blue) and 100 
K(purple). 
4.38 The fractional variation of lattice parameters obtained from LeBail refinement, plotted 
against temperature; Unit cell volume (purple spots), a (blue line), b (pink line), c 
(orange line) and β (sky blue dashed line). 
4.39 The fractional variation of lattice parameters obtained from Rietveld refinement, 
plotted against temperature; Unit cell volume (purple spots), a (blue line), b (pink 
line), c (orange line) and β (sky blue dashed line) 
 
5.1 Molecular diagrams of fumaric acid (i), (ii) maleic acid , (iii) nicotinamide and iv) 
isonicotinamide 
5.2 Powder X-ray diffraction patterns of the  starting materials, fumaric acid (orange), 
nicotinamide (red) and the fumaric acid:nicotinamide multi-component material 
(black). 
5.3 Solid state IR spectra of the fumaric acid and nicotinamide mix (dashed line) and 
fumaric acid:nicotinamide multi-component crystal (solid) 
5.4 Powder X-ray diffraction data of the starting materials fumaric acid (orange) and 
nicotinamide (red). The fumaric acid:nicotinamide multi-component from solvent 
mediated recrystallisation (black), fumaric acid:nicotinamide from 10 minutes of 
LAG (green), from 15 minutes of LAG (purple), from 20 minutes of LAG (blue) and 
fumaric acid:nicotinamide from sonic slurry (dark red). 
__________________________________________________________________________________ 
List of figures 
 
5.5 Molecular structures used in the DE structure solution, torsion angles are indicated by 
arrows. Hydrogen atoms excluded from the calculation are shown in brackets. 
5.6 Evolutionary progress plot for the successful solution of fumaric acid:nicotinamide 
showing the best Rwp (blue) and the mean  Rwp (pink) for each generation. 
 
5.7 The final Rietveld plot for fumaric acid:nicotinamide. The experimental diffraction 
data is shown by red circles, the calculated diffraction pattern by solid green line and 
reflection positions are marked by black dots. The difference between the 
experimental and calculated diffraction pattern is shown by the pink line. 
5.8 The molecular structure of fumaric acid:nicotinamide. Showing the atom numbering 
scheme. Displacement ellipsoids are drawn at the 50 % probability level and H atoms 
are shown as small spheres of arbitrary radii. 
5.9 Fumaric acid and nicotinamide looking down the a axis. Carbon, nitrogen, oxygen 
and hydrogen atoms are shown in black, blue, red and white respectively 
5.10 A view along the b axis, showing the hydrogen bonded sheets in the (010) plane. 
Carbon, nitrogen, oxygen and hydrogen atoms are shown in black, blue, red and white 
respectively. 
5.11 Nicotinamide molecule from fuamric acid:nicotinamide. The green molecule 
represents single crystal positions and the blue molecule represents final refined 
powder positions (non-hydrogen atoms only). 
 
5.12 Fumaric acid molecule from fumaric acid:nicotinamide. The green molecule 
represents single crystal positions and the blue molecule represents final refined 
powder positions (non-hydrogen atoms only) 
 
5.13 Diffraction peak of fumaric acid:nicotinamide over the temperature range 
investigated, 295 K (blue), 250 K (pink), 200 K (green), 150 K (sky blue) and 100 K 
(purple). 
__________________________________________________________________________________ 
List of figures 
 
5.14 The fractional variation of lattice parameters obtained from LeBail refinement, plotted 
against temperature; Unit cell volume (purple spots), a (blue line), b (pink line), c 
(orange line) and β (sky blue dashed line).  
5.15 The fractional variation of lattice parameters obtained from Rietveld refinement, 
plotted against temperature. Unit cell volume (purple dashes), a (blue), b (pink), c 
(orange) and β (sky blue dashes). 
5.16 Powder X-ray diffraction patterns of the starting materials, maleic acid (orange) and 
nicotinamide (red). The maleic acid:nicotinamide multi-component material product 
A (black) and product B (purple) 
5.17 Solid state IR spectra of maleic acid and nicotinamide mix (dashed line) and the new 
multi-component crystal product A (solid line). 
5.18 Proposed mechanism for the isomerisation of maleic acid when cocrystallised with 
nicotinamide  
5.19 The powder X-ray diffraction patterns of product A (blue) and product B (red). 
5.20 The powder X-ray diffraction patterns of fumaric acid:nicotinamide (black) and 
maleic acid:nicotinamide product B (purple).   
5.21 Powder X-ray diffraction patterns of the starting materials, maleic acid (orange), 
nicotinamide (red). The maleic acid:nicotinamide multi-component  material product 
A from solvent mediated crystallisation (balck), sonic slurry (green) and 
mechanochemical grinding (purple). 
5.22 Molecular structures used in the DE structure solution, torsion angles are indicated by 
arrows. Excluded hydrogen atoms are shown in brackets. 
5.23 Maleic acid molecule from maleic acid:nicotinamide. The red molecule represents 
single crystal positions and the blue molecule from the DE solution 16.43. (non-
hydrogen atoms only). 
5.24 Nicotinamide molecule from maleic acid:nicotinamide. The red molecule represents 
single crystal positions and the blue molecule from the DE solution 16.43. (non-
hydrogen atoms only) 
__________________________________________________________________________________ 
List of figures 
 
5.25 The molecular structure of maleate:nicotinamide. Showing the atom numbering 
scheme and the hard intermolecular hydrogen bonds within the asymmetric unit 
(dashed lines). Displacement ellipsoids are drawn at the 50 % probability level and H 
atoms are shown as small spheres of arbitrary radii. 
5.26 Packing of maleate ions and nicotinamide molecules, viewed along the a axis. 
 
5.27 A Hydrogen bonding network running in maleate:nicotinamide. 
5.28 X-ray powder diffraction peaks of maleate:nicotinamide over the temperature range 
investigated, 295 K (blue), 250 K (pink), 200 K (green), 150 K (sky blue) and 100 K 
(purple). 
5.29 The fractional variation of lattice parameters obtained from the LeBail refinement 
against temperature, Unit cell volume (purple spots), a (blue line), b (pink line), c 
(orange line). 
5.30 The fractional variation of lattice parameters obtained from the Rietveld refinement 
against temperature. Unit cell volume (purple spots), a (blue line), b (pink line), c 
(orange line). 
5.31 Powder X-ray diffraction patterns of the starting materials, maleic acid (orange) and 
isonicotinamide (red) and the maleic acid:isonicotinamide multi-component material 
(black). 
5.32 Powder X-ray diffraction patterns of the starting materials, maleic acid (orange) and 
isonicotinamide (red). The maleic acid:isonicotinamide solvent mediated multi-
component material (black), sonic slurry (purple) and mechanochemically ground 
(orange). 
5.33 The molecular structure of maleate:isonicotinamide. Showing the atom numbering 
scheme and the hard intermolecular hydrogen bonds within the asymmetric unit 
(dashed lines). Displacement ellipsoids are drawn at the 50 % probability level and H 
atoms are shown as small spheres of arbitrary radii. 
5.34 Maleate ions and isonicotinamide molecules ribbons running in the (011) plane. 
 
5.35 Sheets of meleate ions and isonicotinamide molecules 
 
6.1 Molecular structure of oxamic acid 
6.2 Cis and trans isomers of oxamic acid 
6.3 The powder diffraction pattern of oxamic acid Form I (red) and Form II (blue) 
6.4 Diffraction pattern of oxamic acid ground for 10 minutes in ethyl acetate (pink) and 
methanol (blue) 
__________________________________________________________________________________ 
List of figures 
 
6.5 High temperature DSC trace of oxamic acid form II 
6.6 A dendogram produced by a PolySNAP, comparing simulated and experimental 
powder diffraction patterns for oxamic acid. Codes 1 and 2 represent forms I and II of 
oxamic acid, 3 (ciscis_ai50), 4 (ciscis_ak61), 5 (transcis_ai48), 6 (transcis_aj74), 7 
(transcis_ak35), 8 (transcis_am52), 9 (transtrans_de50), 10 (transcis_fc58), 11 
(transtrans_am58), 12 (transtrans_am62), 13 (transtrans_da59), 14 (transtrans_am56), 
15 (transtrans_af42). 
6.7 The molecular structure of oxamic acid and torsion angle 
6.8 Differential evolution progress plot for the successful solution of oxamic acid, 
showing the best % Rwp (blue) and the mean % Rwp (pink). 
6.9 The final Rietveld plot for oxamic acid. Experimental diffraction data is shown by red 
circles. The calculated diffraction pattern is shown by the solid green line. The 
difference is shown below in pink. Reflection positions are marked black dots. 
6.10 Projection down the a axis showing the infinitely hydrogen bonded sheet of oxamic 
acid form I 
6.11 A view along the b axis of oxamic acid. Infinitely hydrogen sheets running along the 
b axis. 
6.12 Overlay of single crystal structure and cis DE solution of oxamic acid 
6.13 Hydrogen bonding network in cis(trans)-oxamic acid conformer. 
6.14 Hydrogen bonding network in cis(cis)-oxamic acid conformer 
 
6.15 Model A, B and C, of oxamic acid 
6.16 The fractional variation of lattice parameters obtained from LeBail refinement, plotted 
against temperature. Unit cell volume (purple dashes), a (blue) , b (pink), c (orange) 
and β (green) . 
 
 
__________________________________________________________________________________ 
List of figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
__________________________________________________________________________________ 
List of figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
__________________________________________________________________________________
List of tables 
 
List of tables 
 
1.1 The seven crystal systems 
 
4.1 Initial lattice parameters, DE structure solution parameters, refined lattice parameters 
from Rietveld refinement and single crystal determination and Rietveld agreement 
factors. 
4.2 Hydrogen bond geometry in oxamic acid:isonicotinamide, (Å and °). 
 
4.3 The results from a number of DE calculations with variation in F (mutation rate) and 
NP (population size). For each epoch the final Rwp (in %) is given and figures within 
brackets indicate at which generation convergence was achieved. Runs giving the 
correct structure solution are indicated by green; the gold cell indicates the lowest Rwp 
achieved and the starting point for the successful structure refinement. Runs that have 
not converged by the maximum allowed number of generations are shaded grey. 
 
4.4 MDE results for each epoch from five runs. For each epoch the final Rwp (in %) is 
given and figures within brackets indicate at which generation convergence was 
achieved. Runs giving the correct structure solution are indicated by green; the gold 
cell indicates the lowest Rwp achieved and the starting point for the successful 
structure refinement. 
 
4.5 Lattice parameters from the LeBail fitting of oxamate:isonicotinamide. ∆L/L0 values 
are given in square brackets. 
4.6 Lattice parameters from the Rietveld refinement of oxamate acid:isonicotinamide. 
∆L/L0 values are given in square brackets. 
4.7 Linear thermal expansion co-efficients of the lattice parameters of 
oxamate:isonicotinamide. 
__________________________________________________________________________________
List of tables 
 
4.8 Initial lattice parameters, DE structure solution parameters, refined lattice parameters 
from Rietveld refinement and single crystal determination and Rietveld agreement 
factors. 
4.9 Intermolecular parameters for the oxamic aicd:nicotinamide co-crystal adduct (Ǻ) 
4.10 The results from a number of DE calculations with variation in F (mutation rate). For 
each epoch the final Rwp (in %) is given and figures within brackets indicate at which 
generation convergence was achieved. Runs giving the correct structure solution are 
indicated by green; the gold cell indicates the lowest Rwp achieved and the starting 
point for the successful structure refinement. Runs that have not converged by the 
maximum allowed number of generations are shaded grey. 
4.11 Lattice parameters from the LeBail fitting of oxamate:nicotinamide. ∆L/L0 values are 
given in square brackets. 
4.12 Rietveld lattice parameters of oxamate:nicotinamide ∆L/L0 values are given in square 
brackets. 
4.13 Linear thermal expansion co-efficients of the lattice parameters of oxamic 
acid:nicotinamide salt. 
 
5.1 Initial lattice parameters, DE structure solution parameters, refined lattice parameters 
from Rietveld refinement and single crystal determination and Rietveld agreement 
factors. 
5.2 Hydrogen bonds geometry in fumaric acid:nicotinamide (Å and °). 
5.3 The results from a number of DE calculations with variation in F (mutation rate) and 
NP (population size). For each epoch the final Rwp (in %) is given and figures within 
brackets indicate at which generation convergence was achieved. The gold cell 
indicates the lowest Rwp achieved and the starting point for the successful structure 
refinement. Runs that have not converged by the maximum allowed number of 
generations are shaded grey. 
5.4 Lattice parameters from the LeBail fitting of fumaric acid:nicotinamide. ∆L/L0 values 
are given in square brackets. 
5.5 Rietveld lattice parameters of fumaric acid:nicotinamide 
__________________________________________________________________________________
List of tables 
 
5.6 Linear thermal expansion co-efficients of the lattice parameters of fumaric 
acid:nicotinamide. 
5.7 Initial lattice parameters, DE structure solution parameters and single crystal 
determination. 
5.7 Hydrogen bonds geometry in maleic acid:nicotinamide (Å and °). 
5.8 The results from a number of DE calculations with variation in F (mutation rate) and 
NP (population size). For each epoch the final Rwp (in %) is given and figures within 
brackets indicate at which generation convergence was achieved. Runs that have not 
converged by the maximum allowed number of generations are shaded grey. Runs 6-9 
the preferred orientation was set to 1.64575  in the [001] direction. 
5.9 Hydrogen bonds geometry in maleic acid:nicotinamide (Å and °). 
5.10 Lattice parameters from the LeBail fitting of maleate:nicotinamide product A. ∆L/L0 
are given in square brackets 
5.11 Lattice parameters from the Rietveld fitting of maleate:nicotinamide product A. 
∆L/L0 are given in square brackets 
5.12 Linear thermal expansion co-efficients of maleate:nicotinamide 
5.13 Single crystal parameters of maleate:isonicotinamide 
5.14 Hydrogen bonds geometry in maleate:isonicotinamide (Å and °). 
 
6.1 Solvent screen of oxamic acid 
6.2 Initial lattice parameters, DE structure solution parameters, refined lattice parameters 
from Rietveld refinement and single crystal determination and Rietveld agreement 
factors 
6.3 Hydrogen bond geometry in oxamic acid, Å and ° 
6.4 Indexed lattice parameters of oxamic acid form II 
__________________________________________________________________________________
List of tables 
 
6.5 The results from a number of DE calculations with variation in F (mutation rate) and 
NP (population size). For each epoch the final Rwp (in %) is given and figures within 
brackets indicate at which generation convergence was achieved. Each run has been 
classed as either cis or trans.  
6.6 The results from a number of DE calculations with variation in F (mutation rate) and 
NP (population size). For each epoch the final Rwp (in %) is given and figures within 
brackets indicate at which generation convergence was achieved. 
6.7 The results from a number of DE calculations with variation in F (mutation rate) and 
NP (population size). For each epoch the final Rwp (in %) is given and figures within 
brackets indicate at which generation convergence was achieved 
6.8 Linear thermal expansion co-efficients of the lattice parameters of oxamic acid 
 
 
 
 
 
 
  
__________________________________________________________________________________ 
List of equations 
 
 
List of Equations 
 
1.1 Bragg’s law 
1.2 Reverse Fourier transform of the diffraction pattern 
1.3 % Rwp, yiobs is the experimentally observed intensity at a value of 2θ and yicalc is the 
calculated intensity at 2θ. 
1.4 The creation of a trial structure from members of the preceding population. K is the 
recombination factor and F is the mutation factor  
1.5 Gibbs free energy of a system  
1.6 Where Cv is equal to the heat capacity, R (ideal gas constant), h (planck constant), k 
(Boltzmann constant), T (temperature in K), υ (frequency) 
1.7 Lennard Jones empirical function 
1.8 a) Linear thermal expansion of a material where L0 and is the original length, ∆L is 
the change in the length and α is the thermal expansion co-efficient 
b) Linear thermal expansion of a material where V0 is the original volume, ∆V is the 
change in the volume and α is the thermal expansion co-efficient 
2.1 yi(calc) calculation used to in the calculation of % Rwp 
2.2 Contribution of the m
th
 Bragg peak to the intensity at point i 
3.1 Transparency shift error 
4.1 Linear thermal expansion at constant pressure L0, is the shortest length recorded dL 
and δT are the change in length and temperature respectively over the temperature 
range 
 
 
__________________________________________________________________________________ 
List of equations 
 
 
 
 
 
 
 
 1. Introduction 
  1 
1.0 Introduction  
 
Crystallography is defined in the Oxford English dictionary as the branch of physical 
science which treats the structure of crystals and their systematic classification. The 
etymology of the word crystallography derives from the Greek, Κρύσταλλος (crystal) 
and γραφίά (writing). The modern day field of crystallography celebrates its centenary 
in 2012, after the work of Max von Laue demonstrated that X-rays were 
electromagnetic in nature and were diffracted by crystalline materials. However, the 
interest in crystals and their properties has long preceded the mathematical approach 
developed by Laue, as crystals have long been admired for their ascetically pleasing 
nature and their debatable mystical power.  
The field of crystallography is ever expanding, mainly due to the rapid development 
of technology that complements the field; whether it is that of more sensitive 
instrumentation or greater computer power, aiding with the running of structure 
solution algorithms. The field can truly be considered to be multidisciplinary as it 
crosses many scientific interfaces, illustrated by the award of the Nobel Prize for 
chemistry in 2009 to Ramakrishnan, Steitz and Yonath for the studies of the structure 
and function of the ribosome 1, 2 using protein crystallography.  
The Nobel Prize for physics in 2009 was awarded to the inventors of the charge-
coupled device (CCD), Willard Sterling Boyle and George Smith3; a discovery that 
has vastly improved the detection of diffracted X-rays. 
Crystallography has shaped many scientific advances in the 20th century, as it enables 
us to position atoms in three dimensions. In the context of molecular materials, the 
arrangement and packing of molecules within the crystal structure controls the 
macroscopic properties of the molecular crystalline solid. Armed with this vital 
structural information, chemists can aim to manipulate the crystalline structure in 
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order to deliver molecular solids with preferential physical and chemical properties; in 
effect “crystal engineering”. 
Molecular crystallography is the central approach encompassing the research 
contained within this thesis. Crystal engineering approaches are employed in the 
design of the materials covered here and both powder and single-crystal diffraction 
used to investigate the resulting materials. The solution of crystalline structure from 
powder X-ray diffraction still remains a non-trivial task and hence a comparison of 
the two techniques is used. The ability to use pxrd effectively in these cases allows the 
solid state chemist to probe systems potentially inaccessible via traditional single 
crystal approaches.   
1.1 The fundamentals of crystalline solids 
A crystalline solid contains a three dimensional periodic long-range order. The 
smallest repeating unit of a crystalline solid is known as a unit cell. The unit cell is 
defined by three vectors a, b and c, which form a parallelepiped (figure 1.1). The 
three vectors are intercepted by three angles α, β, and γ.  The whole extended 
crystalline structure can be reproduced by translational symmetry of the unit cell in all 
directions. If each molecule was to be represented by a single point, the resulting 
regular array of points, repeating in nature, connected by translational symmetry, 
would be known as the lattice of the structure. 
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Figure 1.1: Unit cell parallelepiped 
 
Within the unit cell there is a sub-unit known as the asymmetric unit. The asymmetric 
unit often describes the structural motif within a unit cell, which after the application 
of the symmetry operations (i.e. rotation, reflection, inversion and translation) allowed 
by the space group, generates the complete crystal structure. The asymmetric unit may 
contain one or more molecules, or even a fraction of a molecule if the molecule 
contains symmetry within itself.  
The combination of both reflection and rotation symmetry implies restrictions onto 
the lattice parameters of the unit cell. The result of these restrictions is that crystalline 
solids can broadly be sub-divided into seven crystal systems (Table 1.1). In addition 
to the seven crystal systems there are four lattice types known as primitive (P), body 
centred (I), face-centred (F) or C-centred (A, B, C), as shown in figure 1.2.  
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Table 1.1: The seven crystal systems 
Crystal System Unit cell dimensions Bravais lattices Essential symmetry  
Cubic a = b = c 
α = β = γ = 90˚ 
P, I, F Four C3 axes 
Hexagonal a = b ≠ c 
α = β = 90 ˚, γ = 120 ˚ 
P One C6 axis 
Trigonal a = b = c 
α = β = γ  ≠ 90˚ 
P (R)  One C3 axis 
Tetragonal a = b ≠ c 
α = β = γ = 90˚ 
P, I One C4 axis 
Orthorhombic a ≠ b ≠ c 
α = β = γ = 90˚  
P, C, (A), I, F Three C2 axis 
and/or mirror 
planes 
Monoclinic a ≠ b ≠ c 
α = β = 90 ˚ ≠ β 
P C (I) One C2 axes and/or 
mirror plane 
Triclinic a ≠ b ≠ c 
α ≠ β ≠ γ  
P None 
 
 
        i)   ii)      
iii) iv)    
Figure 1.2: Lattice types, i) Body centred (I), ii) Primitive (P), iii) C centred, iv) F 
centred  
 
 
 
 1. Introduction 
  5 
1.2 Space groups 
Whereas a point group is the complete collection of all symmetry points passing 
through a central point describing the symmetry of a single individual object, a space 
group is the complete collection of all symmetry elements that describe an infinitely 
repeating pattern. By combination of the 7 crystal systems, 14 Bravais lattices and the 
32 point groups, we are able to define 230 unique space groups.  
 
1.3 X-ray diffraction from crystalline solids 
X-ray diffraction from crystalline solids is an established phenomenon discovered by 
a German physicist, Max von Laue in 1912, who was interested in the way light and 
crystals interacted with one another. Von Laue demonstrated mathematically that 
X-rays were diffracted by crystalline materials and established that X-rays are 
electromagnetic in nature. He received the Nobel Prize in physics in 1914 for this 
work.  Subsequent work allowed Sir William Bragg and his son Sir Lawrence Bragg 
to establish a new area of science which led to the analysis of crystal structure by the 
means of X-ray diffraction. The use of X-rays as a device for discovering the precise 
three dimensional crystal structure of molecular solids was entirely due to the Braggs 
and their work was recognised by the award of the Nobel Prize, jointly to father and 
son, in 1915.     
It was shown that electromagnetic radiation (X-rays) with a wavelength similar to that 
of interplanar distances (d) in crystal planes (of the order 1Å) incident on planes of 
atoms, results in X-rays being scattered both constructively and deconstructively.  
Bragg’s law (equation 1.1) is the central to diffraction as it gives the geometric 
conditions under which a diffracted beam can be observed. The Bragg model as 
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shown in figure 1.3, can be seen as the reflection of the incident radiation by parallel 
planes of atoms. The planes which are defined by Miller indices (hkl) will only give 
rise to constructive interference when the second beam, which has travelled the extra 
distance of AB + BC, is an integral (n) multiple of the wavelength (λ). 
 
 
Figure 1.3 The geometric conditions required for Bragg diffraction 
 
θλ sin2dn =  
Equation 1.1: Bragg’s law 
 
The standard source of laboratory X-rays is the X-ray tube. X-rays are produced when 
electrons decelerate as a consequence of hitting a metal target in an evacuated 
enclosure (most commonly copper or molybdenum). Electrons are drawn to the target 
as a highly positive charge is kept on the target/anode. Most of the kinetic energy is 
converted into heat but a small amount of the kinetic energy causes an electron in a 
core atomic orbital to be ejected. An electron from a higher orbital fills the core hole 
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and the resulting drop in energy results in emission of radiation of a definite 
wavelength. Several transitions are possible producing a broad spectrum of 
background radiation, with a series of intense maxima. In the case of a Cu anode, 
CuKα1,2, transitions produce a maxima at wavelengths(λ) equal to 1.54433 and 
1.54051 Å respectively. Metal filters or monochromators can be used to select the 
required wavelength.  
More intense X-rays can be produced from a synchrotron storage ring in which 
electrons moving at relativistic speed are contained by magnetic fields. The radiation, 
which is emitted tangentially at numerous stations situated just off the storage ring, 
from which X-rays that are produced are both tuneable and of a higher flux4. 
X-rays interact with electrons in a solid and hence X-ray diffraction gives a 
measurement of electron density within a unit cell of a crystalline system. The X-rays 
are scattered from the electron cloud surrounding an atom at the same frequency as 
the primary beam, known as Thomson scattering, and are collected on a detector. In 
the forward direction (2θ = 0˚) all the electrons scatter X-rays in the same phase, but 
as 2θ increases, the intensity of the scattered X-rays decreases due to destructive 
interference. The value of the scattering factor is therefore proportional to the number 
of electrons in the atom, and therefore small organic molecular materials are not good 
X-ray scatterers.   
 
1.4 The crystallographic phase problem 
A diffraction pattern is related to the Fourier transform of the electron density (see 
equation 1.2). Thus it should be straightforward to obtain the electron density from 
the diffraction pattern, and hence solve the crystal structure.  
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Equation 1.2: Reverse Fourier transform of the diffraction pattern 
 
The image of electron density, )(xyzρ  is obtained by adding all of the diffracted 
beams with their correct amplitudes and phases. The intensity of the scattered 
radiation (X-rays) is directly proportional to the square modulus of the structure 
factor. The diffraction pattern gives only information on intensities and no 
information on the associated phases of the intensities, thus eluding to the 
crystallographic phase problem, where it is not possible to calculate the reverse 
Fourier Transform from the diffraction pattern. In traditional crystallographic 
approaches the phase problem is solved using ‘direct methods’5 in which statistics and 
probability are employed to compute the values of the phases. In a centrosymmetric 
system the phase choice is 0 or π, whereas for a non-centrosymmstric system may lie 
anywhere between 0 and 2π. 
 
1.5 Single crystal vs. powder diffraction 
Single crystal X-ray diffraction experiments require a crystal of a certain quality and 
size in order to successfully obtain diffraction data that will lead to an accurate 
structure solution. A preliminary rotational image is often taken before the collection 
of intensities to assess the quality of the crystal. This preliminary data may also be 
used to index the crystal system which in turn deciphers the orientation matrix 
selected for the collection of further data. To record the intensity of individual 
reflections from lattice planes (hkl) the crystal is systematically moved in three 
dimensions (Φ, Ω, 2θ) with respect to the beam. The resulting diffraction data are 
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resolved into three dimensional reciprocal space, with the relative positions of the 
diffraction maxima used to determine the lattice parameters of the unit cell. The 
intensities of the diffraction maxima are determined by the structure factor 
modulus )(sF . After data collection, corrections concerning instrumental factors, 
polarization effects, X-ray absorption and potential crystal decomposition, are applied 
to the entire structure. A simple schematic of single crystal diffraction is shown by 
figure 1.4. 
 
Figure 1.4: Diffraction from an oriented single crystal 
 
In powder X-ray diffraction (pxrd) there are many crystallites that satisfy the Bragg 
criterion for diffraction from planes (hkl). Hence, unlike single crystal X-ray 
diffraction in which the diffraction maxima are resolved into three dimensions, cone-
shaped Debye rings are formed (Figure 1.5). The diffraction data is collected by 
taking a slice through the Debye ring along 2θ. This process compresses three 
dimensional data into one dimension (2θ) and results in the inherent problems 
associated with pxrd data, peak overlap. This can be a particular problem when 
probing molecular materials with large unit cells and low symmetry, as this 
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combination leads to a high density of peaks. The inability to extract accurate 
integrated peak intensities I(s) and accurate peak positions from pxrd results in the 
structure solution process being challenging and more limited in terms of the 
complexity of analysis possible in comparison to single crystal diffraction. 
 
 
Figure 1.5: Diffraction cones of scattered X-rays, diffracted from a powder sample. 
 
Structures solved via this route are often less precise and of lower accuracy to that of 
single crystal structures. However, pxrd data is a vital source of information if good 
quality crystals of the system under investigation cannot be grown, or the method of 
synthesis is not conducive to the production of good-quality crystals, i.e. when using 
mechanochemical synthesis (section 1.18). Powder diffraction is often used in cases 
where there are problems in crystal growth, twinning, or where extreme experimental 
conditions are required.   
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1.6 Preferred orientation 
There are however problems that can arise with the powder sample itself. An ideal 
powder sample contains crystallites in random orientations ensuring that not one 
orientation is artificially more likely to satisfy the Bragg diffraction criterion than 
other. Preferred orientation occurs when some orientations are favoured and occur 
more in the sample. This phenomenon is more likely to occur with certain crystallite 
morphologies, e.g. anisotropic crystallites (long needles or flat platelets). If preferred 
orientation does occur, certain reflections related by a particular set of Miller indices 
within the diffraction pattern, will be distorted in terms of intensity. This compounds 
the problems encountered when extracting intensity information needed in the 
structure solution process as the intensities do not arise purely from atomic positions. 
The powder structure solution approach based on the traditional process of extracting 
intensities from the diffraction pattern is affected more by the presence of preferred 
orientation than with direct space approaches (section 1.13) as the inclusion of a 
structural model can restrict the impact of preferred orientation in subsequent 
refinement. 
In order to avoid preferred orientation, sample preparation is very important. 
Commonly, the occurrence of preferred orientation can be minimised (or better 
detected) using a capillary in the packing of the powder sample. This geometry is 
favourable over a flat disc in the case of plate-like crystals which tend to align 
themselves parallel to the surface of the disc. In a capillary, more random packing of 
the crystallites leads to more ideal sample. Other experimental approaches include 
mixing the sample with an amorphous material, grinding to reduce the anisotropic 
nature of the crystals, and spray drying6. 
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However, powder samples containing a high amount of preferred orientation can still 
be fully structurally characterised using pxrd data, as illustrated in the structure 
solution of oxamate:nicotinamide (section 4.2). This is often done through the use of 
Rietveld refinement which can be used to model the effect of preferred orientation 
effectively with the March-Dollase function7. 
 
1.7 Structure solution from powder diffraction 
Structure solution from pxrd is intrinsically a difficult problem as discussed in section 
1.5. The motivation behind the advancement and development of full structural 
solution of organic molecular materials from pxrd is that many small organic 
molecular materials cannot be prepared as good-quality crystals. 
A pxrd experiment contains the same information as a single crystal experiment but 
the data is compressed into one dimension (2-theta) resulting in peak overlap. This 
problem is further compounded as many organic molecular materials often contain a 
large unit cell and low space group symmetry which results in a higher number of 
unique peaks with distorted intensities.  
Traditionally, pxrd it most commonly used as a qualitative method of phase 
identification, e.g. fingerprinting of materials or analysis of mixtures. However, due to 
the rapid development in the power of X-ray sources (e.g. synchrotron radiation), 
detectors e.g. imaging plates and charged coupled devices and computational structure 
determination methods, pxrd has been used to determine an ever growing number of 
increasingly complex crystal structures. Single crystal X-ray diffraction remains the 
technique of choice, but powder methods have advanced significantly over the last 
decade6, 8.  
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The overall process of structure determination from pxrd can be sub-divided into three 
distinct sections (figure 1.6): 
1) Indexing of the unit cell from peak positions in the diffraction data and space 
group assignment from systematic absences. 
2) Structure solution; location of approximate atomic positions from peak 
intensity data. 
3) Structure refinement, most commonly using the Rietveld profile-fitting 
method9.  
 
 
Figure 1.6: A flow diagram outlining the processes involved in structure solution from 
pxrd.  
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1.7.1 Indexing 
Indexing a powder diffraction pattern successfully aims to determine the correct unit 
cell parameters and crystal class of a sample. The process of indexing can often be the 
defining step in the overall process of crystal structure solution from pxrd. If a unit 
cell cannot be determined, the rest of the structure determination process cannot 
continue. Many indexing algorithms have been developed including TREOR9010, 
ITO11 and DIVCOL9112. These reproduce peak positions generated from possible sets 
of lattice parameters. A figure-of-merit such as M20
13 is used to rank the generated 
lattice parameters. In this thesis, a suite of indexing algorithms, CRYSFIRE14 has 
been used.  
Peak overlap can make the selection of precise positions of reflections difficult in a 
diffraction pattern, but there are other factors which can prevent fast and reliable 
indexing. The presence of an impurity phase will lead to problems as the peaks used 
for indexing are not indicative or reliable. A common source of error is also 
introduced by the zero-point correction of the diffractometer, where the position of 
the sample in real terms is different to the calibrated position. This error may be 
estimated and corrected for by the use of internal and external standards. 
Due to the nature of some solid-state molecular synthesis approaches, for example 
liquid assisted grinding, poor quality powder samples may be produced, resulting in 
peak broadening, further exaggerating the issue of peak overlap in the diffraction 
pattern. 
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1.7.2 Space group assignment 
 A space group may be assigned to a crystal system by methodically assessing the 
systematic absences in the diffraction pattern. Due to the symmetry restraints related 
to specific space groups, some reflections (hkl) will be systematically absent from the 
diffraction pattern, regardless of unit cell contents. To allow unambiguous space 
group assignment, peaks need to distinguishable from one another in the case of 
conventional laboratory data (at least 0.05˚ in 2θ). 
 If systematic absences are not explicit in defining a space group the structure solution 
step may be run with a selection of possible space groups. Complementary solid state 
techniques, such as solid state NMR (nuclear magnetic resonance) 15, aid in space 
group assignment as the number of molecules present in the asymmetric group of the 
unit cell can be determined.  
 
1.7.3 Pattern decomposition 
When the correct unit cell has been identified through indexing, a ‘structureless’ 
refinement (LeBail16 or Pawley17), known as pattern decomposition is used to achieve 
a more accurate description of the lattice parameters, zero-point and pseudo-voigt 
peak shape. Diffraction maxima are established along with instrumental settings that 
account for zero point error through a series of least squares refinement cycles. Unlike 
a Rietveld refinement, the peak intensities are also treated as refinable variables. If the 
pattern decomposition step is completed satisfactorily, the information is then used in 
the structure solution step and will allow for the final model to be more stable in the 
final refinement.  The process of pattern decomposition produces a “target” agreement 
factor (% Rwp) which the structure solution (and refinement) steps are aiming towards. 
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The pattern decomposition also extracts integrated intensities from the pattern that 
could be used in a direct methods structure solution or a chi-squared based direct 
space approach. 
 
1.7.4 Structure solution  
Two distinct approaches are taken towards structure solution from pxrd; traditional 
methods and the direct space approach. The traditional approach is based on methods 
used in structure solution from single crystal X-ray diffraction, where individual 
intensities (I(hkl)) are extracted from individual reflections directly from the powder 
diffraction pattern. One problem with this approach is that of peak overlap (refer to 
section 1.9) and the inability to extract reliable intensities. However, the approach has 
been successful in the structure solution of molecular materials from pxrd18-20. 
The second and more recently developed approach to solving crystal structure from 
pxrd is a ‘direct space’ approach. In this technique a “trial” structure is produced in 
isolation to that of the experimental powder diffraction pattern. A suitable figure-of-
merit indicator (in our case % Rwp) is used to compare the similarity of the trial 
structure and the experimental diffraction pattern. The R-factor is taken from the 
Rietveld program9 and compares the whole digital diffraction profile (equation 1.3).  
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Equation 1.3: % Rwp, yiobs is the experimentally observed intensity at a value of 2θ and 
yicalc is the calculated intensity at 2θ, wi is the weight assigned to the intensity 
associated with data point i. 
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A term quoted throughout chapters 4, 5 and 6 is χ2 (equation 1.4 & 1.5), which 
describes the goodness of fit of an observed distribution (experimental diffraction 
pattern) against a theoretical one (model produced diffraction pattern).  
( )[ ] 21/'exp' ∑−=−= iie ywPNectedRR   [Equation 1.4] 
ewp RR /
2 =χ      [Equation 1.5]  
Equation 1.4: Re, P is the number of parameters adjusted, N is the number of 
observations, wi is the weight assigned to the intensity associated with data point I, yi 
is the experimentally observed intensity at a value of 2θ 
 
Equation 1.5: χ2 is equal to the square of the ratio of Rwp over Re 
 
 
Reliable peak shape parameters and accurate lattice parameters are calculated in the 
pattern decomposition process is performed by LeBail16 or Pawley17 approaches) and 
this information is key to the calculation of a reliable Rwp indicator. 
The measure of structural complexity also differs in both approaches; in the 
traditional approach the number of atoms in the asymmetric unit defines the difficulty 
of the problem, whereas in the direct space approach it is the number of variables 
involved in the problem that sets the complexity. The variables required to define a 
structure in a direct space solution can be grouped into three sections; the position of 
the molecule in the unit cell (x,y,z), the orientation of the molecule (θ,Φ,Ψ), and the 
molecular conformation where freely rotating sections of the molecule are taken into 
account. The hypersurface of Rwp is defined by the set of variables described above 
and hence incorporates prior crystallographic and chemical knowledge. This acts to 
reduce the dimensionality of the hypersurface (rather than treating individual atoms) 
making the structure solution more efficient.  
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This study concentrates on the differential evolution direct space approach to solving 
crystal structures using pxrd. There are several other types of direct space approaches 
that can be found in the literature that use various optimisation techniques to search 
the hypersurface, such as Monte Carlo21-26, simulated annealing27-31, genetic 
algorithms32-35 and grid searches36-40. All of these approaches have been successful in 
correctly solving crystal structures from pxrd data, but vary widely in terms of 
computational efficiency. 
 
1.7.5 Differential evolution 
Differential evolution (DE) is an evolutionary algorithm that is widely used in the 
optimisation of real space parameters41, 42. It is a population based optimisation 
technique that uses a concept of fitness (% Rwp) to find a global minimum. DE 
maintains a population of trial structures by producing offspring from trial structures 
through a combination of mutation and recombination (equation 1.6). 
 
Offspring = Parent + K (Random1- Parent) + F ( Random 2- Random 3) 
Equation 1.6: The creation of a trial structure from members of the preceding 
population. K is the recombination factor and F is the mutation factor. 
 
At the start of the calculation, the trial structures are spread across the hypersurface, 
as structural parameters for each trial structure are chosen at random. This will lead to 
the production of distinct and diverse offspring as the initial vectors between members 
of the population are likely to be large. As the calculation progresses the population 
will become more alike and less diverse, leading to the shortening of vectors and 
resulting in convergence of the calculation. 
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In the DE, each member of the population produces a trial (or offspring) structure 
which is assessed for its fitness using % Rwp (equation 1.3) as the experimental 
powder diffraction pattern is compared with that simulated from the trial structure. 
Each member of the population produces an offspring using equation 1.4. If the 
offspring is fitter than its parent, then the offspring replaces the parent in the 
population, the opposite is true if the parent is fitter than its offspring. This 
deterministic approach gives efficient convergence. After each generation is 
completed, both mean and best % Rwp are calculated and the next generation 
commences in which the process is repeated. Convergence is achieved when the mean 
and best % Rwp are equal, i.e. when the population of structures are the same. The DE 
technique produces a structure which is only the starting point for Rietveld 
refinement9; in which more flexible structural features are often introduced. More 
details of the DE and its implementation are given in chapter 2.   
 
1.7.6 Rietveld refinement  
As mentioned above, the starting point for a Rietveld refinement9 is a crystal structure 
which has been generated by structure solution, in this case from the DE. In order for 
a refinement to be successful, the crystal structure generated from the DE will have to 
be close to, or a good description of, the final structure. The refinement considers 
every point in the powder diffraction pattern as an individual intensity, and then 
compares it to the diffraction pattern simulated by the model, using % Rwp as a figure 
of merit (equation 1.3). Individual parameters that define the structure (e.g. atomic 
coordinates) are adjusted by a series of least-square refinements in order to achieve 
the optimal fit between the two diffraction patterns. Geometric restraints are typically 
used in a refinement and are 0.01 (tight restraints) on bonds to hydrogen atoms and 
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0.05 (soft restraints) on bonds between non-hydrogen atoms. The restraints are based 
on standard molecular geometries derived from prior chemical knowledge43; this bias 
will ensure that the final refined model will be chemically acceptable. Refinements 
which contain soft restraints generally allow a more stable refinement in the case of 
molecular structures than those without. 
Rietveld refinement can be carried out using a number of different programs; GSAS44, 
TOPAS45, FULLPROF46 and RIETAN47 are amongst the most popular in the 
crystallographic community. For a refinement to be deemed successful it must satisfy 
three criteria; (i) the model must produce a pattern which is in good visual agreement 
with that of the experimentally produced diffraction pattern, (ii) the agreement factor 
(% Rwp) must be close to that of the agreement factor produced from the pattern 
decomposition step (Lebail16 or Pawley) and (iii) the crystal structure must make both 
visual and structural sense. In the case of the structures considered in this thesis, this 
latter check is often judged on expected or predictable hydrogen bond network 
(chapters 4 and 5). Refinements are often unsuccessful and unstable but this may not 
always indicate an incorrect model. This may instead be due to poor quality data or 
sample effects such as preferred orientation which interferes with reflection intensity 
(see experimental section 3). However, it is important the input model from the 
structure solution is of sufficient quality or the refinement will fail.  
 
1.8 Polymorphism 
Crystalline polymorphism (Greek: poly = many, morph = form) is a comparatively 
established area of solid state chemistry that continues to attract considerable 
academic and industrial attention. As with most areas of science, an all encompassing 
definition is often hard to assert, but a working definition was given by McCrone48 “a 
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solid crystalline phase of a given compound resulting from the possibility of at least 
two different arrangements of the molecule of that compound in the solid state”. This 
phenomenon challenges the field of the organic solid state and our understanding of 
crystal packing, intermolecular interactions and crystal growth.  
The explosion in the volume of research into the phenomenon of polymorphism has 
followed the rapid development of solid state research techniques, e.g. faster data 
acquisition in X-ray crystallography in conjunction with the advancements in other 
solid state techniques such as infra-red spectroscopy, NMR and Raman spectroscopy. 
The occurrence of polymorphism is significant both academically and industrially as 
the ability of a molecule to adopt more than one crystal structure often leads to 
significant variation in physical properties such as melting points, bioavailability, 
chemical stability and solubility.  
The stability of polymorphic forms is dependent on relative free energy; the most 
stable system having the lower free energy. The most prominent polymorphic form 
experimentally may not be the most thermodynamically stable, as kinetic factors may 
also play a role. The thermodynamic relationship between polymorphic forms may be 
represented by the equation 1.7 below; 
 
G = H – TS 
Equation 1.7: Gibbs free energy of a system 
 
At 0 K the ‘TS’ term disappears, at which, the most stable polymorphic form has the 
lowest energy.49  
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In a review by McCrone it was proposed48, that “the number of forms known for a 
given compound is proportional to the time and money spent in research on that 
compound”. This is probably still true as there remains a lack of control of 
polymorphic behaviour and only limited understanding of polymorphic systems. 
Despite much research still to be done in this area, polymorphism is not a rare 
occurrence, as confirmed by the incidence of polymorphism reported in the 
Cambridge Structural Database (CSD) where one third of APIs (active pharmaceutical 
ingredients) display polymorphic behaviour50. Even though there are many recorded 
instances of polymorphism in the CSD, the control and prediction of the occurrence of 
multiple crystal forms for an API is still a goal for pharmaceutical manufacture; i.e. 
the selection of the most thermodynamically stable polymorph and the ability to 
manufacture it consistently51. “Disappearing polymorphism” is an interesting and well 
documented phenomenon52, 53 in which polymorphic forms of materials are isolated 
and characterised. These forms subsequently disappear and are unable to be isolated, 
even when exhaustive polymorphic screens are conducted. This phenomenon has 
served only to increase the ‘mystique’ around polymorphic behaviour and is 
obviously of great concern industrially, however, with modern research techniques 
some cases of disappearing polymorphism are being resolved54.  
The discovery of a new polymorph of an API may not need to be a problem; it allows 
pharmaceutical companies to patent new intellectual property. In the UK, the inventor 
needs to establish that the new crystal modification offers considerable difference in 
physical and biological properties49. There have been many well documented cases of 
polymorphism which have transcended chemistry to the legal world.  
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1.9 Structure prediction 
In 1985, Maddox stated, "One of the continuing scandals in the physical sciences is 
that it remains impossible to predict the structure of even the simplest crystalline 
solids from knowledge of their composition55. "  
Even though this quote is over twenty years old, the field of crystal structure 
prediction remains a challenging prospect. The goal of crystal structure prediction is 
to be able to predict the full crystal structure given only the structure of the molecule. 
The ability to do this, in a reliable and robust fashion, would circumvent any need for 
expensive experimental exhaustive polymorph screening of new materials. The 
successful prediction of the most thermodynamically stable crystal structure of a 
material and any potential polymorphs will ensure pharmaceutical companies avoid 
the problem of a product converting to a different polymorphic form which happens 
to be thermodynamically more stable. This would avoid potential costly patent 
challenges and product recalls such as Ritonovair53. Crystal structure prediction may 
also be used as a tool to design systems which possess desired crystal habits or 
properties56 based on their relationship with intermolecular interactions and crystal 
growth.  
The quote from Maddox still remains unsatisfied, as crystal structures still remain 
unpredictable on the whole, however, blind tests57-60 organised by the Cambridge 
Crystallographic Data Centre (CCDC) have shown some measured success and 
developments in the field.  
An example where experimental and crystal structure prediction have complimented 
each other is given by Hulme61. Before this study only one polymorphic form of 5-
fluorouracil (used in chemotherapy) was known. Through crystal structure prediction 
calculations it was shown that another polymorph had the potential to be accessed 
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experimentally as it was close, energetically, to the known form. A second polymorph 
was subsequently successfully isolated experimentally and structurally characterised 
corresponding to the predicted second form. 
Unfortunately, the global minimum of an energy landscape does not always reliably 
indicate the experimentally obtained polymorph of the material. Crystal structure 
prediction approaches consider only thermodynamic factors, neglecting 
experimentally based considerations such as crystal growth and solvent effects. The 
crystal structure prediction calculations are traditionally run at 0 K and hence no 
thermal effects are taken into account. This difference in temperature affects the 
relative stability of the polymorph observed but it also has to be considered when 
analysing any predicted structure. Typically, the unit cell volume expands with 
increasing temperature, although movement in molecular orientations often dictated 
by steric considerations can lead to small decreases in lattice parameters. The lattice 
parameters of predicted structures can be parameterised to room temperature by 
applying thermal expansion coefficients, but many crystal structures behave 
anisotropically. This also leads to problems when comparing powder diffraction 
patterns from an experimental structure and that simulated from predicted structures 
when validating or rationalising prediction results. 
 
1.10 Thermal behaviour  
The study of intermolecular forces and the crystal packing of molecules in the 
crystalline state are of fundamental importance in the design and understanding of the 
bulk behaviour of small organic molecules. A significant amount of qualitative 
information on these intermolecular interactions can potentially be determined from 
investigation of the thermal behaviour of a material. 
 1. Introduction 
  25 
The heat capacity of a molecular solid signifies the energy absorbed by the crystal 
during heating. A theoretical approach developed by Einstein in 1907 (equation 1.8), 
assumed that each atom vibrates about its equilibrium position at a certain frequency 
(υ). By employing Plancks quantisation assumption, Einstein was able to predict 
observed experimental trends.     
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Equation 1.8: Where Cv is equal to the heat capacity, R (ideal gas constant), h (planck 
constant), k (Boltzmann constant), T (temperature in K), υ (frequency) 
 
Traditionally, atoms are thought to vibrate from their equilibrium position in a crystal 
structure in a harmonic fashion. If this description were to be true, then the 
equilibrium atomic position will be invariant of temperature.    
 
 
Figure 1.7: A symmetric vibronic harmonic oscillator 
 
However, as most materials expand on heating, this indicates that the model of a 
simple harmonic oscillator moving in a classical symmetric potential (figure 1.7) is 
not a good portrayal of intermolecular interactions and distances. This model is 
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invariant of temperature and hence an asymmetrical description of the potential is 
used e.g: Lennard-Jones (equation 1.9); 
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Equation 1.9: Lennard Jones empirical function 
 
The r-12 term represents the repulsive component and the r-6 term the attractive part of 
the function, σ is the collision diameter and ε is the well depth. 
When the temperature of a substance changes, the energy that is stored in the 
interactions between atoms changes. When this increases, so does the length of the 
molecular bond. Hence, solids typically expand upon heating and contract upon 
cooling, although, there are many reported cases of negative thermal expansion62, 63. 
The response of the material to temperature change is expressed as its co-efficient of 
thermal expansion, which can be represented as both a linear or volumetric co-
efficient (equation 1.10a and 1.10b); 
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Equations 1.10a: Linear thermal expansion of a material where L0 and is the original 
length, ∆L is the change in the length and α is the thermal expansion co-efficient.  
 
Equations 1.10b: Linear thermal expansion of a material where V0 is the original 
volume, ∆V is the change in the volume and α is the thermal expansion co-efficient 
 
Anistropic thermal expansion is most common in molecular materials with low 
symmetry as the thermal behaviour is distributed unequally across the three axes with 
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the angles between these axes (e.g. in monoclinic or triclinic systems) subject to 
thermal changes. Newman’s principle64 states that the symmetry elements of any 
physical property of a crystal must include the symmetry elements of the point group 
of that material. The relationship between thermal behaviour, structure and 
intermolecular interactions will be investigated in this thesis by powder diffraction. A 
similar qualitative study has discussed this relationship in the structure of glipizide.65  
 
1.11 Forms of organic solids 
The classification and definition of organic solid state form is an important process 
that has promoted much debate66-70. The dendogram shown in figure 1.8, illustrates 
the level of complexity associated with this classification and indeed the variation of 
properties that are available for a particular molecular component. In addition to these 
shown below there are hydrates and solvates of varying stoichiometry both for the 
form itself and any cocrystal of that form. Although all these variants of solid form 
may display consistent solution chemistry, in terms of solid-state chemistry they must 
be treated as an independent or new material. As the results in this thesis are focussed 
on cocrystal and salt formation the subsequent discussion will be limited to these 
types of material. 
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Figure 1.8: The classification of organic solids71. 
 
1.11.1 Cocrystals vs. Salts 
Salt formation and more recently co-crystallisation of APIs represent alternative solid 
forms that provide a route to physical properties that can deliver more desirable 
therapeutic capabilities. The cocrystal in particular represents an approach in which 
the physical properties can be enhanced whilst retaining the chemical properties of the 
individual components within the cocrystal.   
There has been a lively discussion in the literature70, 72, 73 regarding a definition that 
gratifies all areas of crystallography and solid state pharmaceutical chemistry. A 
widely excepted definition was given by A.B. Aakeröy74 in which he defines co-
crystalline materials as “materials that are constructed from homogenous crystalline 
materials that contain two or more neutral building blocks that are present in definable 
stoichiometric amounts”. This serves to make a clear distinction between cocrystals 
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and the ideology behind co-crystallisation, however, is not a new one, the first 
mention of the term “co-crystal” was in 196375. 
A key aspect to the definition used above, is the consideration of two or more neutral 
building blocks in which case the material is a cocrystal. If the proton has transferred 
from the acid to the base as shown in figure 1.9, the resulting complex is termed a 
salt. 
 
Figure 1.9: Classification of a cocrystal (left) and a salt (right) 
 
Does the position of the hydrogen atom within these materials affect its physical 
properties? Initial work by Aakeröy74 has shown that it does, hence the importance of 
the definition and the distinction between a cocrystal and a salt in the crystallographic 
community. This study was based on a statistical analysis of over 80 salts and 
cocrystals, with the aim of being able to prepare multi-component molecular materials 
with expected stoichiometries and thus promoting particular heterosythons which 
could control the physico-chemical properties. When a salt had been formed, 45% had 
unexpected stoichiometry and/or chemical composition (solvate) compared to that of 
cocrystal formation which had only 5% with unexpected stoichiometry. Even though 
the statistical pool of structures analysed was small, this general trend demonstrates 
one advantage of using cocrystals rather than salts in pharmaceutical formulation. 
It is widely accepted that reaction between an acid and a base with a ∆pKa (∆pKa = 
pKa (base) – pKa (acid)) greater than 3 a is likely to produce a salt76. As with all 
general rules, great care must be taken if using ∆pKa as a predictive tool for the 
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propensity of a proton transfer between the acid and the base, as pKa is the negative 
logarithm of the acid dissociation in solution and not the solid state. Based upon 
experimental evidence 76, 77, if the system is in the range 0 < ∆pKa < 3 crystallisation 
can produce a salt, cocrystal or a disordered material, with the precise location of the 
proton highly dependent upon the packing and local steric environment. For example 
the pKa of oxamic acid, isonicotinamide and nicotinamide (chapter 4) are 2.5, 3.4 and 
3.6 respectively. This places both the oxamic acid:nicotinamide and oxamic 
acid:isonicotinamide multi-component materials in the 0 < ∆pKa  < 3 range. Based on 
∆pKa the outcome is uncertain, whether salts, cocrystals or a disordered materials. 
Physical effects such as temperature, stoichoimetric ratio of the starting materials and 
the choice of solvent of crystallisation can have a substantial effect on the salt 
cocrystal continuum. A variable temperature neutron study of a pentachlorophenol/4-
methlypyridine complex78 showed that the proton moved closer to the oxygen and 
hence became more neutral in character with increasing temperature. This behaviour 
was also observed with a urea:phosphoric acid 1:1 salt, in which the proton migrated 
toward to the phosphate oxygen, becoming centred between the base and the acid at 
elevated temperatures79. It is also reported that more polar the solvent selected for the 
crystallisation medium, the higher the probability of a salt being formed.80 In acid-
base pairs with a small ∆pKa, it is possible to observe different stoichoimetric ratios 
giving different ionization states.81 As pKa, solvent, temperature and stoichiometric 
ratio of the starting materials all play a role in determining the position of the acidic 
proton in the salt cocrystal continuum, manipulation of these variables can lead to an 
intuitive synthetic strategy in the production of a salt or cocrystal, but the unique 
molecular environment of each material will affect the amount of proton transfer 
observed.   
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It is clear that the ability to locate the precise position of the proton in these materials 
is important. The lack of resolution afforded by conventional pxrd experiments means 
that this technique alone is not sufficient to fully classify a new multi-component 
material as a salt or cocrystal. Complementary techniques will be employed within 
this project in order to achieve full structural classification. In previous studies, the 
extent of proton transfer has been determined from single crystal X-ray and neutron 
diffraction82 and by the consideration of bond lengths and angles of atoms involved83. 
Infra-red spectroscopy is also used to aid classification of organic molecular 
materials, based on the observation of O-H, N-H and COOH signals83. Disorder can 
often lead to ambiguous solid state classification, as the proton has partial occupancy 
on both the acid and the base; within these types of adduct a continuum exists 
between the extremes of the salt and the cocrystal.84 
 
1.11.2 Cocrystal applications 
Figure 1.10 clearly illustrates the increased awareness interest and research into 
organic molecular co-crystals over the last decade. The increase in number of 
structures submitted to the CSD may also be attributed to the advances made in 
crystallographic techniques. 
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Figure 1.10: Frequency of occurrence of organic molecular co-crystals in the 
Cambridge Structural Database from 1988 to 2007. For the purposes of this graph, co-
crystals are distinct from solvates, hydrates, and simple salts.85  
 
In recent studies, molecular cocrystals have been shown to make improvements in 
bioavailability86-88, humidity resistance89 and mechanical stability90 of APIs. A 
demonstration of the enhancement of physical properties is shown via the co-
crystallisation of three new pharmaceutical co-crystals of the API fluoxetine (the 
active ingredient in the antidepressant drug Prozac) with three organic acids, this 
approach highlights the viability of crystal engineering, as all three organic acids use a 
hydrogen bond to a chloride ion to form a more stable molecular species which have 
different solubility and dissolution rates to that of the API fluoxetine91. 
Regardless of the enhancement of physical properties, there remains no marketed drug 
products that manipulate the advantages of co-crystallisation92 (although there are 
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products close to release)93. This may be due to the production of a metastable form 
which could manifest itself in the product lifecycle, which in turn could have 
detrimental effects on bioavailability or manufacturing processes for example or 
simply due to the many years to get a new pharmaceutical to market or the potential 
hesitancy for the pharmaceutical industry to develop a new class of form with their 
APIs. The need for both academic and industrial research into the ever developing 
area of co-crystallisation, therefore, remains valid.      
 
1.11.3 Cocrystal synthesis 
A number of synthetic methods have been successfully used in the synthesis of co-
crystalline materials including; solution recrystallisation, sonic slurry and 
mechanochemical techniques (check section 1.18). However, this search for co-
crystals and the scaling up of their production in an industrial setting is a non-trivial 
task. Solution recrystallisation is a well established purification technique, whereas 
cocrystallisation via the same route involves the introduction of two or more materials 
in to solution and the production of a crystalline phase containing both components, 
rather than two phases each of a single component. Regardless of the method of 
synthesis, the potential conformers or starting materials must contain both strong 
hydrogen bond donors and acceptors of which a compatible combination is preferable, 
in order to form intermolecular interactions.     
For solution mediated cocrystallisation to be a success, the solubilities of the starting 
materials need to be comparable to prevent the crystallisation of one cocrystal former 
before cocrystallisation can take place94. A ternary phase diagram illustrates the 
complexity of a solvent mediated co-crystallisation of a binary system. The 
solubilities of the starting materials are integral to these phase diagrams, as 
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differences alter the morphology of the phase space region in which the formation of a 
co-crystal formation is thermodynamically favourable.  
 
A) B)  
Figure 1.11: Schematic representations of isothermal ternary phase diagrams with (A) 
showing similar solubilities between starting components 1 and 2 in solvent S and (B) 
showing a system with a difference between solubilities of the starting components 1 
and 2 in solvent S. Region A represents component 1 and solvent, B represents 
component 1 and cocrystal, C represents cocrystal, D represents component 2 and 
cocrystal, E represents component 2 and cocrystal and finally F represents solution.94   
 
The ternary phase diagrams shown in figure 1.11 are derived from a limited number 
of experimentally derived phase diagrams.95, 96 Alternative synthetic methods have 
been developed to circumvent this problem of non-comparable solubilities, including 
liquid (or solvent) assisted grinding (1.11.4) and sonic slurry (1.11.4) as viable and 
intuitive synthetic routes.  
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1.11.4 Reduced solvent methods for cocrystallisation 
synthesis  
Cocrystals and salts are traditionally produced by cold recrystallisation through 
solvent evaporation. This technique is favoured as it is the simplest method to scale 
up to industrial sized experiments97. However an alternative method, “solvent drop 
grinding”98 has many advantages over the traditional solvent-based method, these 
include the drastic reduction in the amount of solvent needed for a co-crystallisation 
experiment, leading to a greener route for production. The treatment and reduction of 
organic solvents is an important issue in the chemical industry as a large amount 
accrue annually.  
The mechanochemical approach to the formation of co-crystals was reported as early 
as 189399 through the formation of the quinhydrone co-crystal. This field remained 
undeveloped until work by Etter100 developed the technique in the field of 
supramolecular chemistry.  
Solvent drop grinding is an intuitively simple technique in which two starting 
materials, in stoichiometric ratios, are ground together in the presence of a minimal 
amount of solvent. Neat or dry grinding of starting materials preceded the use of 
liquid assisted grinding or solvent drop grinding, either using a pestle and mortar or a 
ball mill. Even though many successful co-crystallisations have been carried out this 
way100, it was shown that a small amount of a solvent could act with  physical effects 
(e.g. lubrication) or via the chemical properties of the solvent (e.g. formation of 
intermediates such as solvates), leading to enhanced polymorphic control, higher 
quality of crystallisation and higher yield, allowing the range of systems to be studied 
to widened101. The improved efficiency of the mechanochemical approach over that of 
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solvent recrystallisation can be attributed to the reduction in solvent competition and 
the solubilities of the starting materials.  As discussed earlier, the variation in kinetics 
between a mechanochemical approach and solvent recrystallisation can also produce 
different cocrystal form such as stoichiometry or solvation.    
In conjunction with liquid assisted grinding a “sonic slurry” method has also been 
incorporated as a method of producing molecular cocrystals. The use of ultrasound to 
form co-crystals, with the starting material suspended in a minimum amount of 
solvent, avoids the inherent differences in the solubilities of the starting materials 
because the formation of the new co-crystalline phase is due to the growth and 
collapse of bubbles of micrometer-sized dimensions associated with intense, short 
lived heating and pressure102. The process of crystallising, co-crystallising and 
screening for solid pharmaceutical forms was patented in 2007 by Childs103. 
 
1.11.5 Cocrystal Design 
To aid intensive cocrystal screening, the development of robust supramolecular 
strategies and computational techniques to predict the formation of cocrystals is also 
increasingly important. Overall, it appears that computational energy landscapes can 
predict that the majority of cocrystals are more stable than their components. 
However, cocrystallisation does not show a dramatic increase in stabilisation on a 
lattice energy scale, with the increase in stabilisation only being comparable to a 
polymorphic energy difference. Current investigations104, 105 raise the concern with the 
approximations used in the evaluation of relative energies and the kinetic factors 
involved in the formation of cocrystals. Our understanding of the factors that govern 
the formation of hydrogen bonding motifs and direct packing motifs are also still 
evolving. The most common self assembly approach is that postulated by Etter100, 106 
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and establishes a hierarchy or ranking of potential supramolecular synthons based on 
the best donor group bonding to the best acceptor group. The aim of ‘crystal 
engineers’ is to manipulate and develop strategies (such as Etters Rules) to select 
systems which display robust preferential synthons. 
The successful synthesis of multi-component systems relies on the preferential 
formation of heteromeric synthons rather than the formation of strong interactions 
within the individual components of the cocrystal formers. Carboxylic acids and 
amides are two commonly used functional groups in crystal engineering because they 
from robust hydrogen bond networks via both O—H---O and N—H---O dimers107 and 
are therefore good candidates for the formation of multi-component molecular 
networks. 
Both isonicotinamide and nicotinamide have demonstrated the propensity for 
cocrystal formation with a range of carboxylic acids 108-112, showing a preference for 
the formation of a heteromeric acid-pyridine hydrogen bond (A in figure 1.12). The 
formation of synthon A was correctly proposed by Aakeroy112 using the self assembly 
rules formulated by Etter for a carboxylic acid:isonicotinamide cocrystal. The 
guidlines proposed by Etter106 are: 
1) All good proton donors and acceptors are used in hydrogen bonding 
2) Six-membered-ring intramolecular hydrogen bonds form in preference to 
intermolecular hydrogen bonds 
3) The best proton donors and acceptors remaining after intramolecular 
hydrogen-bond formation form intermolecular hydrogen bonds to one another. 
A synthon energy calculation conducted by Vishweshwar 108 also illustrated the 
preference for formation of synthon A over an acid-amide bond and homomeric 
hydrogen bonding. The stoichiometry of the starting materials has also been shown to 
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have an effect on other hydrogen bonding networks observed in these acid-amide 
systems. Those formed with a monocarboxylic acid in 1:1 or a dicarboxylic acid in a 
2:1 ratio show a preference for the formation of synthon B, whereas cocrystals with 
the dicarboxylic acid in a 1:1 ratio tend to form synthon C. Synthons D and E are both 
homomeric, with D being an acid-acid synthon and E an amide-pyridine synthon. All 
these synthons are shown below in figure 1.12 and form the basis of many of the 
materials covered in this thesis. 
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Figure 1.12: Potential synthons found in acid-amides cocrystals 
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1.12 Aims 
The aim of the work reported in this thesis is to investigate many areas of organic 
molecular crystallography; from the development of solvent free synthetic methods on 
both binary and multi-component molecular systems, to the full structural 
characterisation of these materials by both single and powder X-ray diffraction. 
Spectroscopic techniques will be used to complement the classification of the 
materials under investigation. Further structural insight will be probed by a study of 
the thermal behaviour of each material over the range 100-295 K. Research into areas 
of both industrial and academic importance are presented here, as the materials 
studied address important aspects of polymorphic and cocrystalline behaviour. The 
work reported in this thesis aims to; 
• To synthesise a number of new multi-component materials; oxamic 
acid:nicotinamide, oxamic acid:isonicotinamide, fumaric acid:nicotinamide, 
maleic acid:nicotinamide and maleic acid:isonicotinamide. 
• Investigate the use of “reduced solvent” synthetic methods for these multi-
component and binary structures. 
• Use pxrd to solve the crystal structure of these a number of multi-component 
systems, using complementary techniques to aid in the classification (salt or 
cocrystal) of the system.  
• Make a direct comparison of structures solved by powder and single crystal 
diffraction to evaluate the reliability of structure solution from pxrd in this 
type of material. 
• Assessment of the DE algorithm in application to multi-component systems 
and optimisation of the control parameters and efficiency of the algorithm. 
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• Comparison of structures formed by isomers isonicotinamide and 
nicotinamide. 
• Investigate the thermal behaviour of these systems over the range 100-295 K 
and relate the anisotropic expansion to the crystal packing of the material. 
• Investigate the polymorphic behaviour of oxamic acid, using neutron, single 
and powder diffraction, and relate these results to predication.  
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2. Methodology  
 
 
2.1 Variable temperature X-ray diffraction 
 
2.1.1 Software and data handling 
 
X-ray powder diffraction data collected as a RAW file was converted to a UXD 
format using Diffract file exchange [XCH] and an in-house Perl-based converter used 
to create data files (GSA, XDD) that are required for input into other crystallographic 
software. 
Information about previously published crystal structures (as in the case of 5-
fluorouracil) was downloaded from the Cambridge Structural Database (CSD) in the 
form of crystallographic information files (CIF) format
1
. The CIF was opened in 
Mercury
2
 for the generation of a powder diffraction pattern and to be used as a 
diagnostic test to confirm that the experimental pattern contained no chemical or 
physical impurity and was of the same phase as that previously reported. The unit cell 
parameters from the CIF were then used as a starting point for the LeBail profile 
fitting procedure in GSAS
3
. In cases where the previously published crystal structure 
had been determined at room temperature, this set of lattice parameters was used as a 
starting point for the LeBail fit. The lattice parameters produced from the room 
temperature LeBail fit were in turn used as a starting point for 250 K data and the 
process repeated sequentially down the temperature range. 
 
2.2 Structure solution from X-ray powder diffraction 
As discussed in the introduction, the determination of crystal structures from pxrd is 
an intrinsically difficult task, predominately due to the problem of peak overlap. The 
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approach taken in this thesis was to fully structurally characterise materials from 
powder X-ray diffraction using a direct space evolutionary algorithm approach based 
on DE (differential evolution). 
Prior to the direct space calculation, unit cell indexing (1.7.1) space group assignment 
and pattern decomposition (i.e. LeBail) (1.7.3), are completed in order to fully 
describe the unit cell parameters and peak profile characteristics that remain constant 
throughout the calculation. Any errors introduced to the structure solution process at 
this stage will be transmitted into the direct space search, alluding to a false solution.  
An XDD file was created via the in-house Perl-based converter and opened in XFIT
4
. 
The XFIT
4
 program was used to determine the positions of the peaks required for 
indexing, and this information was used in the CRYSFIRE
5
 program. CRYSFIRE
5
 is 
used to run a suite of indexing programs, the results are collated in a summary file. 
All possible unit cells are then listed in order of merit. To verify that the lines selected 
in XFIT
4
 are generated by a specific unit cell, Chekcell
6
 was used. The space group 
was then determined by examining the systematic absences in the diffraction pattern 
and then verifying the space group by international crystallographic tables and 
Chekcell
6
. The GSA file was read into GSAS
3
 via the EXPGUI platform. Background 
points in the diffraction pattern were also identified via the EXPGUI.  
% Rwp (equation 1.3) is the driving force behind the DE calculation, but a 
disadvantage of this is that it is a computationally expensive cost function. One of the 
main advantages of DE as an experimental optimisation technique is that the cost 
function is derived from a physical experiment, in this case a powder diffraction 
pattern. The calculation for % Rwp in this work is the same as that used in the Rietveld 
refinement (which follows the direct space calculation). This is one advantage of 
using % Rwp as the cost function, as direct comparisons can be made in “fitness” 
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between the refined crystal structure and the direct space solution. Equation 2.1 is 
used to calculate yi(calc) in a % Rwp calculation. 
2
,)()( ∑+=
m
miii Fmsbgycalcy φ  
Equation 2.1: yi(calc) calculation used to in the calculation of % Rwp 
 
Where yi(bg) is the background intensity at the i
th
 data point, s is the scale factor, Fm  
is the modulus of the structure factor of the m
th
 Bragg peak, mi,φ is the contribution of 
the m
th
 Bragg peak to the intensity at point i, which is calculated by equation 2.2 
below; 
mimimmi ALpmM ,, )22( θθσφ −=  
Equation 2.2: Contribution of the m
th 
Bragg peak to the intensity at point i. 
Where Mm is the reflection multiplicity, Lpm gives a description of the peak shape and 
the Lorentz-polarization correction, Ai,m represents the peak symmetry and 
( )mi θθ 22 −  is the profile function of the m
th
 Bragg peak. 
This direct space approach implicitly considers the extraction of individual structure 
moduli directly from the diffraction pattern, % Rwp, is a whole profile optimization 
function with the pattern digitalised to intensities at each point in the diffraction 
pattern. This approach results in an expensive cost function due to the size of 
calculation required when compared to the extraction of )(sF  values directly from 
the diffraction pattern. 
In order to increase the efficiency and speed of the DE calculation, many aspects of 
the calculation remain constant and unaltered throughout the whole search, unit cell 
parameters and the peak profile parameters, which are a result of a combination of 
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indexing and pattern decomposition, remain constant.  mi,φ  and yi(bg) also remain 
fixed.  
The calculation of the cost function can also be reduced using other assumptions. The 
absorption of X-rays by the sample can be neglected as organic samples have a low 
absorption co-efficient and powder samples are nominally thin. X-ray extinction is not 
calculated as the sample is thin and therefore the crystallite length falls within the 
extinction length (Pendellösung period). The final calculation that can be omitted is 
the March-Dollase correction which tackles the problem of preferred orientation 
(section 1.6). This correction is mostly commonly applied at the refinement stage, but 
in severe cases can be introduced as a variable parameter in the % Rwp calculation to 
help guide the structure solution process.
7
 
Direct space calculations rely on chemical knowledge in order to construct the % Rwp 
hypersurface. In this work the molecular model is constructed using standard bond 
lengths and geometries
8
, using Chem3D pro (pro version 3.5.2)
9
. Trial crystal 
structures are then converted and described by a list of elements (Γ): e.g. the position 
(x,y,z) and orientation (θ,Φ,Ψ) of a molecular model in the unit cell and the 
conformation of the molecule defined by variable torsion angles (τ1…. τn). 
The implementation of the DE is incorporated into the POSSUM
10
 program package, 
along with routines for other direct space structure solution methods, such as grid 
search simulated annealing and Monte Carlo. POSSUM
10
 is a cross-platform suite 
written in Perl.  
As discussed in the introduction, DE maintains a population of trial structures using 
Equation 1.4, as offspring or trial structures are produced by a combination of vectors 
(mutation and recombination) as the hypersurface is searched. Initially, the trial 
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structures within the population are randomly distributed across the hypersurface, 
each described by a set of elements (Γ). Like many direct space methods, DE uses a 
greedy criterion to make the decision as to whether to accept the offspring trial 
structure over that of its parent in the previous generation; this is done by direct 
comparison of % Rwp. If the % Rwp of the trial structure is fitter than its parent, then it 
replaces its parent as a member of the population, otherwise the offspring is discarded 
and the parent trial structure remains in the population for the next generation. This 
‘greedy’ decision process is relatively efficient and fast, but can be prone to be 
trapped in local minima upon the hypersurface (figure 2.1).  
 
 
Figure 2.1 : An example of local minimum and the global minimum on an energy 
hypersurface 
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This problem can be overcome by using a diverse initial population and then 
searching the hypersurface using a combination of vectors (recombination and 
mutation). Due to random distribution of the initial generation of trial structures at the 
start of the DE calculation, these initial vectors will be large and distinct offspring 
will be produced (often far from the parents). As the generations progress, the 
population will become less diverse, resulting in the shortening of search vectors as 
the calculation reaches convergence (where mean and best % Rwp are equivalent). The 
production of offspring structures as presented in equation 1.4 is illustrated in figure 
2.2 and the overall DE process in figure 2.3   
 
 
Figure 2.2: Production of an offspring trial structure using a combination of variables 
of the parent (P) and randomly selected individuals (R1, R2 and R3) 
 
 
The recombination vector (K) represents the difference between genetic material from 
the parent to one random member (R1) and the mutation vector (F) represents the 
difference in parameters possessed by two random members of the population (R2 and 
R3). The mutation component is to establish significant differences between the child 
and its original parent to discourage premature convergence 
                                                         2. Methodology 
                                                                                                                                      53 
 
 
Figure 2.3 Flow diagram of the DE calculation process 
 
The relative size of the vectors i.e. the values of K and F can be altered using 
POSSUM
10
. The selection of vector size is an important decision as vector size can 
have a direct influence on the success of the direct space search and its efficiency; 
vectors which are too large can miss narrow minima, whereas vectors which are too 
small can lead to premature convergence as the direct space calculation becomes 
trapped in a local minima. Figure 2.4 shows an DE progress plot, in which 
convergence (when Rwp of mean equals the best and all the population is in the same 
place on the hypersurface) is reached at generation 1438.  
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Figure 2.4: Evolutionary progress plot for the successful solution of oxamic 
acid:nicotinamide showing the best  Rwp (blue) and the mean Rwp (pink) for each 
generation. 
 
The DE calculation also invokes boundary conditions; this keeps the search within a 
defined space and is a useful way of introducing prior crystallographic knowledge to 
direct the search (e.g. unit cell size and molecular rotational parameters). If the sum of 
the two vectors were to place a trial structure outside the pre-defined boundary 
conditions, then a mid-point function approach is invoked, where the offspring is half 
way between the parameter value of the parent and the boundary value that has been 
exceeded. 
DE searches can also be influenced by previous calculations by “seeding” the search. 
Seeding is incorporated by including the genetic information values for each 
parameter of up to 5 different solutions that look promising from previous 
calculations. This reduces the search space as the seeded DE will use ‘good’ 
parameter values as a starting point. 
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3. Experimental 
 
3.1 Instrumentation  
The following instruments were used for X-ray powder diffraction data collection: 
3.1.1 Bruker AXS D5000 high-resolution powder diffractometer  
The sample was ground using a pestle and mortar and mounted onto a flat disc with 
transparent tape, creating a circular area within the centre of the disc of approximately 
10mm in diameter. The instrument was set in transmission mode with a position-
sensitive detector covering 8˚ in 2θ using a Cu radiation source CuKα1 1.54056 Å (Ge 
monochromated). Data was collected using several different ranges and scan times. 
The shorter runs were collected over a 2θ range from 10˚ ≤ 2θ ≤ 45˚ over 40 minutes 
and measured in steps of 0.020240˚ in 2θ, with an overnight scan from 10˚ ≤ 2θ ≤ 85 
˚and measured in steps of 0.020375˚ in 2θ. 
 
3.1.2 Bruker AXS D5005 high-resolution X-ray powder diffractometer 
This instrument was set in reflection mode with a position-sensitive detector covering 
8˚ in 2θ using a Cu radiation source, CuKα 1.5418 Å. The low temperature stage used 
on this diffractometer was an Oxford Instruments CCC1101T. Data sets were 
collected over the range of 10˚ ≤ 2θ ≤ 45˚, measured in steps of 0.014102˚ over a total 
collection time of three hours. Each sample was run at the following range of 
temperatures 10, 50, 100, 150, 200, 250 and 295 K. The sample was ground using a 
pestle and mortar and using tape was attached on the reverse side of the sample 
holder.  
This modification was made in order to reduce zero point and transparency effects in 
the data (section 3.1.4) 
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3.1.3 Sample effects using the Bruker AXS D5005 high-resolution X-ray powder 
diffractometer  
The organic samples investigated here are affected by transparency. Transparency is 
caused by the penetration of the X-ray beam into the sample, effectively lowering the 
level of the diffraction surface with penetration depth being a function of Bragg angle. 
This affects the observed peak positions in the resulting diffraction pattern. As a 
consequence, there is a reduction in the quality of the data produced as a zero point 
error is effectively invoked. The effect of transparency is enhanced in organic samples 
are they display low absorbance of X-rays. Equation 3.1 shows the correction for 
transparency shift error, where µeff is the effective linear absorption coefficient and R 
the goniometer radius. 
 
                                                      
effR
p
µ2
1
=                                          [Equation 3.1] 
The problem of zero point error is enhanced further if the crystalline sample contracts 
anisotropically as the temperature is lowered and therefore the powder level does not 
remain in the calculated position. This problem of sample displacement leads to a 
shift in peak positions in the diffracted pattern, incorporating errors into the process of 
unit cell parameters calculation.  
To counter these effects of transparency and thermal contraction, the sample holder 
was inverted and the sample mounted onto the brass stage as a thin layer within tape, 
as shown in figure 3.1. However, bespoke instrumental arrangement itself also leads 
to a zero point error, but with the distinct advantage of being constant throughout the 
temperature range in which the crystalline sample was investigated. The brass peaks 
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that appear in the diffraction pattern from the sample holder can easily be taken into 
account when analysing the data1.  
 
a) Traditional approach 
 
b) Modified setup 
Figure 3.1: Diagram showing the techniques used to mount the sample onto the 
sample holder for collection of low-temperature data on D5005. 
 
Preferred orientation is another sample effect that can lead to artificially intense or 
weak Bragg peaks in the diffraction pattern. In a ‘perfect’ powder sample with no 
preferred orientation the crystallites need to be randomly distributed throughout the 
sample, allowing all orientations to occur to satisfy the diffraction condition.  
It is a combination of the instrumental geometry and the morphology of the crystals 
that determines the amount preferred orientation observed; the more anisotropic 
morphologies such as needle and plate like crystals suffer most from preferred 
orientation. In reflection mode (as in D5005), the crystallites often align themselves 
parallel to the sample bed, with very few crystallites aligning themselves 
perpendicular to the sample holder. Preferred orientation may be reduced, not 
completely, by careful sample preparation and placing of sample onto the stage, for 
example, mixing with amorphous silica, spray drying and grinding2. Experimental 
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setups, such as sample geometry can help to evenly distribute the orientations of 
crystallites, i.e. flatplates/capillaries.      
 
3.1.4 Bruker AXS D5000 high-resolution powder diffractometer fitted with 
Oxford Cryostream and capillary stage 
Due to the detrimental sample effects discussed in the previous section, additional low 
temperature data were collected on the Bruker AXS D5000 in a capillary setup. To 
record low temperature data, an Oxford crysostream 700 series was attached to the 
diffractometer. The cryostream has a temperature range of 80-500 K. The cryostream 
does not reach as low temperatures as achieved by the D5005 setup; due to the quality 
of the data produced, the crystream and capillary stage was the preferred option. 
Liquid nitrogen is drawn up, via a vacuum insulated transfer line, into the coldhead of 
the cryostream. Once inside the coldhead, the liquid nitrogen passes through a heater 
which boils the liquid nitrogen (77 K). The vapour flows to the heat exchanger, 
through the temperature controller, to arrive at the inlet of the pump at approximately 
10 K below room temperature. The nitrogen gas is then dried to ensure there is no 
moisture in the gas flow which would cause icing on the walls of the capillary. The 
gas flows to the Cryostream head once more where it is re-cooled. The gas 
temperature is regulated by a heater and sensor before entering the nozzle and out 
over the sample. 
As for other powder data collection, the sample was ground using a pestle and mortar. 
The sample was then transferred to the capillary and aligned on the vertical 
goniometer head. The capillary had a depth of 55 mm and a diameter of 0.5 mm. The 
instrument was set in transmission mode with a position-sensitive detector covering 8˚ 
in 2θ using a Cu radiation source CuKα1 1.54056 Å (Ge monochromated). Data sets 
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were recorded for each sample at the following range of temperatures 295, 250, 200, 
150 and 100 K.  
 
3.1.5 Bruker APEXII CCD Single Crystal diffractometer  
Single crystal data were collected off site by the EPSRC national crystallography 
service at the University of Southampton. A Bruker APEXII CCD diffractometer and 
a Bruker Kappa CCD diffractometer both at the windows of a Bruker FR591 rotating 
anode (λMo-Kα = 0.71073 Å) at 120 K, were used to collect data.  The data collections 
were driven by COLLECT3 and processed by DENZO.4 Absorption corrections were 
applied using SADABS.5 The structures were solved in SHELXS974 and were refined 
by a full-matrix least-squares procedure on F2 in SHELXL-97.4 All non-hydrogen 
atoms were refined with anisotropic displacement parameters. All hydrogen atoms 
were added at calculated positions and refined by use of a riding model with isotropic 
displacement parameters based on the equivalent isotropic displacement parameter 
(Ueq) of the parent atom. Figures were produced using ORTEP3 for Windows
6 while 
structural analysis was carried out in PLATON.7  
 
3.1.6 Perkin Elmer Pyris 1 DSC (differential scanning calorimeter) 
Thermal events were measured using a Perkin Elmer Pyris 1 DSC (Perkin Elmer 
Analytical Instruments, Norwalk, Connecticut, USA). DSC runs were performed in an 
atmosphere of flowing dry nitrogen gas of high purity (20 ml min-1) using standard 
crimped aluminium pans. The instrument was calibrated within indium. Low 
temperature DSC traces were recorded using the method shown below; 
• Hold 1.0 min at 20˚C 
• Cool from 20 ˚C to -180˚C at a rate of 5˚C/min 
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• Hold for 1.0 min at -180˚C 
• Heat from -180˚C to 20˚C at a rate of 5˚C/min 
• Hold for 1.0 min at 20˚C 
High temperature DSC traces were collected using the method shown below; 
• Hold 1.0 min at 20˚C 
• Heat from 20˚C to 240˚C at 5˚C/min 
• Hold for 1 min at 240˚C 
• Cool from 240˚C to 20˚C at 5˚C/min 
• Hold for 1 min at 20˚C 
 
3.1.7 Solid state NMR (nuclear magnetic resonance spectrometer) 
Solid-state C13 NMR data were collected off site by the EPSRC solid-state NMR 
services at Durham University. The spectra were recorded using a Varian Unity Inova 
spectrometer and a 7.5mm (rotor o.d) MAS probe. 
 
3.1.8 Solution NMR (nuclear magnetic resonance spectrometer) 
Solution state 1H NMR spectra were recorded at 300.18 MHz on a Bruker AC300 
spectrometer with a 5mm diameter quad probe using residual solvent as a reference. 
Samples were dissolved in dimethyl sulfoxide (DMSO). 
 
3.1.9 Solid state Infra-red 
Spectra were obtained in the reflectance mode using an FT-NIR spectrometer 
(Thermo Fisher Scientific, Nicolet Anatris Near IR Analyzer) equipped withan 
InGaAs detector and a quartz lamp.  
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3.1.10 High pressure liquid chromatography (HPLC) 
Analytical HPLC was performed using a Dionex summit HPLC system with 
chromeleon software. A Summit P580 quaternaty low pressure gradient pump with 
built-in vacuum degassor was used along with a Summit UVD 170s UV/VIS multi-
channel detector with analytical flow cell. The analytical column was Luna 10u C18 
(250mm x 4.6mm).  
 
3.2 Synthetic technique for cocrystal/salt synthesis 
3.2.1 Solvent mediated crystallisation 
Starting materials were dissolved in the minimum amount of solvent and the solution 
was then hot filtered. The beaker was covered with Para-film then pierced. Solid 
material was then obtained following crystallisation from solution over a period of 
time depending on the system under investigation. The solid material was then filtered 
from the solution using a Büchner funnel vacuum filtration. 
 
3.2.2 Incubator controlled solvent-mediated crystallisation 
Starting materials were dissolved in the appropriate solvent and placed inside the 
Memmert incubator (IPP400). The temperature profile of the crystallisation was 
controlled using the Memmert MEMory card interface using the Celsius 2007 
software8. The temperature profile used included (i) a temperature rise to 60 ˚C, (ii) a 
holding period of 3 hours, (iii) cooling to 20 ˚C over a period of a further 5 hours. 
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3.2.3 Liquid assisted grinding  
Stoichiometric amounts of the starting materials were placed in a mortar along with 
0.05 ml of solvent and ground together with a pestle for a period of time, ranging 
from 5 to 20 minutes. 
 
3.2.4 Slurry sonication 
Stoichiometric amounts of the starting materials were placed in a small glass vial. A 
small amount of solvent is then added to the vial which is then sonicated at room 
temperature for 10 minutes. 
 
3.2.5 Dry Grinding 
Stoichiometric amounts of the starting materials were placed in a mortar and ground 
with a pestle for a period of time, ranging from 5 to 20 minutes. 
 
3.3 Preparation and characterisation of systems under investigation 
3.3.1 Oxamic acid:isonicotinamide  
3.3.2 Synthesis 
All starting materials and solvents were purchased from Sigma Aldrich. Equimolar 
amounts of oxamic acid (0.17 g, 1.88 mmol) and isonicotinamide (0.23 g, 1.88 
mmol), in warm methanol. The mixed solution was stirred, cooled to room 
temperature and on slow evaporation of the solvent, a white crystalline solid was 
formed after 1 day and filtered from the solution. The same product was obtained 
following (i) slow recrystallisation of equimolar amounts from ethanol, (ii) liquid 
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assisted grinding for 5 minutes using 1.2577 mmol of each starting material with 0.05 
ml of methanol and (iii) sonic slurry in which 1.2577 mmol of each starting material 
was added to 5ml of solvent in a small vial and sonicated at room temperature for 10 
minutes.  
 
3.3.3 NMR analysis 
The stoichiometry of the components in the new crystalline solid was confirmed as 
1:1 from the solution 1H nmr spectrum (figure 3.2). 
 
Figure 3.2: 1H NMR of oxamic acid:isonicotinamide product (from 1:1 starting ratio) 
using DMSO as solvent. 1H NMR 300MHz (DMSO-d6):  δ = 8.90 ppm (dd, 2H), 8.4 
ppm (s, 1H), 8.21 ppm (s, 1H), 7.8 ppm (d, 4H). 
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As shown within the figure 3.2, the amide protons present on the isonicotinamide and 
oxamic acid exist in different chemical environments. This is due to the the C-N bond 
showing greater double bond character via resonance. This double bond character 
restricts free rotation around the double bond9. This is evident as two peaks are 
assigned to the amine protons, (8.4 ppm and 7.8 ppm). The same is true on the oxamic 
molecule, with two peaks assigned to the amine protons, (8.2 ppm and 7.8 ppm). 
 
3.3.4 HPLC results 
Please find the HPLC result in appendix A. The result confirmed the presence of both 
the oxamic acid and isonicotinamide in the new crystalline phase. 
 
3.3.5 DSC analysis 
The new 1:1 material was characterised by DSC (appendix B). This confirms that 
there is no phase transition from room temperature to the melt. Melting points of 
starting materials and the new adduct were measured using melting point apparatus, 
oxamic acid (210˚C), isonicotinamide (155-157˚C), oxamic:isonicotinamide (205-
207˚C)  
 
3.3.6 Preparation of sample for single crystal diffraction 
A crystal of oxamic acid:isonicotinamide was successfully grown using 0.2300 g and 
0.1677 g of isonicotinamide and oxamic acid respectively, following the incubator 
solvent-mediated crystallisation method (section 3.2.2).  
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3.3.7 Stoichiometric diversity 
The stoichiometric diversity of this system was probed using 0.2302g (2.585mmol) 
and 0.6314g (5.17mmol) of oxamic acid and isonicotinamide respectively, following 
the recrystallisation method as described above in 3.11.1. Please see appendix C, for a 
comparison of oxamic acid:isonicotinamide in 1:1 and 1:2 stoichiometries. The 
powder patterns show that 1:2 stoichiometry matches the pure isonicotinamide 
powder pattern. 
3.4 Oxamic acid:nicotinamide 
3.4.1 Synthesis  
All starting materials and solvents were purchased from Sigma Aldrich. Equimolar 
amounts of oxamic acid (0.2309 g, 2.58 mmol) and nicotinamide (0.3158 g, 2.58 
mmol), were dissolved in warm methanol. The mixed solution was stirred, cooled to 
room temperature and on slow evaporation of the solvent, a white crystalline solid 
was formed after 5 days, and filtered from solution. The same product was obtained 
following (i) slow recrystallisation of equimolar amounts from ethanol, (ii) liquid 
assisted grinding for 5 minutes using 1.2577 mmol of each starting material with 0.05 
ml of methanol and (iii) sonic slurry in which 1.2577 mmol of each starting material 
was added to 5ml of solvent in a small vial and sonicated at room temperature for 10 
minutes.  
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3.4.2 NMR analysis 
The stoichiometry of the components in the new crystalline solid was confirmed as 
1:1 from the solution 1H nmr spectrum (figure 3.3). 
 
Figure 3.3: 1H NMR of oxamic acid:nicotinamide multi-component crystal (from 1:1 
starting ratio) using DMSO as solvent. 1H NMR 300MHz (DMSO-d6):  δ = 9.10 ppm 
(dd, 1H), 8.7 ppm (d, 1H), 8.21 ppm (dt, 3H), 7.8 ppm (d, 1H) 7.7 (d, 1H), 7.5 (d, 
1H). 
 
As discussed in the case of oxamic acid:isonicotinamide the amide protons in both 
oxamic acid and nicotinamide are resolved producing two nmr singals. 
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3.4.3 HPLC result 
Please find the HPLC result in appendix A. The result confirmed the presence of both 
the oxamic acid and nicotinamide the in the new crystalline phase. 
 
3.4.4 DSC analysis 
 The new 1:1 material was thermally characterised by DSC (appendix D). This 
confirms that there is no phase transition from room temperature to the melt. The 
melting point of both starting materials and oxamic acid:nicotinamide were measured 
using melting point apparatus, oxamic acid (210˚C), nicotinamide (128˚C) and 
oxamic acid:nicotinamide (180-182˚C) 
 
3.4.5 Preparation of sample for single crystal diffraction 
A crystal of oxamic acid:nicotinamide was successfully grown using 0.23458 g and 
0.3217 g of oxamic acid and nicotinamide respectively, following the incubator 
solvent-mediated crystallisation method (section 3.2.2).  
 
 
3.5 Fumaric acid:nicotinamide 
3.5.1 Synthesis 
All starting materials and solvents were purchased from Sigma Aldrich. Equimolar 
amounts of fumaric acid (0.1829g, 1.498 mmol) and nicotinamide (0.1739g, 1.498 
mmol), were dissolved in warm methanol. The mixed solution was stirred, cooled to 
room temperature and on slow evaporation of the solvent, a white crystalline solid 
weas formed after 8 days. The same product was obtained following (i) slow 
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recrystallisation of equimolar amounts from ethanol, (ii) liquid assisted grinding for 5 
minutes using 1.2259 mmol of each starting material with 0.05 ml of methanol and 
(iii) sonic slurry in which 1.2259 mmol of each starting material was added to 5ml of 
solvent in a small vial and sonicated at room temperature for 10 minutes.  
 
3.5.2 NMR analysis 
 
Figure 1.4: NMR of fumaric acid:nicotinamide product (from 1:1 starting ratio) using 
DMSO as solvent. 1H NMR 300MHz (DMSO-d6):  δ = 13.2 ppm (s, 2H), 9.10 ppm 
(dd, 1H), 8.7 ppm (d, 1H), 8.21 ppm (dt, 1H), 8.19 ppm (s, 1H) 7.8 ppm (d, 1H) 7.6 
(d, 1H), 6.6 (d, 2H). 
 
 
The stiochoimetric ratio of fumaric acid and nicotinamide was confirmed by the 
integration of peaks from the 1H NMR (figure 3.4). 
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3.5.3 Melting point analysis 
The new phase was thermally characterised by measuring the melting point. This was 
found to be 171-172°C and compares to that of the starting materials, 287°C and 
128°C for fumaric acid and nicotinamide respectively. 
 
3.5.4 Preparation of sample for single crystal diffraction 
A single crystal of fumaric acid:nicotinamide was successfully grown using 0.2421 g 
(2.0858 mmol) and 0.2547 g of fumaric acid and nicotinamide respectively, and 
following the incubator solvent-mediated crystallisation method (section 3.2.2).  
 
3.5.5 Stoichiometric diversity  
The stoichiometric diversity of the system was probed with 1(fumaric acid): 
2(nicotinamide), using 0.2518068 g of fumaric acid and 0.531 g (4.34mmol) of 
nicotinamide, following the recrystallisation method (3.5.1). Please see appendix E 
for X-ray powder diffraction. 
 
3.6 Maleic acid:nicotinamide 
3.6.1 Synthesis (product A) 
All starting materials and solvents were purchased from Sigma Aldrich. Equimolar 
amounts of maleic acid (0.2309g, 2.58 mmol) and nicotinamide (0.3158g, 2.58 
mmol), were dissolved in warm ethanol. The mixed solution was stirred, cooled to 
room temperature and on slow evaporation of the solvent, a white crystalline solid 
was formed after 2 day. The same product was obtained following (i) slow 
recrystallisation of equimolar amounts from ethanol, (ii) liquid assisted grinding for 5 
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minutes using 0.931 mmol of each starting material with 0.05 ml of ethanol and (iii) 
sonic slurry in which 0.931 mmol of each starting material was added to 5ml of 
solvent in a small vial and sonicated at room temperature for 10 minutes.  
 
3.6.2 NMR analysis (product A) 
 
Figure 3.5: 1H NMR of maleic acid and nicotinamide product A multi-component 
crystal (from 1:1 starting ratio) using DMSO as solvent. 1H NMR 300MHz (DMSO-
d6):  δ = 9.10 ppm (dd, 1H), 8.7 ppm (dd, 1H), 8.21 ppm (dt, 2H), 7.8 ppm (d, 1H) 7.6 
(d, 1H), 6.2 (d, 2H). 
 
The stiochoimetric ratio (1:1) of maleic acid:nicotinamide product A was confirmed 
by the integration of peaks from the 1H NMR. No hydroxyl signal was detected for 
maleic acid in the spectra, this due to the propensity of the hydroxyl proton to 
exchange with the water in the highly hygroscopic DMSO and the hydrogen bonding 
afforded by the close proximity of the hydroxyl groups in the maleic acid molecule.  
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3.6.3 DSC analysis (product A) 
The new 1:1 material was thermally characterised by DSC (appendix F). This 
confirms that there is no phase transition from room temperature to the melt. The 
melting point of both starting materials and maleic acid:nicotinamide were measured 
using melting point apparatus, maleic acid (131˚C), nicotinamide (128˚C) and oxamic 
acid:nicotinamide (116-117˚C). 
 
3.6.4 Preparation of sample for single crystal diffraction (product A) 
A single crystal of maleic acid and nicotinamide product A was successfully grown 
using, 0.2213 g (1.907 mmol) and 0.2329 g of maleic acid and nicotinamide 
respectively, following the incubator solvent-mediated crystallisation method (section  
3.2.2). 
 
3.6.5 Synthesis (product B) 
All starting materials and solvents were purchased from Sigma Aldrich. Equimolar 
amounts of fumaric acid (0.2309g, 2.58 mmol) and nicotinamide (0.3158g, 2.58 
mmol), were dissolved in warm methanol. The mixed solution was stirred, cooled to 
room temperature and on slow evaporation of the solvent, a white crystalline solid 
was formed after 5 day (maleic acid and nicotinamide, product A). The crystallites 
were left in solution for a further 7 days and yellow crystallites had formed (maleic 
acid, product B). The same product (product B) was unattainable from (i) slow 
recrystallisation of equimolar amounts from ethanol, (ii) liquid assisted grinding for 5 
minutes using 0.915 mmol of each starting material with 0.05 ml of methanol and (iii) 
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sonic slurry in which 0.915 mmol of each starting material was added to 5 ml of 
solvent in a small vial and sonicated at room temperature for 10 minutes.  
 
3.6.6 NMR analysis (product B)  
The stiochoimetric ratio (1:1) of maleic acid:nicotinamide product B was confirmed 
by the integration of peaks from the 1H NMR. Unlike the 1H NMR of product A, a 
hydroxyl signal is present at 13.2 ppm. The presence of the hydroxyl signal suggests 
the isomerisation10 of maleic acid to the trans isomer, fumaric acid. 
 
Figure 3.6: 1H NMR of maleic acid and nicotinamide product B (from 1:1 starting 
ratio) using DMSO as solvent. 1H NMR 300MHz (DMSO-d6):  δ = 13.2 (s, 2H), 9.10 
ppm (dd, 1H), 8.7 ppm (dd, 1H), 8.21 ppm (dt, 2H), 7.8 ppm (d, 1H) 7.6 (d, 1H), 6.2 
(d, 2H). 
 
3.6.7 DSC analysis (product B) 
The new 1:1 material was thermally characterised by DSC (appendix G). This 
confirms that there is no phase transition from room temperature to the melt. The 
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melting point of both starting materials and maleic acid:nicotinamide product B were 
measured using melting point apparatus, maleic acid (131˚C), nicotinamide (128˚C) 
and oxamic acid:nicotinamide (171-172˚C). 
 
3.6.8 Preparation of sample (product B) for single crystal diffraction 
A crystal of maleic acid:nicotinamide product B was successfully grown using 0.2050 
g (1.766 mmol) and 0.2156 g of maleic acid and nicotinamide respectively, following 
the incubator solvent-mediated crystallisation method (section 3.2.2). 
 
3.7 Maleic acid:isonicotinamide 
3.7.1 Synthesis 
All starting materials and solvents were purchased from Sigma Aldrich. Equimolar 
amounts of the two starting materials maleic acid (0.2867g, 2.47 mmol) and 
isonicotinamide (0.3021g, 2.47 mmol), were dissolved in warm methanol. The mixed 
solution was stirred, cooled to room temperature and on slow evaporation of the 
solvent, a white crystalline solid was formed after 2 days. The same product was 
obtained following (i) slow recrystallisation of equimolar amounts from ethanol, (ii) 
liquid assisted grinding for 5 minutes using 1.3150 mmol of each starting material 
with 0.05 ml of methanol and (iii) sonic slurry in which 1.054 mmol of each starting 
material was added to 5ml of solvent in a small vial and sonicated at room 
temperature for 10 minutes.  
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3.7.2 NMR analysis 
The stiochoimetric ratio (1:1) of maleic acid:isonicotinamide was confirmed by the 
integration of peaks from the 1H NMR. As described in section in 3.6.2, no signal is 
seen for the hydroxyl protons in maleic acid.  
 
Figure 3.7: 1H NMR of oxamic acid and isonicotinamide multi-component crystal 
(from 1:1 starting ratio) using DMSO as solvent. 1H NMR 300MHz (DMSO-d6):  δ = 
8.90 ppm (dd, 2H), 8.4 ppm (s, 1H), 8.21 ppm (s, 1H), 6.2 ppm (d, 2H). 
 
 
3.7.3 Preparation of sample for single crystal diffraction 
A crystal of maleic acid:isonicotinamide was successfully grown using, 0.2147 g 
(1.8502 mmol) and 0.2259g of maleic acid and nicotinamide respectively, and 
following the incubator method (section 3.2.2). 
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3.8 Succinic acid:nicotinamide 
3.8.1 Synthesis  
All starting materials and solvents were purchased from Sigma Aldrich. Equimolar 
amounts of the two starting materials succinic acid (0.2300g, 1.94 mmol) and 
nicotinamide (0.2378g, 1.94 mmol), were dissolved in warm methanol. The mixed 
solution was stirred, cooled to room temperature and on slow evaporation of the 
solvent, a white crystalline solid was formed after 3 days. Powder X-ray diffraction 
patterns of starting materials and new multi-component phase are shown in appendix 
H.  
 
3.9 Adipic acid:nicotinamide 
3.9.1 Synthesis 
All starting materials and solvents were purchased from Sigma Aldrich. Equimolar 
amounts of the two starting materials adipic acid (0.180g, 1.23 mmol) and 
nicotinamide (0.1504g, 1.23 mmol), were dissolved in warm methanol. The mixed 
solution was stirred, cooled to room temperature and on slow evaporation of the 
solvent; a white crystalline solid was formed after 5 days. Powder X-ray diffraction 
patterns of starting materials and new multi-component phase are shown in appendix 
I. 
 
3.10 Oxamic acid 
3.10.1 Solvent mediated recrystallisation 
Oxamic acid was purchased as a white powder (≥ 96 % pure) from Sigma Aldrich. 
The possibility of polymorphic behaviour of oxamic acid was investigated by 
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conducting a solvent screen, which included solvent mediated crystallisation (section 
3.2.1) of oxamic acid from a plethora of solvents.  
 
3.10.2 Neutron powder diffraction 
Neutron powder diffraction data were collected using the BT-1 32 detector neutron 
powder diffractometer at the NIST Center for Neutron Research reactor, NBSR. A 
Cu(311) monochromator with a 90° take-off angle, λ = 1.5402(1) Å, and in-pile 
collimation of 15 minutes of arc were used. Data were collected over the range of 3-
168° 2θ with a step size of 0.05°. 
The sample was loaded in a vanadium can sample container of length 50 mm and 
diameter 9.2 mm. Data were collected under ambient conditions. 
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4.0 Cocrystallisation of oxamic acid:isonicotinamide 
and oxamic acid:nicotinamide 
 
Within this chapter, the co-crystallisation or adduct formation of oxamic acid with 
both nicotinamide and isonicotinamide will be attempted. All of these materials are 
considered as GRAS (generally recognized as safe) and are FDA (Food and Drug 
Administration) approved. Oxamic acid itself has useful medicinal properties, in that 
it can affect the role of glycolysis in the growth of tumour cells1.  To date, the crystal 
structure of oxamic acid is still unpublished, however it has been reported2 that 
oxamic acid could potentially be an impurity in various APIs, hence the full structural 
characterisation of the molecule is important (chapter 6.0). 
Isonicotinamide (pyridine-4-carboxamide) has been shown to act as a robust building 
block within a multi-component crystal3-6 and is a strong candidate as a potential 
component in a multi-component crystal with a suitable API. Isonicotinamide is low 
cost, widely available, has a low melting point (155-157 °C) and a molecular weight 
under 300 amu. All these factors are considered in a pharmaceutical screening process 
and allow for the screen to be a cheaper and more efficient process7. Nicotinamide (3-
pyridinecarboxamide) is also a well established co-crystal former8-12and is also a 
vitamin (B3). The molecular diagrams of all three individual components are given in 
figure 4.1. 
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(i) (ii) (iii)  
Figure 4.1: Molecular diagrams of (i) oxamic acid, (ii) isonicotinamide and (iii) 
nicotinamide 
 
As discussed in the introduction, both isonicotinamide and nicotinamide have 
demonstrated their affinity for cocrystal formation with carboxylic acids. In addition 
the generation of a well defined hierarchy of supramolecular synthons makes their 
behaviour in this chapter potentially predictable (figure 1.12). Oxamic acid itself is 
also a useful architectural unit when designing hydrogen bonding synthons. The 
molecule contains both strong hydrogen bond acceptors (in the form of the carbonyl 
oxygen atoms) and donors (in the form of a hydroxyl oxygen and amide nitrogen). In 
other multi component materials contained in the CSD, oxamic acid is present in salt 
form, (oxamate). The tendency of an acid to give up a proton to form an acid-base 
complex is measured by the negative logarithm of the acid dissociation constant, pKa. 
Typically13, a difference of 2 to 3 pKa units often results in the formation of a salt. 
However the application of an aqueous based measurement such as pKa to a solid 
state situation must be considered when using the differences in pKa as a predictive 
tool in solid salt or neutral cocrystal formation. Potential dimeric synthons formed by 
the oxamate anion are shown in figure 4.2. 
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Figure 4.2: Potential dimeric sythons for the oxamate unit.  
 
The other remaining hydrogen bond sites are available for providing a cross-link 
between neighbouring 1-D motifs creating a 2-D scaffolding. These architectures 
have been presented previously14 and introduced as acid-acid(I), amide-acid (II) and 
amide-amide (III) synthons. Oxamic acid also lends itself well as a possible candidate 
to undergo polymorphic transitions and as a useful stepping-stone in the design of 
hydrogen-bonded supramolecular architectures. 
 
4.1 Characterisation of oxamic acid and isonicotinamide  
Pxrd was used to confirm that the product of crystallisation (1:1, methanol) was a new 
crystalline phase, and did not contain any of the two starting materials (figure 4.3). 
The stoichiometric ratio of the two starting materials was confirmed by 1H NMR 
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(section 3.3.3) and the presence of both materials in the new crystalline system was 
confirmed by HPLC (section 3.3.4). 
Figure 4.3: Powder X-ray diffraction patterns of the starting materials, oxamic acid 
(orange) and isonicotinamide (red) and the oxamic acid:isonicotinamide multi-
component material(black) 
 
 
Infra-red spectroscopy was performed on the new crystalline phase and compared to 
that recorded from a mixture of starting materials. The spectra of the two are 
significantly different, alluding to the synthesis of a new multi-component crystal 
with different hydrogen-bonding characteristics to that of the component mixture, 
(figure 4.4). The presence of two broad peaks at 2444 cm-1 and 1884 cm-1 is 
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characteristic of an acid----N heterocylic hydrogen bond, and is viewed as evidence 
for multi-component crystal formation. The absence of such bands would be 
interpreted as a lack of multi-component formation15. In terms of classifying the 
multi-component crystal as a salt or cocrystalline material from this data, it has been 
illustrated in the literature16 that if an acidic proton is transferred to a heterocyclic 
nitrogen, very broad peaks would appear around 2500 ± 100 cm-1, and for individual 
N+-H bonds, peaks would appear at 3250 ± 50 cm-1. As illustrated in figure 4.4, peaks 
are present at 2444 cm-1 and 3222 cm-1 allude to a proton transfer and consequently 
the new material is a salt. 
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Figure 4.4: Solid state IR spectra of the oxamic acid and isonicotinamide mix (red) 
and the new multi-component crystal (blue). 
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In parallel with traditional solvent-mediated recrystallisation, pxrd (figure 4.5) was 
used to confirm that the same bulk crystalline phase was produced by both LAG 
(section 3.2.2) and sonic slurry (section 3.2.2) methods.  
 
Figure 4.5: Powder X-ray diffraction data, listed from bottom to top, of the starting 
materials oxamic acid (orange) and isonicotinamide (red). Oxamic 
acid:isonicotinamide crystallised from solution mediated crystallisation (black), 
oxamic acid:isonicotinamide ground for 5 minutes(purple), oxamic 
acid:isonicotinamide ground for 15 minutes (blue), oxamic acid: isonicotinamide 
ground for 20 minutes (green) and oxamic acid:isonicotinamide from sonic 
slurry(dark red). 
 
As discussed previously (section 1.11.4), the mechanochemical production of multi-
component crystals can be advantageous over traditional approaches. However, a 
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distinct disadvantage is illustrated in figure 4.5, in the production of poor quality 
crystallites when compared to those produced by solvent-mediated evaporation. The 
synthesis by grinding is rapid; after only a period of 5 minutes, the synthesis of the 
multi-component crystal is achieved, albeit with some nicotinamide starting material 
being evident. The diffraction pattern shows signs significant peak broadening due to 
the increase in particle size. After more grinding the quality of the crystallites 
decreases significantly (figure 4.5). The crystallite quality produced by sonic solution, 
(figure 4.5), is better than that produced by the mechanochemical synthesis. However, 
in terms of solvent reduction, the sonic slurry method is not as environmentally sound 
as mechanochemical grinding. 
 
4.2 Structure solution and refinement from laboratory pxrd data 
The X-ray powder diffraction data set used for structural analysis was collected over a 
period of 8 hours and over the range 10˚ ≤ 2θ ≤ 85˚.  The data were indexed on the 
basis of the first 20 observable reflections using the indexing program CRYSFIRE17 
(appendix J) and the P21/n space group assigned by consideration of systematic 
absences. The profile parameters were refined using the whole-profile-fitting LeBail18 
method in the GSAS19 program to improve the fit of the lattice, zero-point and profile 
parameters. Structure solution was carried out using the DE; the technique (section 
1.14) as implemented in the program POSSUM20. 
From density considerations it was concluded that the asymmetric unit contained one 
isonicotinamide and one oxamic acid molecule. Hence the structural model used in 
the DE calculation comprised both molecules, constructed using standard bond 
lengths21 and angles, but excluding the hydroxyl and amine hydrogen atoms (figure 
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4.6). Each molecule is defined by 7 DE elements: 3 parameters (θ,Φ,Ψ) to define the 
orientation of each molecule within the unit cell (bounds 0 - 360˚), 3 parameters 
(x,y,z) to define the position of each molecule in the unit cell (bounds 0-1) and one 
unconstrained torsion angle (0-360˚) to define the conformation of each molecule. 
The molecules were moved independently in the structure solution resulting in a 14 
parameter problem. 
 
N
N(H2)O
HH
H H
O
O(H)
(H2)N
O  
Figure 4.6: Molecular structures used in the DE structure solution, torsion angles are 
indicated by arrows, excluded hydrogen atoms are shown in brackets.  
 
 
The parameters used in the successful DE calculation were, K = 0.99, F = 0.5, Np = 
140 and Gmax = 2000. Convergence was achieved after 1638 generations with the best 
solution with Rwp = 20.53 %. Figure 4.7 illustrates the evolutionary progress of the 
DE calculation clearly showing a steep decline in Rwp after a prolonged plateau.  
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Figure 4.7: Differential evolution progress plot for the successful structure solution of 
oxamic acid:isonicotinamide showing the Rwp of the best individual in blue and the 
mean % Rwp of the population in pink.  
 
4.3 Rietveld refinement  
The DE solution was used as a starting point for refinement using the GSAS program 
package22. The positions of all atoms were refined subject to soft constraints 
(weighting factor of 0.001 for bond distances and 0.005 for geminal non-bonded 
distances) on standard geometry. Hydrogen atoms that were not included in the DE 
calculation and were placed in calculated positions according to the expected 
hydrogen bonding network. Isotropic atomic displacement parameters were refined. 
For the non-H atoms, isotropic atomic displacement parameters were refined 
constrained according to atom type or environment. Refinement of a preferred 
orientation parameter in the [010] direction was required, with the fraction of 1.02(1). 
Figure 4.8 shows the final Rietveld profile for oxamic acid:isonicotinamide. Structure 
solution parameters from both pxrd and sxrd are shown in Table 4.1. 
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Figure 4.8: The final Rietveld profile for oxamic acid:isonicotinamide. The 
experimental diffraction pattern is shown by red circles, the calculated diffraction 
pattern is shown by a solid green line, and the difference plot as a solid pink line. 
Reflection positions are marked by black dots. 
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Table 4.1: Initial lattice parameters, DE structure solution parameters, refined lattice 
parameters from Rietveld refinement and single crystal determination and Rietveld 
agreement factors. 
Compound Oxamic acid and 
isonicotinamide 
Crystal data  
Chemical formula C6H6N2O+ 
H2NC(=O)C(=O)OH 
Mr 211.17 
Indexing  
Space group P21/c 
Initial a / Ǻ 3.7319(1) 
Initial b / Ǻ 7.7319(2) 
Initial c / Ǻ 30.3089(1) 
Initial β / ˚ 90.080(2) 
Initial V / Ǻ 3 876.838(3) 
  
Structure solution  
LeBail Rwp / % 3.07 
LeBail Rp / % 2.31 
LeBail χ2 1.876 
DE elements  
K 0.99 
F 0.5 
Np 140 
Average Rwp / % 50.25 
Best Rwp / % 20.53 
Refinement  
Rwp / % 3.35 
Rp / %  2.51 
R2F / % 0.2462 
χ2 2.598 
Preferred orientation 
fraction [and direction] 
1.02471 [010] 
No of parameters 70 
 
No. of restraints 51 Single Crystal values 
Final a / Ǻ 3.7311(1) 3.7386(18) 
Final b / Ǻ 7.7435(8) 7.771(3) 
Final c / Ǻ 30.284(3) 30.372(13) 
Final β / ˚ 90.21(1) 90.15(2) 
Final V / Ǻ 3 874.91(13) 882.4(6) 
Temperature K 295 296 
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4.4 Oxamic acid:Isonicotinamide structure  
 
Even though the refinement of the crystal structure from pxrd data was deemed 
successful, a single crystal structure solution was also undertaken to afford a higher 
degree of confidence in the structure especially concerning the conformation of the 
amide group in the isonicotinamide and the groups in the oxamic acid molecule which 
contain similar scattering factors. The crystal structure description is based upon the 
single crystal data collected on a Bruker Smart 6000 diffractometer equipped with a 
CCD detector and a copper tube source. The structures were solved by direct methods 
and refined using Shelx9723. Hydrogen atoms were found by Fourier methods and 
constrained using a riding model. Anisotropic displacement parameters were used for 
non-H atoms; H-atoms were given isotropic displacement parameters equal to 1.2 
times the equivalent isotropic displacement parameter of the atom to which they are 
attached. An incubator was used to grow a single crystal of suitable quality and size, 
as described in section 3.2.2.. The geometry of the oxamate anion displays similar 
characteristics to other published structures14, 24 in that its almost planar, with an 
interplanar angle O1-C1-C2-O2 of 4.78(5) º, and that the variation in the C-O bond 
lengths shows localisation of the carboxylate carbonyl group indicating a trans 
geometry; the C2-O2 and C2-O3 bond lengths are 1.263(4) (C-O) and 1.230(4) Å 
(C=O) respectively (appendix K). The presence of an intramolecular hydrogen bond 
within the oxamate ion, donated from N1 via H1B to O3, also contributes to the 
planarity of the anion as noted in other structures of this type14. The conformation of 
the amide group in the isonicotinamide molecule shows considerable deviation from 
planarity, C4-C5-C8-O8 angle of 154.6(4) °, arising from the formation of strong 
hydrogen bonds by the amide group both within and between supramolecular layers 
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(Table 4.2). This distortion is not uncommon as the amide group is involved in 
formation of intermolecular interactions both within and above or below the plane of 
the dimer motif4, 25  The single crystal structure also allows for the categorisation of 
the multi-component crystal, as the hydroxyl proton is transferred from the oxamic 
acid molecule to the heterocyclic nitrogen, forming a salt. Details of the oxamic 
acid:isonicotinamide single crystal structure can be found in appendix K. The 
molecular structure of oxamic acid:isonicotinamide and the atomic numbering system 
is shown in figure 4.9. 
Figure 4.9: The molecular structure of oxamic acid:isonicotinamide. Showing the 
atom numbering scheme and the hard intermolecular hydrogen bonds within the 
asymmetric unit (dashed lines). Displacement ellipsoids are drawn at the 50% 
probability level and H atoms are shown as small spheres of arbitrary radii. 
 
The supramolecular structure of oxamic acid:isonicotinamide is determined through 
six intermolecular hydrogen bonds; four strong N-H….O==C hydrogen bonds and 
two N(heterocyclic)-H+…O- (Table 4.2). All strong hydrogen-bond donors and 
acceptors are used in the hydrogen bond network. The isonicotinamide and oxamate 
ions are linked by a bifurcated N(heterocyclic)-H+…O- hydrogen bond in which the 
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protonated heterocyclic N2 of the isonicotinamide acts as a hydrogen bond donor, via 
H2, to both the amide oxygen O1 and the deprotonated carboxyl O3 on the oxamate 
anion. Each isonicotinamide molecule is then connected to another at (3-x,-1-y,-z) to 
form an  R 22 (8) dimer through complementary N-H….O hydrogen bonds in which N8 
acts as a donor via H8A to O8. The remaining four strong hydrogen bonds link 
together the oxamate anions forming an infinite zig-zag chain of dimers defined by 
R 22 (9) rings and propagated by the 21 screw-axis at (0.25, y, 0.25). The amide N1 acts 
as a donor through H1A to O3 at (0.5-x, -0.5+y, 0.5-z) while O3 accepts from (0.5-x, 
0.5+y, 0.5-z), as shown in figure 4.10 and figure 4.11. 
 
 
 
Figure 4.10: A view along the a axis showing an infinitely hydrogen bonded sheet in 
the (105) plane. Hydrogen bonds are shown by a dotted green line. (Unit cell shown) 
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Figure 4.11: A view of the hydrogen-bonded crystal structure of oxamic 
acid:isonicotinamide shown in projection down the a-axis. All six intermolecular 
hydrogen bonds are indicated as dashed lines; five interactions within a sheet (green) 
and one between sheets (black). The intramolecular hydrogen bond within the 
oxamate ion is not shown and H atoms not involved in hydrogen bonding have been 
omitted for clarity. (Unit cell shown). 
 
As postulated by Etter26, 27, the hydrogen bond networks present in the oxamic acid: 
isonicotinamide structure are typical of acid-amide systems albeit in this case 
following protonation. The best donor (carboxyl) forms a hydrogen bond to the best 
acceptor (pyridine N) and the second best donor and acceptor combination are 
propagated via amide linkages in both the oxamic acid and isonicotinamide 
molecules. As previously synthon energy calculations show28, the acid-pyridine 
hydrogen bond is favoured over the acid-amide.   
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Table 4.2: Hydrogen bond geometry in oxamic acid:isonicotinamide, (Å and °).  
Donor—H---Acceptor D—H H---A D....A <(DHA) 
N1-H1A....O3i 0.86 2.01 2.872 177 
N1-H1B....O1ii 0.86 2.22 2.972 146 
N1-H1B....O3 0.86 2.40 2.734 104 
N2-H2...O1 0.86 2.16 2.826 133 
N2-H2...O2 0.86 1.99 2.730 143 
N8-H8A...O8iii 0.86 2.09 2.948 176 
N8-H8B...O2iv 0.86 2.14 2.904 147 
Symmetry codes: (i) 0.5 –x, -0.5 +y, 0.5 –z; (ii) 0.5-x, 0.5 +y, 0.5 –z; (iii) 3 –x, -1 –y, 
-z; (iv) 1 +x, -1 + y, z 
 
 
 
4.5 Comparison of the Single crystal vs. Powder structure 
 
To aid method development for the solution of multi-component crystal structures 
from pxrd, structures solved from pxrd data can be compared to those solved using 
single crystal methods. In cases such as this structure, with groups of similar 
scattering behaviour, this allows us to assess areas of potential problems, such as the 
orientation flip of similar functional groups, which can be indistinguishable for poor 
quality pxrd data and can result in false structure solutions. Figure 4.11 illustrates the 
crystal packing in both the powder and single crystal solutions. 
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Figure 4.12: A section of the hydrogen bonded sheet of oxamic acid:isonicotinamide. 
From single crystal data (left) and from pxrd data (right). 
 
 
As clearly shown in figure 4.12, the orientation of the functional groups in both the 
oxamate and isonicotinamide moieties are identical in both the single crystal (left) and 
the powder (right). This observation illustrates the power of the direct space approach 
in the solution of multi-component crystals. In this case, the structure is correct and 
functional groups of similar electron density have been placed in the correct 
orientation regardless of the intrinsic problems which are associated with pxrd data. A 
proton was placed on the pyridine N, on the basis of IR data (section 4.1). 
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However, one major advantage associated with single crystal experiment is the ability 
to confirm the classification of the multi-component crystal structure as either a co-
crystal or a salt. The determination of the hydrogen atom (either as the neutral acid or 
protonated amide) is only achievable with the data quality and quantity available in a 
single crystal experiment, in comparison to that of a powder diffraction experiement. 
In this strucutre the proton transfer was confirmed by the single crystal experiment. 
Below in figures 4.13 and 4.14, direct comparisons between the single crystal atomic 
positions, the best DE solution and the final refined atomic positions are shown.   
 
Figure 4.13: Isonicotinamide molecule from oxamic acid: isonicotinamide. The green 
molecule represent single crystal positions, red molecule represent DE solution 20.53 
and the blue molecule represents final refined positions. 
 
   4. Cocrystallisation of oxamic acid:isonicotinamide and oxamic acid:nicotinamide 
                                                                                                                                                     
98 
 
 
Figure 4.14: Oxamic acid molecule from oxamic acid:isonicotinamide. The green 
molecule represents single crystal positions, red molecule represent atoms from DE 
solution 20.53 and the blue molecule represents the final refined atom positions. 
 
The subsequent analysis confirmed that the crystal packing obtained by powder 
methods was correct. The minimum, maximum and mean distances between pairs of 
corresponding atoms in the single and refined powder structures was calculated at 
0.098, 0.3644 and 0.201 Å respectively. 
 
4.6 The efficiency of the DE algorithm  
 
As shown in figure 4.7, the evolutionary progress plot of the successful DE 
calculation on the oxamic acid:isonicotinamide structure highlights areas in the 
calculation where the DE plateau indicated little to no progress in terms of optimising 
the Rwp. The plateau is followed by a steep decline, indicative of the deterministic 
nature of the DE algorithm, but also suggesting a shallow and deep global minimum. 
The large plateau region allows for further enhancement of the algorithm efficiency in 
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tackling such parameterised problems as oxamic acid:isonicotinamide. In table 4.3, 
the results from a number of DE runs (and epochs) are shown. The DE structure 
solution of oxamic acid:isonicotinamide is the first 14 parameter problem with two 
independent molecules in the asymmetric unit, to which the DE has been applied. By 
variation of the DE control parameters in a number of calculations it should become 
clear which combination of parameters are suitable for this type of optimisation 
problem. Values of F and Np were chosen for variation between limits chosen from 
previous DE studies29 and K was fixed throughout at 0.99. For each combination of 
parameters, five epochs were calculated. 
Table 4.3 illustrates that as expected, the large population sizes coupled with a 
mutation factor of 0.5 fail to locate the narrow global minimum within the number of 
generations allowed. Many results did not converge and reached Gmax (maximum 
number of generations allowed in one epoch before the calculation is halted and 
proceeding epoch initiates), extension to larger values of Gmax would give more 
indication of the convergence of the DE calculation with these higher population 
values. 
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Table 4.3: The results from a number of DE calculations with variation in F (mutation 
rate) and NP (population size). For each epoch the final Rwp (in %) is given and 
figures within brackets indicate at which generation convergence was achieved. Runs 
giving the correct structure solution are indicated by green; the gold cell indicates the 
lowest Rwp achieved and the starting point for the successful structure refinement. 
Runs that have not converged by the maximum allowed number of generations are 
shaded grey. 
Run F NP epoch 1  epoch 2  epoch 3  epoch 4  epoch 5  
1 0.3 130 31.59(276) 33.55(270) 32.68(342) 34.55(311) 30.53(337) 
2 0.4 130 31.96(644) 30.27(842) 28.19(613) 33.88(806) 31.91(612) 
3 0.5 130 23.67(1457) 22.85(950) 27.41(1197) 32.03(1415) 27.39(1253) 
5 0.5 140 28.44(1500) 22.31(1500) 27.42(1459) 41.22(1500) 29.61(1075) 
6 0.5 140 28.77(1238) 30.28(1329) 20.53(1642) 23.76(1705) 29.48(1483) 
7 0.5 140 29.58(1467) 24.29(1689) 28.47(1073) 27.65(1187) 26.06(1800) 
8 0.5 156 28.28(1500) 34.02(1419) 28.15(1260) 23.53(1260) 40.99(1500) 
9 0.5 156 33.24(1239) 33.54(1500) 27.77(1420) 39.72(1500) 39.81(1500) 
10 0.5 160 41.29(1500) 32.99(1500) 37.01(1500) 39.16(1500) 40.23(1500) 
11 0.5 195 36.97(1500) 41.07(1500) 38.91(1500) 39.79(1500) 42.22(1500) 
12 0.5 195 40.08(1500) 39.93(1500) 40.22(1500) 40.35(1500) 39.05(1500) 
13 0.5 195 41.69(1500) 20.75(1383) 40.29(1500) 37.36(1500) 41.74(1500) 
14 0.5 221 42.22(1800) 37.99(1800) 39.19(1800) 41.56(1800) 42.94(1800) 
15 0.5 221 40.47(1800) 35.78(1800) 39.89(1800) 40.51(1800) 37.9(1800) 
16 0.5 221 39.38(1800) 38.68(1800) 37.69(1800) 26.64(1800) 36.59(1800) 
17 0.5 286 41.79(1500) 43.1(1500) 40.4(1500) 42.79(1500) 42.35(1500) 
 
 
Smaller population sizes with a mutation factor F = 0.5 produced more successful 
runs, with a combination of F = 0.5 and NP = 140 leading to the successful global 
minimum. Figure 4.15, illustrates the effect of F (mutation parameter) on the progress 
of the DE calculation. 
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Figure 4.15: Variation of mutation rate F with constant population size. F = 0.3, 0.4 
and 0.5 are shown by green, orange and blue lines respectively. Dotted lines represent 
the best Rwp of the population with the corresponding solid line representing the mean 
Rwp of the population. 
 
The calculation with F = 0.5 (shown in blue), shows the greatest progression in terms 
of Rwp, as the larger mutation factor avoids the premature convergence demonstrated 
by F = 0.3 and 0.4.    
As the structure solution from the DE has an Rwp higher than might be expected ( DE 
solution Rwp = 20.53%; LeBail fit Rwp = 3.07 %) a ‘mini DE’ (MDE) calculation 
was performed (Table 4.4). In a mini DE the calculation is seeded with 5 previous 
solutions, from the main DE calculation. This aims to encourage the population 
towards promising solutions and excluding large areas of the Rwp hypersurface that 
have been covered by the DE calculation29. 
 
   4. Cocrystallisation of oxamic acid:isonicotinamide and oxamic acid:nicotinamide 
                                                                                                                                                     
102 
 
Table 4.4: MDE results for each epoch from five runs. For each epoch the final Rwp 
(in %) is given and figures within brackets indicate at which generation convergence 
was achieved. Runs giving the correct structure solution are indicated by green; the 
gold cell indicates the lowest Rwp achieved and the starting point for the successful 
structure refinement.  
Run F NP epoch 1  epoch 2  epoch 3  epoch 4  epoch 5  
1 0.3 140 19.28(182) 19.98(272) 19.91(252) 19.78(1500) 19.96(1500) 
2 0.4 140 19.14(307) 19.14(203) 19.14(213) 19.15(187) 19.94(203) 
3 0.5 140 20.75(1480) 20.75(1055) 20.75(856) 20.75(999) 20.75(1304) 
4  0.5 140 19.14(1179) 19.14(946) 19.14(980) 19.14(1420) 19.14(999) 
5 0.5 180 19.14(307) 19.14(203) 19.14(213) 19.14(187) 19.14(203) 
 
As illustrated in table 4.4, the mini DE, locates a structure solution (numerous times) 
on Rwp lower than that of the original DE calculation. On comparison of the structure 
itself it was deemed that this optimisation had not located a structure solution that was 
significantly different from the initial minimum (Rwp = 20.53 %) and hence 
refinement of this lower Rwp structure was not performed. 
 
4.7 Thermal behaviour of oxamic acid:isonicotinamide 
The thermal behaviour of oxamic acid:isonicotinamide was probed by collecting a 
series of data sets over the temperature range 100-295 K, using the  Bruker AXS 
D5000 high-resolution X-ray powder diffractometer fitted with Oxford Cryostream 
and capillary stage (section 3.1.4). The process of extracting information regarding 
the thermal behaviour of the crystal lattice was based on a non-model biased LeBail 
fitting procedure18. Lattice parameters derived from the single crystal structure were 
used as a starting point for the LeBail fit based on the data collected at 295 K. After a 
stable refinement was achieved, the resulting lattice parameters were used as the 
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starting point for the LeBail fit of the data set collected at 250 K. The process was 
continued in this way for the data sets collected at 200, 150 and 100 K. There was no 
evidence of a phase change over the temperature range investigated.  
Figure 4.16 illustrates the migration of diffraction peaks to a higher 2-theta with an 
increase in temperature. 
 
Figure 4.16: Two diffraction peaks of oxamate:isonicotinamide over the temperature 
range investigated, 295 K(blue), 250 K (pink), 200 K (orange), 150 K (sky blue) and 
100 K(purple) 
 
The lattice parameters from these LeBail fits are given in Table 4.5 and plotted in 
figure 4.17. It is clear from these that, the general trend is that of expansion, with the 
exception of β which decreases as the temperature rises. The ∆L/L0 values quoted in 
table 4.5, indicate the percentage change in the lattice parameter and are calculated by 
the difference between lattice parameter at given temperature and the lattice 
parameter at temperature 0 (in this study 100K), divided by the lattice parameter at 
temperature 0.  Figure 4.16 illustrates clearly that the expansion is non-linear, with the 
parameters achieved at 250 K being larger than those at 295 K.  
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Table 4.5: Lattice parameters from the LeBail fitting of oxamate:isonicotinamide. 
∆L/L0 values are given in square brackets. 
Temperature 
(K) a (Å) b (Å) c (Å) β˚ 
Volume 
(Å3) % Rwp χ
2 
100 
3.6585(6) 
[0.00] 
7.669(2) 
[0.00] 
30.167(8) 
[0.00] 
92.238(11) 
[0.00] 
846.1(4) 
[0.00] 
4.04 3.012 
150 
3.6776(6) 
[0.0052] 
7.675(2) 
[0.0008] 
30.214(8) 
[0.0013] 
91.989(11) 
[-0.0026] 
852.4(4) 
[0.0075] 
6.00 3.050 
200 
3.6978(5) 
[0.0107] 
7.692(1) 
[0.0030] 
30.168(8) 
[0.0038] 
91.762(10) 
[-0.0050] 
857.7(4) 
[0.0136] 
5.84 2.813 
250 
3.7392(7) 
[0.0219] 
7.737(1) 
[0.0089] 
30.289(9) 
[0.0038] 
90.721(15) 
[-0.0165] 
876.2(5) 
[0.0355] 
7.77 4.078 
295 
3.7322(3) 
[0.0201] 
7.743(1) 
[0.0096] 
30.294(4) 
[0.0039] 
90.168(8) 
[-0.0223] 
875.4(3) 
[0.0347] 
4.59 1.427 
 
Figure 4.17: The fractional variation of lattice parameters obtained from the LeBail 
refinement, plotted against temperature; Unit cell volume (purple spots), a (blue line), 
b (pink line), c ( orange line) and β ( sky blue dashed line). 
 
This is somewhat unexpected, so an alternative fitting procedure was employed to 
investigate whether this was a true structural effect or a refinement anomaly. It has 
been suggested elsewhere30 that the process of pattern decomposition to obtain 
accurate and reliable lattice parameters from multi-temperature data sets may be 
potentially problematic. Low symmetry unit cells contain a high density of 
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reflections, unlike in a Rietveld refinement, which is model baised, there is no 
indication of the relative intensities of different reflections; this can lead to mis-
identification of the reflections which pose little or no intensity. This can, in turn, 
result in errors being introduced into the cell refinement. In a model biased Rietveld 
refinement the problem of misidentification does not arise and hence Rietveld 
refinement31  was performed for each data set with the aim of extracting more reliable 
lattice parameter information, the resulting lattice parameters are shown in Table 4.6 
and in figure 4.18. 
As is clear from figure 4.18, the thermal expansion of the lattice parameters is linear 
with respect to temperature, except for β in which the decrease is linear. This is a clear 
example, supporting previous literature30, 32, that caution must be applied to thermal 
expansion data retrieved from using pattern decomposition methods such as LeBail 
fitting. 
 
Table 4.6: Lattice parameters from the Rietveld refinement of oxamate 
acid:isonicotinamide. ∆L/L0 values are given in square brackets. 
Temperature 
(K) a (Å) b (Å) c (Å) β˚ 
Volume 
(Å3) 
% 
Rwp χ
2 
100 
3.6526(6) 
[0.00] 
7.7150(19) 
[0.00] 
30.173(9) 
[0.00] 
90.658(14) 
[0.00] 
850.2(4) 
[0.00] 
6.82 4.37 
150 
3.6687(8) 
[0.0044] 
7.721(2) 
[0.0009] 
30.197(11) 
[0.0008] 
90.452(15) 
[-0.0028] 
855.4(6) 
[0.0061] 
4.89 6.274 
200 
3.6894(7) 
[0.0101] 
7.728(3) 
[0.0018] 
30.233(10) 
[0.0020] 
90.263(13) 
[-0.0044] 
862.0(6) 
[0.0139] 
4.87 4.880 
250 
3.7109(5) 
[0.0160] 
7.734(2) 
[0.0025] 
30.265(8) 
[0.0030] 
90.040(12) 
[-0.0068] 
868.6(5) 
[0.02160] 
5.59 3.315 
295 
3.7316(5) 
[0.02162] 
7.7443(19) 
[0.0038] 
30.287(8) 
[0.0038] 
89.80(1) 
[-0.0095] 
875.3(4) 
[-0.02941] 
4.37 2.816 
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Figure 4.18: The fractional variation of lattice parameters obtained from Rietveld 
refinement, plotted against temperature; Unit cell volume (purple spots), a (blue line), 
b (pink line), c (orange line) and β (sky blue dashed line). 
 
Thermal expansion at constant pressure (equation 4.1) can be described by a linear 
thermal expansion along its primary crystallographic axes. L0, is the shortest length 
recorded, dL and dT are the change in length and temperature respectively over the 
temperature range. 
 
pT
L
L






∂
∂
=
0
1
α
                                      [Equation 4.1] 
 
The linear thermal expansion of the lattice parameters along their principal 
crystallographic axes are listed in table 4.7.  
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Table 4.7: Linear thermal expansion co-efficients of the lattice parameters of 
oxamate:isonicotinamide. 
Lattice parameter Linear thermal expansion 
co-efficient (K-1) 
a 1.1100 x10-4 
b 1.9473 x10-5 
c 1.92392 x10-5 
β -4.88169 x10-5 
Volume 1.5081 x10-4 
 
It is clear from these coefficients that there is a greater degree of expansion on a than 
the other crystallographic axes. As discussed previously and shown in figure 4.9, in 
the crystal structure of this material, infinitely hydrogen bonded sheets of 
oxamate:isonicotinamide run in the (105) plane. The a direction may be thermally 
labile in comparison to the b and c direction due to the relatively small amount of 
hydrogen-bonding in the a-direction; indeed there is only one type of inter-planar 
hydrogen bond (N(8) —H(8B) …O(2)) that possesses any significant a directionality. 
Expansion (and contraction) in the a direction will also be significantly less sterically 
hindered than the other crystallographic directions. 
 
4.8 Characterisation of oxamic acid:nicotinamide 
This section describes the characterisation of a related multi-component crystal, 
oxamic acid: nicotinamide. Comparison of the oxamic acid adducts of the related 
nicotinamide and isonicotinamide molecules aids in the understanding of both adduct 
formation and structural behaviour. The stoichiometric ratio of the two starting 
materials was confirmed by 1H NMR (section 3.4.2) and the presence of both 
materials in the new crystalline system was confirmed by HPLC (section 3.4.3). 
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Pxrd was used to confirm that the product of crystallisation from a 1:1 starting 
stoichiometry using solvent-mediated synthesis was a new crystalline phase not 
containing the two starting materials (figure 4.19).  
Figure 4.19: Powder X-ray diffraction patterns of the starting materials, oxamic acid 
(orange), nicotinamide (red) and oxamic acid:nicotinamide multi-component material 
(black). 
 
Solid state infra-red spectroscopy was performed on the new crystalline phase and 
compared to that recorded from a mixture of starting materials. The spectra of the two 
are significantly different, alluding to the synthesis of a new crystalline material, with 
different hydrogen-bonding characteristics to that of the component mixture, (figure 
4.20).  The presence of two broad peaks at 2425 cm-1 and 1883 cm-1 is characteristic 
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of an acid----N heterocyclic hydrogen bond, and is viewed as evidence for multi-
component crystal formation, whereas the absence of such bands would be interpreted 
as a lack of multi-component formation15.  In terms of classification as a salt or a 
neutral cocrystalline material, it is illustrated in the literature16 that if an acidic proton 
is transferred to a heterocyclic nitrogen, very broad peaks are present around 2500 ± 
100 cm-1 and for individual N+-H bonds, peaks are present at 3250 ± 50 cm-1. As 
illustrated in figure 4.21, peaks are present at both 2425 cm-1 and 3230 cm-1, implying 
that a proton transfer has taken place and that consequently the new material is a salt. 
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Figure 4.20: Solid state IR spectra of oxamic acid:nicotinamide mix (black) and the 
new multi-component crystal (blue). 
 
In parallel with traditional solvent-mediated recrystallisation, pxrd (figure 4.21) was 
used to confirm that the same bulk crystalline phase was produced by both LAG 
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(section 3.4.1) and sonic slurry (section 3.4.1) methods. As discussed in section 1.18, 
LAG and slurry sonication provide an environmentally conscious route to the 
synthesis of these materials and potentially circumvent the problem of adverse 
solubilities of the starting components. 
 
Figure 4.21: Powder X-ray diffraction data, listed from bottom to top, of the starting 
materials oxamic acid (orange) and nicotinamide (red). Oxamic acid:nicotinamide 
crystallised from solution mediated crystallisation (black), oxamic acid:nicotinamide 
ground for 5 minutes (green), for 15 minutes (purple), for 20 minutes (blue) and 
oxamic acid:nicotinamide from sonic slurry (dark red). 
 
It is clear from figure 4.20, that the same new crystalline phase as produced by cold 
solution recrystallisation in methanol and ethanol was synthetically accessible via 
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both LAG (3.4.1) and sonic slurring (3.4.1). As with the isonicotinamide adduct 
(section 4.1), the sample produced by LAG contains some starting material; the extra 
peak at 14.8˚ matches that of the starting material nicotinamide. The diffraction 
pattern for LAG sample also shows signs of peak broadening and lattice strain. These 
sample effects reduce the resolution of unique reflections in the diffraction pattern and 
thus lead to an increase in complexity when solving multi-component crystals from 
pxrd data. As evident from figure 4.21, the crystallinity of the system does not 
depreciate linearly with time.  
 
4.9 Structure solution and refinement from laboratory pxrd data 
The X-ray powder diffraction data set used for structural analysis was collected over a 
period of 8 hours and over the range of 10˚ ≤ 2θ ≤ 85˚.  The data were indexed on the 
basis of the first 20 observable reflections using the indexing program CRYSFIRE33 
(appendix N) and the  P21/c space group was assigned by consideration of systematic 
absences. The profile parameters were refined using the whole-profile-fitting LeBail18 
method in the GSAS19 program to improve the fit of the lattice, zero point and profile 
parameters. Structure solution was carried out using the DE technique (section 1.14); 
this was implemented using the program POSSUM20. 
From density considerations it was concluded that the asymmetric unit contained one 
oxamic acid and one nicotinamide molecule, hence the structural model used in the 
DE calculation comprised both complete molecules, constructed using standard bond 
lengths21 and angles, but excluding hydroxyl and amine hydrogen atoms (figure 4.22). 
Each molecule is defined by 7 DE elements: 3 parameters (θ,Φ,Ψ) to define the 
orientation of each molecule within in the unit cell (bounds 0 - 360˚), 3 parameters 
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(x,y,z) to define the position of each molecule in the unit cell (bounds 0-1) and one  
unconstrained torsion angle (0-360˚) to define the conformation of each molecule. 
The molecules were moved independently in the structure solution resulting in a 14 
parameter problem. 
 
 
 
 
Figure 4.22: Molecular structures used in the DE structure solution, torsion angles are 
indicated by arrows. Hydrogen atoms excluded from the calculation are shown in 
brackets. 
 
The parameters used in the successful DE calculation were, K = 0.99, F = 0.5, Np = 
140 and Gmax = 1500. The progress plot for the successful DE solution of oxamic 
acid:nicotinamide (figure 4.23) shows the evolutionary progress of the DE calculation 
in terms of Rwp with generation. The progress plot highlights a large plateau as the 
mean Rwp remains relatively constant up to 1300 generations, followed by a steep 
decline in  Rwp down to a minimum of 10.38%. This progress plot shape suggests both 
a deep and narrow minimum in the hypersurface of the direct space search. This is 
similar to the shape found in the oxamic acid:isonicotinamide solution and may be a 
feature indicative of the optimisation route of this type of parameterisation problem. 
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Figure 4.23: Evolutionary progress plot for the successful solution of oxamic 
acid:nicotinamide showing the best  Rwp (blue) and the mean Rwp (pink) for each 
generation. 
 
4.10 Rietveld refinement 
 
The best structure from the DE solution was used as a starting point for refinement 
using the GSAS program package19. The positions of all atoms were refined subject to 
soft constraints (weighting factor of 0.001 for bond distances and 0.005 for geminal 
non-bonded distances) in standard geometry. Hydrogen atoms that were not included 
the DE calculation were placed in calculated positions according to the expected 
hydrogen bonding network. For the non-H atoms, isotropic atomic displacement 
parameters were refined constrained according to atom type or environment. 
Refinement of a preferred orientation parameter in the [011] direction was required, 
resulting in a fraction of 0.71(3). The final Rietveld profile for oxamic 
acid:nicotinamide is illustrated in figure 4.24. Parameters from indexing, DE structure 
solution, Rietveld refinement and single crystal determination are shown in Table 4.8.  
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Figure 4.24: The final Rietveld profile for oxamic acid:nicotinamide. The 
experimental diffraction pattern is shown by red circles, the calculated diffraction 
pattern by a solid green line and the difference plot as a solid pink line. Reflection 
positions are marked by black dots.  
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Table 4.8: Initial lattice parameters, DE structure solution parameters, refined lattice parameters from 
Rietveld refinement and single crystal determination and Rietveld agreement factors. 
Compound Oxamic acid:nicotinamide 
Crystal data  
Chemical formula C6H6N2O + 
H2NC(=O)C(=O)OH 
Mr 211.17 
Dx / mg m-3 
 
1.534 
  
Indexing  
Space group P21/c 
Initial a / Ǻ 6.9878(1) 
Initial b / Ǻ 9.8868(2) 
Initial c / Ǻ 13.7035(1) 
Initial β / ˚ 104.038(1) 
Initial V / Ǻ3 918.468(2) 
  
Structure solution  
LeBail Rwp / % 4.94 
LeBail Rp / % 3.25 
LeBail χ2 10.73 
DE elements  
K 0.99 
F 0.5 
Np 140 
Average Rwp / % 32.45 
Best Rwp / % 10.38 
  
Refinement  
Rwp / % 5.18 
Rp / %  3.81 
R2F / %  13.43 
χ2 14.40 
Preferred orientation 
fraction [and 
direction] 
0.71603 [011] 
No of parameters 73 
 
No. of restraints 43 Single Crystal 
values 
 
Final a / Ǻ 6.9794(1) a / Ǻ 6.9742(14) 
Final b / Ǻ 9.8731(3) b / Ǻ 9.8751(16) 
Final c / Ǻ 13.6899(4) c / Ǻ 13.676(2) 
Final β / ˚ 103.95(0) β / ˚ 103.86(1) 
Final V / Ǻ3 914.86(4) V / Ǻ3 914.5(3) 
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4.11 Oxamic acid:nicotinamide structure 
The following crystal structure description is based upon the single crystal data 
collected on a Bruker Smart 6000 diffractometer equipped with a CCD detector and a 
copper tube source. The structures were solved by direct methods and refined using 
Shelx9723. Hydrogen atoms were found by Fourier methods and constrained using a 
riding model. Anisotropic displacement parameters were used for non-H atoms; H-
atoms were given isotropic displacement parameters equal to 1.2 times the equivalent 
isotropic displacement parameter of the atom to which they are attached. An incubator 
was used to grow a single crystal of suitable quality and size to warrant a single 
crystal diffraction experiment, as described in section 3.4.5. As confirmed by the 
single crystal structure solution the multi-component system can be classified as a salt 
(figure 4.25) that crystallises in the P21/c space group. The supramolecular structure 
of oxamic acid:nicotinamide is determined through eight intermolecular hydrogen 
bonds; four strong N-H…O hydrogen bonds, two N (heterocyclic)-H+…O- hydrogen 
bonds and two weak C-H…O (Table 4.9). Details of the oxamic acid:nicotinamide 
single crystal structure can be found in appendix L. 
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Figure 4.25: ORTEP diagram of the two asymmetric molecules in the multi-
component crystal 
 
The oxamate anion in this structure adopts the expected planar conformation (O1-C1-
C2-O2 of -6.6(4)º) which can again be partly attributed to an intramolecular hydrogen 
bond formed by donation of H1B by N1 to O3 (Table 4.9).  The distinction between 
the C-O bonds in the carboxylate group is not as clear as in oxamic 
acid:isonicotinamide but also infers a trans configuration with C2-O2 and C2-O3 
bond distances of 1.256(3) (C-O) and 1.240(3) Å (C=O) respectively 
All strong hydrogen bond donors and acceptors are used in the hydrogen bond 
network. The nicotinamide and oxamate ions are linked by a bifurcated 
N(heterocyclic)-H+…O- hydrogen bond in which the protonated heterocyclic N2 of 
the nicotinamide acts as a hydrogen bond donor, via H2, to both the amide oxygen O1 
and the deprotonated carboxyl O2 on the oxamate anion. Each nicotinamide molecule 
is connected to another at (2-x,2-y,-z) to form an )8(22R dimer through complementary 
N-H…O hydrogen bonds in which N8 acts as a donor via H8A to O8 (figure 4.26). 
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These hydrogen bonds combine to form a tetrameric unit which acts as a link between 
alternative cationic or anionic sheets, as shown in figure 4.25. 
 
 
Figure 4.26: The tetrameric unit formed in the crystal structure oxamic 
acid:nicotinamide.  Hydrogen bonds are indicated as dashed lines. 
 
A further strong hydrogen bond is donated from the nicotinamide molecule via N8 
acting as a donor through H8B to O3 (1-x,0.5+y,-0.5Z). Two weak hydrogen bonds 
are also donated from the cationic nicotinamide molecule, dimers of nicotinamide 
molecule are hydrogen bonded by C4 donating a hydrogen bond via H4 to O8 (2-x,-
0.5+y, 0.5-z), this soft hydrogen bond forms a C(6) spiral along the 21 screw axis and 
in combination with the dimer R22(8) rings generate a nicotinamide only layer in the 
(011) plane. A second weak hydrogen bond donated from C7 via H7 to O3(1-
x,0.5+y,-0.5Z). 
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Figure 4.27: The plannar oxamate acid sheet as viewed along the a axis. Hydrogen 
bonds are shown by the dotted green line. (Unit cell shown) 
 
 
The anionic layer of oxamate molecules also lies in the (011) plane. The two 
remaining strong hydrogen bonds link together the oxamate anions forming an infinite 
zigzag chain of dimers defined by )8(22R rings and propagated by a C(5) spiral 
running along the 21 screw-axis at (1/2,y,1/4). The amide N1 acts as a donor through 
H1A to O1 at (1-x,-y,-z), while O2 (1-x, 0.5+y, 0.5-z) accepts a hydrogen bond from 
N1 via H1B. 
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Figure 4.28: The nicotinamide sheet, viewed along the a axis. (Unit cell shown) 
 
 
The anionic and cationic layers are linked by the bifurcated N(heterocyclic)-H+…O- 
interactions described earlier, by the last strong N-H…O hydrogen bond donated from 
the nicotinamide N8 acting as a donor through N8B to O3 at (1-x, 0.5+y, -0.5-z) and 
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reinforced by the second soft hydrogen bond so that O3 at (1-x, 0.5+y, -0.5-z) acts as a 
bifurcated acceptor also from C7 via H7. As shown by figure 4.27. 
 
 
Figure 4.29: View along the b axis showing the layered structure of oxamic acid and 
nicotinamide co-crystal adduct. (Unit cell shown). 
 
 
 
Table 4.9: Intermolecular parameters for the oxamic aicd:nicotinamide co-crystal 
adduct (Ǻ) 
Donor-----H… Acceptor D-H H---A D…A <(DHA) 
N(1)—H(1A)…O(1)i 0.86 2.13 2.9831 175 
N(1)---H(1B)…O(2)ii 0.86 2.24 3.0282 153 
N(1)---H(1B)…O(3) 0.86 2.36 2.7037 104 
N(8)---H(8A)…O(8)iii 0.86 2.1 2.9456 169 
N(8)-—H(8B)…O(3)ii 0.86 2.08 2.9227 167 
N(2)---H(2)…O(1) 0.86 2.27 2.9224 132 
N(2)---H(2)…O(2) 0.86 1.86 2.6164 146 
C(7)---H(7)…O(3)ii 0.93 2.21 3.1138 164 
C(4)---H(4)….O(8)iv 0.93 2.28 3.1795 162 
Symmetry codes: (i) 1 - x, - y, - z; (ii) 1 - x, 0.5 + y, -0.5 - z; (iii) 2 - x, 2 - y, - z; (iv) 2 
- x, -0.5 + y, 0.5 - z; 
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4.12 Single crystal vs. Powder structure  
As discussed previously, a single crystal diffraction experiment provides a higher 
quality structure than from pxrd. However, the comparison of structures obtained 
from single crystal and powder methods highlights both the benefits and pitfalls of 
using pxrd data for structure solution and refinement.  In the case of pxrd data, the 
loss of diffraction information, (through peak overlap) can make features in the 
molecule which contain similar electron density hard to distinguish due to the 
resolution available. This can potentially lead to false DE solutions, as the algorithm 
is looking to place a model as close as possible to areas of electron density in the unit 
cell. Although the structure solution of the isonicotinamide adduct was successful, 
this problem is highlighted when looking at the nicotinamide layer in the 
oxamate:nicotinamide structure, as shown in figures 4.30 and 4.31. 
Figures 4.31 and 4.32 clearly show a flip in orientation for the amide functional group 
on the nicotinamide molecule when comparing the DE powder solution of Rwp 10.38 
% to the single crystal structure. The DE solution (Rwp 10.38 %) upon refinement 
reached an Rwp of 5.59 %, however the soft bond restraints on the C-N and C-O bond 
lengths in the amide functional group alluded to a orientation problem. The amide 
group was flipped and further refined down to Rwp 5.19 %, using Rwp as a discrepancy 
to prove that the initial amide orientation in the DE solution Rwp 10.38 % was 
incorrect. However, the DE had located the global minimum as the equivalent crystal 
structure with the amide flipped gave an Rwp of 11.21 %. This anomaly between 
structure solution and refinement is maybe not surprising as the relaxation and 
flexibility introduced in refinement may alter the Rwp surface searched.   
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Figure 4.30: Nicotinamide layer from the single crystal structure of 
oxamate:nicotinamide. 
 
 
Figure 4.31: Nicotinamide layer from the DE solution (Rwp = 10.38%) of oxamate: 
nicotinamide. 
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Conversely, the oxamate layer in oxamate:nicotinamide shows that the functional 
group conformation is correct when comparing the powder to single crystal structure 
(figures 4.32 and 4.33).  
 
Figure 4.32: Oxamate layer from the single crystal structure of oxamate:nicotinamide 
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Figure 4.33: Oxamate layer from the DE solution (Rwp = 10.38 %) of oxamate 
acid:nicotinamide. 
 
The importance of the amide orientation is confirmed by a search of ‘like-
nicotinamide’ systems on the CSD. The search illustrated that both syn and anti 
nicotinamide (shown in figure 4.34) occur regularly in the organic solid state, with 
eleven out nineteen nicotinamide molecules adopting the cis orientation.  
 
Figure 4.34: The syn (left) and anti nicotinamide molecule configuration(right) 
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Pxrd data alone does not possess sufficient resolution to accurately locate the position 
of hydrogen atoms. Complementary techniques to pxrd such as solid state IR are able 
to determine whether proton transfer has taken place (section 4.8). Differences in pKa 
values (greater than two) can be used as a predictive tool for the formation of a salt, 
but this has its shortfalls as pKa are used for the description of the labile nature of the 
acidic protons in solution and not in solids. 
The figures below, 4.35 and 4.36, illustrate how close the pxrd structure is to that of 
the single crystal structure.  
 
Figure 4.35: Oxamate ion molecule from oxamate: nicotinamide. The green molecule 
represents single crystal positions, the red molecule represents atoms from the DE 
solution (10.38) and the blue molecule represents the final refined atomic positions. 
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Figure 4.36:  The nicotinamide molecule from oxamate acid: nicotinamide. The green 
molecule represents single crystal positions, the red molecule represents atom 
positions from the DE solution (10.38) and the blue molecule represents final refined 
positions. 
 
Subsequent analysis confirmed that the crystal packing obtained by powder methods 
was correct, and that minimum, maximum and mean distances between pairs of 
corresponding atoms in the single and refined powder structures was calculated at 
0.0394, 0.3336 and 0.113 Å respectively. 
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4.13 The efficiency of the DE algorithm  
 
As discussed in section 4.9 and by further confirmed by the progress plot in figure 
4.22, global optimisation of multi-component crystal systems often contain large 
plateau regions, subsequently followed by sharp decline in Rwp towards the global 
minimum. However, as illustrated by table 4.10, only one of the DE runs performed in 
this work resulted in a solution suitable for a starting point of a successful Rietveld 
refinement. All other runs were deemed unsuccessful. To fully investigate the 
efficiency of the DE algorithm, a diverse range of both F and NP will need to be fully 
investigated.  
Values of F were chosen for variation between limits chosen from previous DE 
studies29 and K was fixed throughout at 0.99. For each combination of parameters, 
five epochs were calculated. Many results did not converge and reach Gmax; extension 
to larger values of Gmax would give more indication of the convergence of the DE 
calculation with these higher population values. 
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Table 4.10: The results from a number of DE calculations with variation in F 
(mutation rate). For each epoch the final Rwp (in %) is given and figures within 
brackets indicate at which generation convergence was achieved. Runs giving the 
correct structure solution are indicated by green; the gold cell indicates the lowest Rwp 
achieved and the starting point for the successful structure refinement. Runs that have 
not converged by the maximum allowed number of generations are shaded grey. 
. 
Run F NP epoch 1  epoch 2  epoch 3  epoch 4  epoch 5  
1 0.4 140 29.04(1500) 23.18(1425) 26.88(1500) 28.46(1500) 27.04(1003) 
2 0.4 140 31.26(1500) 31.75(1500) 32.56(1499) 32.56(1500)   
3 0.4 140 26.23(1356) 26.63(1207) 28.99(1500) 25.27(1380) 24.45(1076) 
4 0.4 140 29.92(1500) 25.06(1500) 31.11(1500) 30.31(1500) 22.26(1153) 
5 0.4 140 22.12(1500) 21.91(1251) 22.26(1500) 21.73(1500) 21.88(1500) 
6 0.4 140 34.44(1500) 35.56(1500) 27.6(1189) 26.26(1450) 25.97(1499) 
7 0.5 140 35.24(1037) 33.7(1084) 35.36(1031) 35.34(1009) 35.51(1500) 
8 0.5 140 32.19(1500) 10.38(1438) 33.19(1500) 31.73(1500) 31.49(1500) 
 
 
4.14 Thermal Behaviour of oxamate:nicotinamide 
Thermal expansion co-efficients can also give us an insight into the crystal structure 
of oxamate:nicotinamide, in particular the hydrogen bonding networks present within 
the crystal. Figure 4.37, illustrates the migration of diffraction peaks to a higher 2-
theta value as the temperature decreases. The collection of variable temperature data 
sets also confirms that there is no phase transformation over the temperature range 
investigated (100-295 K).  
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Figure 4.37: Two diffraction peaks of oxamic acid:nicotinamide over the temperature 
range investigated, 295 K(blue), 250 K (pink), 200 K(orange), 150 K(sky blue) and 
100 K(purple).  
 
The lattice parameters from these LeBail fits are given in Table 4.11 and plotted in 
figure 4.38. All bar the b direction, show the general trend of expansion. The ∆L/L0 
values quoted in table 4.11, indicating the percentage change of the lattice parameter 
are calculated in the same manner as described in section 4.7. 
 
Table 4.11 :Lattice parameters from the LeBail fitting of oxamate:nicotinamide. 
∆L/L0 values are given in square brackets. 
Temperature 
(K) a (Å) b (Å) c (Å) Beta (˚) 
Volume 
(Å3) 
% 
Rwp χ
2 
100 
6.8305(3) 
[0.00] 
9.8826(6) 
[0.00] 
13.6388(9) 
[0.00] 
103.846(3) 
[0.00] 
893.92(12) 
[0.00] 
4.26 3.239 
150 
6.8650(4) 
[0.0051] 
9.8810(6) 
[-0.0002] 
13.6478(8) 
[0.0007] 
103.921(4) 
[0.0007] 
898.88(13) 
[0.0056] 
4.45 2.936 
200 
6.9007(4) 
[0.01027] 
9.8768(6) 
[-0.0006] 
13.6578(12) 
[0.0014] 
103.869(4) 
[0.0002] 
903.73(15) 
[0.0110] 
4.39 2.62 
250 
6.9435(3) 
[0.0156] 
9.8723(6) 
[-0.0010] 
13.6748(10) 
[0.0026] 
103.921(4) 
[0.0007] 
909.87(13) 
[0.0179] 
4.37 3.143 
295 
6.9777(3) 
[0.0213] 
9.8733(7) 
[-0.0013] 
13.6842(12) 
[0.0034] 
103.979(4) 
[0.0015] 
914.82(16) 
[0.0227] 
6.37 6.637 
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Figure 4.38: The fractional variation of lattice parameters obtained from LeBail 
refinement, plotted against temperature; Unit cell volume (purple spots), a (blue line), 
b (pink line), c (orange line) and β (sky blue dashed line). 
 
 
The above quantitative data on the thermal expansion of oxamate:nicotinamide is 
based on lattice parameters derived from the LeBail18 pattern decomposition 
technique. As discussed in the thermal expansion oxamate:isonicotinamide, Rietveld 
refinements22 were performed for each data set, in order to derive more reliable 
results, with the values given in table 4.12 and shown in figure 4.39.  
 
Table 4.12: Rietveld lattice parameters of oxamate:nicotinamide ∆L/L0 values are 
given in square brackets. 
Temperature(K) a (Å) b (Å) c (Å) β (˚) Volume(Å3) % Rwp χ
2 
100 
6.8268(8) 
[0.00] 
9.8790(13) 
[0.00] 
13.628(3) 
[0.00] 
103.821(7) 
[0.00] 
892.5(3) 
[0.00] 
4.36 14.24 
150 
6.8410(7) 
[0.0021] 
9.8789(12) 
[-0.00001] 
13.634(3) 
[0.0005] 
103.824(7) 
[0.00003] 
894.8(3) 
[0.0025] 
4.83 12.93 
200 
6.9003(6) 
[0.0108] 
9.8756(10) 
[-0.0004] 
13.657(2) 
[0.0021] 
103.873(5) 
[0.0005] 
903.5(3) 
[0.0123] 
4.74 6.565 
250 
6.9432(5) 
[0.0170] 
9.8755(9) 
[-0.0004] 
13.673(2) 
[0.0033] 
103.924(5) 
[0.0010] 
909.9(2) 
[0.0195] 
4.57 5.76 
295 
6.9778(8) 
[0.0221] 
9.8739(14) 
[-0.0005] 
13.6851(3) 
[0.0042] 
103.977(7) 
[0.0015] 
914.9(3) 
[0.0251] 
4.72 12.84 
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 Figure 4.39: The fractional variation of lattice parameters obtained from Rietveld 
refinement, plotted against temperature; Unit cell volume (purple spots), a (blue line), 
b (pink line), c (orange line) and β (sky blue dashed line) 
 
An alternative approach to the analysis of the thermal behaviour of this system is 
given in appendix M. Thermal expansion can be described by a linear thermal 
expansion, using equation 4.1. The results for each principal crystallography axes are 
shown in table 4.13. 
 
Table 4.13: Linear thermal expansion co-efficients of the lattice parameters of oxamic 
acid:nicotinamide salt 
Lattice parameter Linear thermal expansion 
co-efficient (K-1) 
a 1.08971x10-4 
b -6.57774x10-6 
c 1.72475x10-6 
Unit cell volume 1.16296x10-4 
 
The most expansive crystallographic axis in terms of thermal expansion is the a axis, 
with a thermal expansion co-efficient of 1.0897x10-4 K-1. The alternating layers of 
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oxamate and nicotinamide lie in the (011) plane, thus the fewest hydrogen bonds (i.e 
interplanar hydrogen bonds) align closest to this direction. The c axis also shows 
thermal expansion character, with a thermal expansion co-efficient of 1.72475x10-6 K-
1, but with a reduced tendency to expand in relation to the a axis. Within the structure 
there are strong directional hydrogen bonds that lie partially in the [110] direction, 
resulting in the relatively low thermal expansion co-efficient. 
As illustrated in Figure 4.38 and by the thermal expansion co-efficient of -
6.57774x10-6 K-1, the b axis shows negative thermal expansion. Without the aid of the 
known crystalline structure as discussed earlier in this chapter (section 4.9), one 
would hypothesise that the b direction would contain strong and directional hydrogen 
bonds with the contraction potentially also aided by steric considerations. This 
hypothesis can clearly hold as the infinitely hydrogen bonded sheets lie in the (001) 
plane (figures 4.27, 4.28 and 4.29). Negative thermal expansion can then occur in the 
b direction in order to compensate for the thermal expansion occurring along the other 
crystallographic axes in order to limit unfavourable steric interactions.  
4.15 Conclusion 
Within this chapter, the crystal structures of the multi-component systems of 
oxamate:isonicotinamide and oxamate:nicotinamide have been solved by the both 
sxrd and pxrd. The structures have highlighted both the merits and pitfalls of solving 
structures via pxrd, with the amide flip the oxamate:nicotinamide illustrating the 
potentials problems associated with pxrd. Both structures have also been synthesised 
via reduced solvent methods. The use of complementary techniques has confirmed the 
proton transfer in both structures, allowing the systems to be classified as salts and not 
cocrystals. 
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5. Cocrystallisation of fumaric acid:nicotinamide, 
maleic acid: nicotinamide and maleic 
acid:isonicotinamide 
 
As discussed in section 4.0, co-crystallisation provides the chemist with an alternative 
approach in delivering APIs, in which the physical properties can be enhanced whilst 
retaining the chemical properties of the individual components. This chapter describes the 
extension of the attempted cocrystallisation of nicotinamide with unsaturated dicarboxylic 
isomers fumaric acid and maleic acid and isonicotinamide with maleic acid; the molecular 
structures of all starting components are shown in figure 5.1. Fumaric acid, maleic acid, 
nicotinamide and isonicotinamide have pKa values of 3.5, 1.5, 3.6 and 3.4 respectively. As 
discussed previously, a ∆pKa greater than 3 often results in salt.  
 
i) ii)  
iii) iv)  
Figure 5.1: Molecular diagrams of fumaric acid (i), (ii) maleic acid , (iii) nicotinamide and iv) 
isonicotinamide 
 
 
Fumaric acid (trans-butenedioic acid), contains two carboxylic acid moieties, which would 
potentially lend themselves to form hydrogen bonded motifs in the solid state. Fumaric acid 
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also has a number of prospective medicinal uses, particularly for the treatment of multiple 
sclerosis, a condition where the immune system attacks the central nervous system, leading to 
demyelination1. Another common use for fumaric acid is an acidity regulator when added to 
food and is also known as E297. 
Fumaric acid has been previously reported in a 1:2 ratio in a cocrystal with isonicotinamide2. 
Following the structure determination and characterisation of fumaric acid:nicotinamide (1:1) 
described in this chapter the structure of this co-crystal was published3 and the diversity of 
stoichiometry probed, producing crystals containing both 1:2 and 1:1 ratios. In both cases, the 
crystal structures2, 3 were solved using single crystal methods. In this chapter we will describe 
the solution of the crystal structure of fumaric acid:nicotinamide 1:1 using pxrd data and 
single crystal methods, independent of the previously solved crystal structures. 
 
5.1 Characterisation of fumaric acid:nicotinamide 
 
Pxrd was used to confirm that the product of crystallisation was a new crystalline phase with 
no significant presence of the starting materials (figure 5.2). The stoichiometric ratio of the 
starting components in the new material was confirmed as 1:1 by 1H NMR (section 3.5.2). 
 5. Cocrystallisation of fumaric acid:nicotinamide, maleic acid:nicotinamide and maleic 
acid:isonicotinamide 
                                                                                                                                                138 
 
 
 
Figure 5.2: Powder X-ray diffraction patterns of the  starting materials, fumaric acid (orange), 
nicotinamide (red) and the fumaric acid:nicotinamide multi-component material (black). 
  
Further characterisation of the new multi-component crystalline phase was undertaken by 
solid state infra-red spectroscopy which confirmed the presence of a new phase (when 
compared to the spectrum of a mix of the two starting materials), alluding to the synthesis of 
a new multi-component crystal with different hydrogen-bonding characteristics to that of the 
component mixture, (figure 5.3). The presence of two broad peaks at 2340 cm-1 and 1859cm-1 
is characteristic of an acid----N heterocyclic hydrogen bond, and is viewed as evidence for 
multi-component formation4. As illustrated in the literature5, if an acidic proton is transferred 
to a heterocyclic nitrogen, individual N+-H, peaks would appear at 3250 ± 50 cm-1, (as 
observed in the spectra of both oxamic acid:isonicotinamide and oxamic 
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acid:nicotinamide).This is not evident in the IR spectra for fumaric acid:nicotinamide, 
suggesting that the material under investigation is a cocrystal.  
 
 
Figure 5.3: Solid state IR spectra of the fumaric acid and nicotinamide mix (red dashed line) 
and fumaric acid:nicotinamide multi-component crystal (solid black line) 
 
In parallel with traditional solvent-mediated recrystallisation, pxrd was used to confirm that 
the same bulk crystalline phase (figure 5.4) was produced by both LAG (section 3.2.3) and 
sonic slurry (section 3.2.4) methods.  
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Figure 5.4: Powder X-ray diffraction data of the starting materials fumaric acid (orange) and 
nicotinamide (red). The fumaric acid:nicotinamide multi-component from solvent mediated 
recrystallisation (black), fumaric acid:nicotinamide from 10 minutes of LAG (green), from 15 
minutes of LAG (purple), from 20 minutes of LAG (blue) and fumaric acid:nicotinamide 
from sonic slurry (dark red). 
 
The merits and pitfalls of liquid drop grinding and other solvent reduced synthesis of multi-
component crystals are discussed in greater detail in section 1.18. Variation in intensity can 
arise from the practical considerations involved in sample preparation and the crystal 
morphology of the samples leading to preferred orientation of the crystallites (section 1.11.4).  
Research into the stoichiometric diversity of the starting moieties in multi-component crystals 
via mechanochemical and other solvent reduced synthesis methods opens up the possibility in 
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future work to solve crystal structures from pxrd of mixed phase diffraction patterns. 
Mechanochemical crystal synthesis in particular, could lead to a mixture of starting materials 
and new multi-component crystalline phases, where attempts could be made to solve each 
phase separately by direct space methods. This method development in mechanochemical 
synthesis would allow the probing of potential crystalline phases unreachable in terms of 
structure solution via single crystal methods.   
 
5.2 Structure solution and refinement from laboratory pxrd data 
The X-ray powder diffraction data set used for structural analysis was collected over a period 
of 8 hours, and a range of 10˚ ≤ 2θ ≤ 60˚.  The data were indexed on the basis of the first 20 
observable reflections using the indexing program CRYSFIRE6 (appendix O) and the P21/a 
space group assigned by consideration of systematic absences. The profile parameters were 
refined using the whole-profile-fitting LeBail7 method in the GSAS8 program to improve the 
fit of the lattice, zero point and profile parameters. Structure solution was carried out using 
the DE technique (section 1.14) as implemented in the program POSSUM9. 
From density considerations it was concluded that the asymmetric unit contained one fumaric 
acid and one nicotinamide molecule, hence the structural model used in the DE calculation 
comprised both molecules, constructed using standard bond lengths10 and angles, but 
excluding the hydroxyl and amine hydrogen atoms. The nicotinamide molecule is defined by 
7 DE elements and the fumaric acid molecule by 8 DE elements: for each molecule 3 
parameters (θ,Φ,Ψ) were used to define the orientation within the unit cell (bounds 0 - 360˚), 
and 3 parameters (x,y,z) were used to define the position of the molecule in the unit cell 
(bounds 0-1). Nicotinamide contains one unconstrained torsion angle whereas fumaric acid 
contains 2 bounds (0-360˚) to define the conformation of each molecule, as shown in figure 
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5.5. The molecules were moved independently in the structure solution resulting in a 15 
parameter problem. 
N
O
N(H2) (H)O
O
O
O(H)
H
H
H H  
Figure 5.5: Molecular structures used in the DE structure solution, torsion angles are 
indicated by arrows. Hydrogen atoms excluded from the calculation are shown in brackets. 
 
The parameters used in the successful DE calculation were, K = 0.99, F = 0.4, Np = 330 and 
Gmax = 2000. The evolutionary progress plot for the successful DE solution of fumaric 
acid:nicotinamide (figure 5.6) shows the progression of the DE calculation in terms of Rwp 
with generation. As shown in previous examples of DE progress plots (figures 4.6 and 5.6), 
the plots take a characteristic profile as an initial decline in Rwp is followed by a prolonged 
plateau region. After the plateau, the plot declines steeply as it heads rapidly to the minimum 
of the hypersurface, again suggesting a deep and narrow well in the Rwp hypersurface.  
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Figure 5.6: Evolutionary progress plot for the successful solution of fumaric 
acid:nicotinamide showing the best Rwp (blue) and the mean  Rwp (pink) for each generation. 
 
 
5.3 Rietveld refinement 
 
The best structure from the DE solution was used as a starting point for refinement using the 
GSAS program package8. The positions of all atoms were refined subject to soft restraints 
(weighting factor of 0.001 for bond distances and 0.005 for geminal non-bonded distances) 
on standard geometry. Hydrogen atoms that were not included the DE calculation were 
placed in calculated positions according to the expected hydrogen bonding network. For the 
non-H atoms, isotropic atomic displacement parameters were refined constrained according 
to atom type or environment. Refinement of a preferred orientation parameter in the [100] 
direction was required, resulting in a fraction of 0.82750. The final Rietveld plot can be found 
in figure 5.7. Table 5.1 contains structure parameters from both single and powder X-ray 
diffraction determinations. 
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Figure 5.7: The final Rietveld plot for fumaric acid:nicotinamide. The experimental 
diffraction data is shown by red circles, the calculated diffraction pattern by solid green line 
and reflection positions are marked by black dots. The difference between the experimental 
and calculated diffraction pattern is shown by the pink line. 
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Table 5.1: Initial lattice parameters, DE structure solution parameters, refined lattice 
parameters from Rietveld refinement and single crystal determination and Rietveld agreement 
factors. 
Compound Fumaric 
acid:nicotinamide 
Crystal data  
Chemical formula C4H4O4 + C6N2H6O 
Mr 238.2 
Indexing  
Space group P21/a 
Initial a / Ǻ 14.3889(3) 
Initial b / Ǻ 13.8156(2) 
Initial c / Ǻ 5.5583(2) 
Initial β / ˚ 93.517(1) 
Initial V / Ǻ3 1102.980(2) 
 
Structure solution  
LeBail Rwp / % 6.36 
LeBail Rp / % 4.85 
LeBail χ2 1.633 
 
DE elements  
K 0.99 
F 0.4 
Np 330 
Average Rwp / % 13.23 
Best Rwp / % 13.23 
  
Refinement  
Rwp / % 9.40 
Rp / %  7.00 
R2F / % 0.2762 
χ2 3.657 
Preferred orientation fraction  0.82750 [100] 
 
No of parameters 76 Single Crystal   
No. of restraints 52   
Final a / Ǻ 14.3763(13) a / Ǻ 5.5376(4) 
Final b / Ǻ 13.8049(19) b / Ǻ 13.785(1) 
Final c / Ǻ 5.5560(3) c / Ǻ 14.2006(11) 
Final β / ˚ 93.53(0) β / ˚ 92.54(1) 
Final V / Ǻ3 1100.(3) V / Ǻ3 1082.9 (3) 
  Space group P21/c 
  Temperature (K) 200 
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5.4 Fumaric acid:nicotinamide structure  
The following crystal structure description is based upon the single crystal data collected on 
Bruker SMART 6000 diffractometer (λCu-Kα = 1.54178 Å) at 200 K. Further details on the 
single crystal structure solution can be found in appendix P. The structure was solved by 
direct methods and refined using Shelx11. Hydrogen atoms were found by Fourier methods 
and constrained using a riding model. Anisotropic displacement parameters were used for 
non-H atoms; H-atoms were given isotropic displacement parameters equal to 1.2 times the 
equivalent isotropic displacement parameter of the atom to which they are attached. An 
incubator was used to grow a single crystal of suitable quality and size to warrant a single 
crystal diffraction experiment, as described in section 3.2.2. As confirmed by the single 
crystal structure solution, this adduct can be classified as a neutral cocrystal that crystallises 
in the P21/c space group. The final ORTEP diagram from the single crystal solution is shown 
in figure 5.8 
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Figure 5.8: The molecular structure of fumaric acid:nicotinamide (1:1) showing the atom 
numbering scheme. Displacement ellipsoids are drawn at the 50 % probability level and H 
atoms are shown as small spheres of arbitrary radii. 
 
The supramolecular structure of fumaric acid:nicotinamide is determined through five 
intermolecular hydrogen bonds; two strong N-H….O==C hydrogen bonds, one O-H….O==C 
hydrogen bond, one O-H....N(heterocyclic) hydrogen bond and one C-H...O=C interaction, 
all details shown in table 5.2. All strong hydrogen-bond donors and acceptors are used in the 
hydrogen bond network. The conformation of the amide group in the nicotinamide group is 
approximately planar, with a torsion angle of C4-C5-C7-O7 of 174.75(14)°. This planarity is 
due to the formation of strong hydrogen bonds by the amide group only within in flat 
supramolecular layers.   
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The fumaric acid and nicotinamide molecules are linked via the amide nitrogen N7, which 
acts as a double hydrogen bond donor, donating a hydrogen bond via H7A to O9 (1-x,y,z), 
and a second hydrogen bond to O12 (1-x,1-y,-z). The fumaric acid molecule donates two 
hydrogen bonds via its hydroxyl oxygens; from O8 via H8 to O7 (this hydrogen bond in 
combination with the N7-H7A…O9 hydrogen bond forms an acid-amide )8(22R dimer) and a 
second strong hydrogen bond is donated from O11 via H11 to the pyridine N1. A weak C-
H....O hydrogen bond is formed from C4 via H4 to the carbonyl oxygen O12, this hydrogen 
bond propagates in the [010] direction (as illustrated in figure 5.9). 
 
Figure 5.9: Fumaric acid:nicotinamide looking down the a axis. Carbon, nitrogen, oxygen 
and hydrogen atoms are shown in black, blue, red and white respectively. (Unit cell shown) 
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The structure consists of infinitely hydrogen bonded sheets, in the (104) plane, containing 
both fumaric acid and nicotinamide molecules, see figure 5.10. The planar sheets are not 
connected by hydrogen bonds, with a distance of 3.081 Ǻ between the layers. 
 
Figure 5.10: A view along the b axis, showing the hydrogen bonded sheets in the 
(101) plane. Carbon, nitrogen, oxygen and hydrogen atoms are shown in black, blue, 
red and white respectively. 
 
Table 5.2: Hydrogen bonds geometry in fumaric acid:nicotinamide (Å and °). 
Donor—H---Acceptor d(D—H) 
 
d(H-A) 
 
d(D-A)  <(DHA) 
N(7) —H(7A)….O(9)#1 0.880(1) 2.0200(1) 2.8814(17) 166.1 
N(7) —H(7B)…O(12)#2 0.880(1) 2.1800(1) 3.0315(17) 163.2 
O(8) —H(8)……O(7)#3 0.840(1) 1.7900(1) 2.6193(15) 170.8 
O(11) —H(11)….N(1)#4 0.840(2) 1.7900(1) 2.5885(17) 170.0 
C(5) —H(5)…..O2 0.950(1) 2.7500(2) 3.4141(17) 1.31.9 
Symmetry transformations used to generate equivalent atoms: #1( x-1, y, z)   #2 (2-x, y+1, -z)  
#3 (x+1, y,z)   #4 (x-1, y+1/2, z-1/2) 
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5.5 Comparison of the Single crystal vs. Powder structure 
 
To aid the method development for the solution of this type of multi-component crystal 
structures from pxrd, structures solved from pxrd are also compared to those solved using 
single crystal methods. In cases such as this structure, with groups of similar scattering 
behaviour, this allows us to assess areas of potential problems, such as the orientation flip of 
similar functional groups, which can be indistinguishable from poor quality pxrd data and can 
lead to false structure solutions. 
Below in figures 5.11 and 5.12, direct comparison between the single crystal atomic positions 
and the final refined atomic positions of the nicotinamide molecule in fumaric 
acid:nicotinamide. 
 
Figure 5.11: Nicotinamide molecule from fumaric acid:nicotinamide. The green molecule 
represents single crystal positions and the blue molecule represents final refined powder 
positions (non-hydrogen atoms only) 
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Figure 5.12: Fumaric acid molecule from fumaric acid:nicotinamide. The green molecule 
represents single crystal positions and the blue molecule represents final refined powder 
positions (non-hydrogen atoms only) 
The subsequent analysis confirmed that the crystal packing obtained by powder methods was 
correct; minimum, maximum and mean distances between pairs of corresponding atoms in 
the single and refined powder structures was calculated at 0.0621, 0.5556 and 0.2888 Å 
respectively. 
 
5.6 Efficiency of the DE algorithm 
Table 5.3, illustrates that a large population coupled with a mutation rate (F) equal to 0.3 
produced the most successful epoch with a % Rwp of 13.23, this was the starting point for a 
successful Rietveld refinement. As illustrated in figure 5.6, a plateau in Rwp is followed by a 
steep decline, indicative of the deterministic nature of the DE algorithm, but also, suggesting 
a shallow and deep global minimum.  
Values of F and Np were chosen for variation between limits chosen from previous DE 
studies12 and K was fixed throughout at 0.99. For each combination of parameters, five 
epochs were calculated. As shown in figure 5.6, the progression of the DE calculation has a 
prolonged stagnation period followed by a sharp decline towards the global minimum, 
coupled with a trend in this case of smaller mutation vector resulting in lower Rwp. 
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Table 5.3 illustrates that as expected, the large population sizes coupled with a mutation 
factor of 0.5 fail to locate the narrow global minimum within the number of generations 
allowed. Many results did not converge and reached Gmax (maximum number of generations 
allowed in one epoch before the calculation is halted and proceeding epoch initiates), 
extension to larger values of Gmax would give more indication of the convergence of the DE 
calculation with these higher population values. In this case, larger population size, Np = 375 
but small F (0.3).  
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Table 5.3: The results from a number of DE calculations with variation in F (mutation rate) 
and NP (population size). For each epoch the final Rwp (in %) is given and figures within 
brackets indicate at which generation convergence was achieved. The gold cell indicates the 
lowest Rwp achieved and the starting point for the successful structure refinement. Runs that 
have not converged by the maximum allowed number of generations are shaded grey. 
Run F NP epoch 1  epoch 2  epoch 3  epoch 4  epoch 5  
1 0.3 140 20.89(304) 18.18(284) 23.5(286) 20.59(255) 22.11(243) 
2 0.3 140 21.37(334) 18.01(237) 20.44(212) 20.87(208) 24.57(272) 
3 0.4 140 21.94(899) 21.53(580) 16.36(655) 18.87(789) 20.82(613) 
4 0.4 140 16.21(736) 17.77(478) 20.52(553) 14.88(451) 16.75(447) 
5 0.5 150 23.53(954) 17.31(1268) 22.51(1374) 16.6(1498) 27.24(871) 
6 0.6 180 27.34(1500) 25.82(1500) 25.23(1500) 27.92(1500) 27.05(1500) 
7 0.3 225 20.26(297) 22.77(347) 19.72(354) 22.19(467) 20.64(401) 
8 0.3 300 19.59(614) 21.5(480) 14.39(550) 14.41(380) 16.95(560) 
9 0.3 300 22.18(489) 19.48(632) 18.21(627) 17.89(512) 15.86(529) 
10 0.8 300 26.01(3000) 26.34(3000) 27.47(3000) 21.55(3000) 26.66(3000) 
11 0.4 330 17.12(1172) 16.65(1396) 12.95(1658) 20.28(1340) 16.11(1259) 
12 0.4 330 17.34(1632) 17.81(1356) 18.94(1584) 15.29(1451) 15.35(1345) 
13 0.6 330 26.69(3000) 24.83(3000) 13.99(2895) 24.33(3000) 25.03(3000) 
14 0.2 375 16.5(186) 21.99(247) 15.74(230) 17.92(220) 17.21(191) 
15 0.3 375 15.57(725) 15.04(587) 15.96(589) 18.55(557) 15.04(709) 
16 0.3 375 20.2(2948) 13.23(2822) 17.71(3000) 22.84(3000) 26.21(3000) 
17 0.3 375 19.64(619) 16.32(555) 14.1(592) 16.65(812) 18.27(509) 
18 0.4 375 13.34(1798) 13.88(1518) 15.05(1992) 14.76(1930) 19.73(1749) 
19 0.4 375 15.12(2061) 15.4(1532) 20.17(1768) 17.38(1953) 13.7(1926) 
20 0.5 375 25.98(2000) 26.41(2000)    
21 0.5 375 24.95(3000) 22.58(3000) 19.06(3000) 24.77(3000) 26.72(3000) 
22 0.6 375 25.79(3000) 27.35(3000) 25.33(3000) 25.73(3000) 27.01(3000) 
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5.7 Thermal behaviour of fumaric acid:nicotinamide 
The thermal behaviour of fumaric acid:nicotinamide was investigated using a Bruker AXS 
D5000 high-resolution X-ray powder diffractometer fitted with an Oxford cryostream and 
capillary stage (3.1.4) over the temperature range 100-295K. The variable temperature data 
also confirms that there was no phase transformations over the temperature range investigated 
(100-295 K). As described in section 4.7, lattice parameters from the single crystal study 
were used as a starting point for the LeBail fit based on the data collected at 295 K. Figure 
5.13, illustrates the movement in scattering angle of diffraction peaks as the temperature is 
varied; as the temperature increases, the lattice parameters increase and the peak shifts to a 
lower 2θ value. 
  
Figure 5.13: X-Ray powder diffraction peak of fumaric acid:nicotinamide over the 
temperature range investigated, 295 K (blue), 250 K (pink), 200 K (green), 150 K (sky blue) 
and 100 K (purple). 
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The lattice parameters from these LeBail fits are given in Table 5.4 and plotted in figure 5.14. 
It is clear from these that, the general trend in all lattice parameters is that of expansion. The 
∆L/L0 values quoted in table 5.4 indicate the fractional change in the lattice parameter, (as in 
section 4.7).   
Table 5.4: Lattice parameters from the LeBail fitting of fumaric acid:nicotinamide. ∆L/L0 
values are given in square brackets. 
Temperature 
(K) 
a (Å) b (Å) c (Å) β˚ Volume (Å3) 
% 
Rwp 
χ2 
100 
14.027(5) 
[0.00] 
13.740(9) 
[0.00] 
5.507(3) 
[0.00] 
91.90(4) 
[0.00] 
1060.0(1) 
[0.00] 
6.218 8.106 
150 
14.103(4) 
[0.0054] 
13.758(6) 
[0.0013] 
5.526(2) 
[0.0034] 
92.172(2) 
[0.0030] 
1071.45(9) 
[0.0100] 
9.63 7.199 
200 
14.190(2) 
[0.0116] 
13.771(3) 
[0.0023] 
5.5334(12) 
[0.0048] 
92.663(1) 
[0.0083] 
1080.1(5) 
[0.0180] 
6.3 3.292 
250 
14.282(3) 
[0.0182] 
13.793(3) 
[0.0039] 
5.545(2) 
[0.0073] 
93.14(2) 
[0.0134] 
1090.8(7) 
[0.0283] 
5.82 2.664 
295 
14.378(2) 
[0.0250] 
13.802(3) 
[0.0045] 
5.5641(12) 
[0.0103] 
93.50(1) 
[0.0175] 
1102.1(5) 
[0.0389] 
6.16 2.676 
 
 
 
Figure 5.14: The fractional variation of lattice parameters obtained from LeBail refinement, 
plotted against temperature; Unit cell volume (purple spots), a (blue line), b (pink line), c 
(orange line) and β (sky blue dashed line).  
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As previously mentioned (section 4.7), lattice parameters obtained from structureless pattern 
decomposition methods such as the LeBail method can be potentially problematic; 
consequently a series of Rietveld refinements were also performed on each data set (Table 
5.5 and figure 5.15). Lattice parameters acquired via Rietveld refinement should, however, 
also be viewed with caution as the refinement is now model biased, and unlike a LeBail fit, 
the position and intensity of the reflection is no longer independent of atom type and position.    
Table 5.5: Rietveld lattice parameters of fumaric acid:nicotinamide 
 
 
Temperature 
(K) a (Å) b (Å) c (Å) β˚ 
Volume 
(Å3) % Rwp χ
2 
100 
14.036(6) 
[0.00] 
13.752(7) 
[0.00] 
5.512(4) 
[0.00] 
91.87(5) 
[0.00] 
1063.3(1) 
[0.00] 
8.82 8.384 
150 
14.112(4) 
[0.0054] 
13.767(7) 
[0.0011] 
5.522(2) 
[0.0019] 
92.25(2) 
[0.0041] 
1072.0(9) 
[0.0082] 
12.74 14.38 
200 
14.184(4) 
[0.0106] 
13.771(5) 
[0.0014] 
5.529(3) 
[0.0031] 
92.72(4) 
[0.0093] 
1078.7(9) 
[0.0145] 
7.55 7.297 
250 
14.281(4) 
[0.0175] 
13.793(5) 
[0.0030] 
5.546(2) 
[0.0062] 
93.14(3) 
[0.0139] 
1090.7(1) 
[0.0258] 
7.01 4.998 
295 
14.380(3) 
[0.0245] 
13.809(4) 
[0.0042] 
5.565(2) 
[0.0097] 
93.52(3) 
[0.0180] 
1103.0(8) 
[0.0374] 
6.54 3.133 
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Figure 5.15: The fractional variation of lattice parameters obtained from Rietveld refinement, 
plotted against temperature. Unit cell volume (purple dashes), a (blue), b (pink), c (orange) 
and β (sky blue dashes). 
 
Table 5.6 contains the linear thermal expansion co-efficients along the principal 
crystallographic axis of the monoclinic system, (this is calculated using equation 4.1 in 
section 4.7.   
 
Table 5.6: Linear thermal expansion co-efficients of the lattice parameters of fumaric 
acid:nicotinamide. 
Lattice parameter Linear thermal expansion 
co-efficient (K-1) 
a 1.2583 x10-4 
b 2.1372 x10-5 
c 4.9772 x10-5 
Beta 9.2216 x10-5 
Unit cell volume 1.9171 x10-4 
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As evident from figure 5.15, all the parameters increase with temperature. As presented in 
section 5.4, the structure contains hydrogen bonded sheets that run in the (101) plane. This 
direction corresponds to the smallest amount of thermal expansion. The N7 via H7B to O12 
(2+x, 0.5-y, 0.5+Z) runs parallel to the b axis. The infinitely hydrogen bonded sheet dissects 
both the a and c axes, the [011] direction is the most thermally liable of the crystallographic 
axes suggesting thermal expansion in this direction is less sterically hindered than the [110].  
 
 
5.8 Cocrystallisation of maleic acid:nicotinamide 
 
Maleic acid (cis-butenedioic acid), as shown in figure 5.1 (ii), is one of two isomeric 
unsaturated carboxylic acids, the other being fumaric acid (figure 5.1), studied as cocrystal 
formers in this project. The isomerisation of maleic acid to fumaric acid occurs in the melting 
point range 130-140 °C but below 230 °C, at which fumaric acid is dehydrated to make 
maleic anhydride13. Isomerisation can also occur with the aid of a photochemical reaction14. 
The maleic acid ion (maleate) has medicinal properties; VASOTEC (Enalapril Maleate) is a 
maleate salt of analapril, the ethyl ester of enaloprlat, a long-acting angiotension converting 
enzyme inhibitor which lowers blood pressure.15  Maleic acid was reported as monomorphic 
for nearly 124 years after the initial X-ray data were collected in 188116 and followed by 
additional determinations of the crystal structure17, 18. A second crystalline structure was 
discovered19 after a co-crystal of caffeine and maleic acid (2:1) was dissolved in chloroform, 
inducing a polymorphic transition in maleic acid generating form II. The ability of maleic 
acid to form more than one crystalline form implies that it would make a good co-
crystallising agent20. The structural flexibility possessed by the maleic acid molecule 
advocates that the molecule is not locked into an energetically single conformation.  
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In the remainder of this chapter, attempts to perform the co-crystallisation of maleic acid with 
nicotinamide (section 5.8) via a number of solid state synthetic routes will be discussed. 
 
5.9 Characterisation of maleic acid:nicotinamide 
Suitable crystals for single crystal diffraction were grown by solvent mediated 
recrystallisation (section 3.6.1) and full structural characterisation was carried out by single 
crystal diffraction. 
Pxrd was used to confirm that crystallisation produced two new crystalline phases, (figure 
5.16). These two phases will be labelled as product A and product B. The products are 
sensitive to the solvent selected for crystallisation. Product A was crystallised from a 1:1 
starting ratio of maleic acid and nicotinamide in ethanol, and product B was recrystallised 
from a 1:1 ratio of starting materials but in methanol, (see section 3.6.1 and 3.6.5). The 
stoichiometric ratio of the two starting materials in both products A and B was confirmed by 
1H NMR (section 3.6.2 and 3.6.6). 
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Figure 5.16: Powder X-ray diffraction patterns of the starting materials, maleic acid (orange) 
and nicotinamide (red), the maleic acid:nicotinamide multi-component material product A 
(black) and product B (purple) 
 
Product B was subjected to prolonged thermal exposure by heating to 100 ˚C for one week to 
ensure that product B was not a solvate of product A. This exposure to elevated temperature 
turned the crystallites from yellow to red but did not change the crystalline phase. 
Further characterisation of the new multi-component crystalline phase A was undertaken by 
solid state infra-red spectroscopy which confirmed the presence of a new phase when 
compared to the spectrum of a mix of the two starting materials, alluding to the synthesis of a 
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new multi-component crystal with different hydrogen-bonding characteristics to that of the 
component mixture, (figure 5.17). The presence of two broad peaks at 2501 cm-1 and 1896 
cm-1, is characteristic of an acid----N heterocyclic hydrogen bond, and is viewed as evidence 
for multi-component formation4.  
 
Figure 5.17: Solid state IR spectra of maleic acid and nicotinamide mix (black line) and the 
new multi-component crystal product A (red line). 
 
The diffraction pattern of maleic acid:nicotinamide product B was compared to that of 
fumaric acid:nicotinamide, (as illustrated in figure 5.17). This comparison and the subsequent 
single crystal structure determination indicated the occurrence of an unexpected isomerisation 
reaction; the transformation of the maleic acid molecule from a cis to a trans conformation 
during the cocrystallisation process. As mentioned previously, the isomerisation of maleic 
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acid to fumaric acid is normally induced by either by thermal or via photochemical routes. 
The isomerisation of maleic acid to fumaric acid through co-crystallisation has been reported 
in the literature only once21, where it is suggested that a highly polar solvent such as DMF, is 
the driving force behind the mechanism of the isomerisation. In this work, the isomerisation 
only occurs in methanol and not ethanol, even though both solvents share many physical 
properties including both being polar protic solvents. A proposed mechanism for the 
isomerisation is postulated below in figure 5.18. 
 
Figure 5.18: Proposed mechanism for the isomerisation of maleic acid when cocrystallised 
with nicotinamide 
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When cocrystallised from methanol, as explained in section 3.6.5, product A crystallises first 
(maleic acid: nicotinamide); product A then re-dissolves in the solvent and recrystallises as 
product B (fumaric acid:nicotinamide). Both products A and B were isolated when 
crystallising in methanol, the diffraction patterns of these isolated products are shown in 
figure 5.19. 
 
 
Figure 5.19: The powder X-ray diffraction patterns of product A (blue) and product B (red) 
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The result of this isomerisation is a conversion from a salt to a cocrystalline product. The 
pxrd patterns of fumaric acid:nicotinamide and maleic acid:nicotinamide product B are 
shown in figure 5.20.  
Ostwald’s rule22, 23 states that a thermodynamically unstable phase may appear first, with 
more stable forms recrystallising subsequently. Unfortunately, this rule cannot be applied to a 
system such as considered here as it contains two chemically distinct species.. 
Figure 5.20: The powder X-ray diffraction patterns of fumaric acid:nicotinamide (black) and 
maleic acid:nicotinamide product B (purple). 
 
Deleted:  
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A mechanochemical screen was conducted alongside a sonic slurry approach with only 
product A being accessible via the reduced solvent co-crystal synthetic routes, (see figure 
5.21). The diffraction patterns indicate again that the mechanochemical approach creates 
crystallites which are lower in quality as the diffraction peaks are broader and of less relative 
intensity to that of sonic approaches to co-crystal production.  
 
Figure 5.21: Powder X-ray diffraction patterns of the starting materials, maleic acid (orange), 
nicotinamide (red). The maleic acid:nicotinamide multi-component  material product A from 
solvent mediated crystallisation (balck), sonic slurry (green) and mechanochemical grinding 
(purple).   
 
5.10 Structure solution of maleic acid:nicotinamide (product A) 
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The X-ray powder diffraction data set used for structural analysis was collected over a period 
of 8 hours and the range of 10˚ ≤ 2θ ≤ 60˚.  The data were indexed on the basis of the first 20 
observable reflections using the indexing program CRYSFIRE6 (appendix Q) and the Pbca 
space group assigned by consideration of systematic absences. The profile parameters were 
refined using the whole-profile-fitting LeBail7 method in the GSAS8 program to improve the 
fit of the lattice, zero point and profile parameters. Structure solution was carried out using 
the DE technique (section 1.7.5) as implemented is the program POSSUM9. 
From density considerations it was concluded that the asymmetric unit contained one maleic 
acid and one nicotinamide molecule, hence the structural model used in the DE calculation 
comprised both molecules, constructed using standard bond lengths10 and angles, but 
excluding the hydroxyl and amine hydrogen atoms. The nicotinamide molecule is defined by 
7 DE elements and the maleic acid molecule by 8 DE elements: for each molecule 3 
parameters (θ,Φ,Ψ) were used to define the orientation within the unit cell (bounds 0 - 360˚), 
3 parameters (x,y,z) were used to define the position of the molecule (bounds 0-1). 
Nicotinamide contains one unconstrained torsion angles (0-360˚) and maleic acid contains 2 
unconstrained torsion angle (0-360˚) to define the conformation of each molecule, (figure 
5.22). The molecules were moved independently in the structure solution resulting in a 15 
parameter problem. 
 
Figure 5.22: Molecular structures used in the DE structure solution, torsion angles are 
indicated by arrows. Excluded hydrogen atoms are shown in brackets. 
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Initial DE solutions were unsuccessful in locating the global minimum (a successful structure 
solution), with the best DE solution having Rwp of 29.94 %, (Lebail Rwp= 6.60 %). In 
isolation to the powder DE calculation, a single crystal diffraction data set was obtained and 
the structure solution obtained from this. The resulting single crystal structure was refined 
against the powder data, showing a discrepancy in peak intensities between the calculated and 
experimental diffraction patterns, implying a severe case of preferred orientation in the 
powder data. The preferred orientation fraction was refined using the March-Dollase 
correction, in the direction giving a significant 001 ratio of 1.64575. A correction for 
preferred orientation is not refined during the DE calculation, so that the overall efficiency of 
the calculation is maintained. Subsequent DE calculations with this parameter used to 
describe the preferred orientation, gave a better solution, with a best Rwp of 16.43 % (figures 
5.23 and 5.24).   
 
Figure 5.23: Maleic acid molecule from maleic acid:nicotinamide. The red molecule 
represents single crystal positions and the blue molecule from the DE solution 16.43. (non-
hydrogen atoms only) 
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Figure 5.24: Nicotinamide molecule from maleic acid:nicotinamide. The red molecule 
represents single crystal positions and the blue molecule from the DE solution 16.43. (non-
hydrogen atoms only) 
The subsequent analysis confirmed that the crystal packing obtained by powder methods was 
incorrect; minimum, maximum and mean distances between pairs of corresponding atoms in 
the single and refined powder structures was calculated at 2.7208, 6.2564 and 3.932 Å 
respectively. The initial lattice parameters, DE structure solution parameters and single 
crystal determination details are shown in table 5.7 
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Table 5.7: Initial lattice parameters, DE structure solution parameters and single crystal 
determination. 
Compound maleic 
acid:nicotinamide 
product A 
Crystal data  
Chemical formula C4H4O4 + 
C6N2H6O 
Mr 238.2 
Indexing  
Space group Pbca 
Initial a / Ǻ 6.4374(1) 
Initial b / Ǻ 10.8654(1) 
Initial c / Ǻ 29.1677(2) 
  
Initial V / Ǻ 3 2040.138(2) 
 
Structure solution  
LeBail Rwp / % 6.60 
LeBail Rp / % 5.24 
LeBail χ2 1.431 
 
DE elements  
K 0.99 
F 0.4 
Np 330 
Average Rwp / % 16.43 
Best Rwp / % 16.43 
Preferred orientation 
fraction [and direction] 
1.64575 [001] 
No of parameters 15 
No. of restraints 62 
  
Single Crystal values  
  
a / Ǻ 6.3710(2) 
b / Ǻ 10.8535(3) 
c / Ǻ 29.1693(8) 
β / ˚ 92.54(1) 
V / Ǻ 3 2016.99 
Space group Pbca 
 
 
 5. Cocrystallisation of fumaric acid:nicotinamide, maleic acid:nicotinamide and maleic 
acid:isonicotinamide 
                                                                                                                                                170 
 
 
5.11 Efficiency of the DE algorithm 
The DE calculation for maleic acid:nicotinamide was unsuccessful, as discussed in section 
5.10. Values of F and Np were chosen for variation between limits chosen from previous DE 
studies12 and K was fixed throughout at 0.99. For each combination of parameters, five 
epochs were calculated. Table 5.8, illustrates the impact of preferred orientation upon the 
algorithms progress. 
Table 5.8: The results from a number of DE calculations with variation in F (mutation rate) 
and NP (population size). For each epoch the final Rwp (in %) is given and figures within 
brackets indicate at which generation convergence was achieved. Runs that have not 
converged by the maximum allowed number of generations are shaded grey. Runs 6-9 the 
preferred orientation was set to 1.64575  in the [001] direction. 
Run F NP epoch 1  epoch 2 epoch 3 epoch 4 epoch 5 
1 0.5 300 38.96(2000) 38.66(2000)  /  /  / 
2 0.5 150 30.78(3000) 39.37(3000)  /  /  / 
3 0.5 210 39.71(4000) 37.78(2662) 30.37(3832) 30.81(3573) 29.94(2199) 
4 0.4 210 32.39(1758) 31.00(2200) 33.68(1741) 31.6(2484) 31.4(2989) 
5 0.5 300 31.06(3690) 32.1(2726) 38.38(4000)  /  / 
6 0.4 300 25.8(2689) 25.29(3016)  /  /  / 
7 0.3 280 23.49(551) 20.93(221) 19.52(153) 17.3(114) 17.15(142) 
8 0.4 280 20.1(1846) 16.43(1650) 16.44(1680) 16.44(1753) 16.45(1855) 
9 0.5 280 19.25(3577) 19.28(2554) 19.50(3600) 19.25(3590) 19.25(1842) 
 
 
5.12 Maleate acid:nicotinamide (product A) structure 
The following crystal structure description is based on the single crystal data collected on 
Bruker SMART 6000 diffractometer (λCu-Kα = 1.54178 Å) at 200 K. Further details on the 
single crystal structure solution can be found in appendix R. An incubator was used to grow a 
single crystal of suitable quality and size to warrant a single crystal diffraction experiment, as 
(see section 3.6.4). The crystalline structure is a disordered material, with 50% occupancy of 
the disordered hydrogen across both the H8 site and H11 site. The single crystal structure also 
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confirms the migration of a proton from one carboxyl site on the maleic acid moiety onto the 
heterocyclic nitrogen of the nicotinamide moiety giving a salt. The ORTEP diagram showing 
the atom labelling and hydrogen atom positions is shown in figure 5.25. 
 
Figure 5.25: The molecular structure of maleate:nicotinamide, showing the atom numbering 
and the hard and soft intermolecular hydrogen bonds within the asymmetric unit (dashed 
lines). Displacement ellipsoids are drawn at the 50 % probability level and H atoms are 
shown as small spheres of arbitrary radii. 
 
The supramolecular structure of maleate:nicotinamide is determined through three 
intermolecular hydrogen bonds and one intramolecular hydrogen bonds; three strong N-
H….O hydrogen bonds (two N-H....O and one N+-H....O-), and one disordered O-H….O 
hydrogen bonds, all details are shown in table 5.9. All strong hydrogen-bond donors and 
acceptors are used in the hydrogen bond network. The conformation of the amide group in 
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the nicotinamide group is approximately planar, with a torsion angle of C4-C5-C7-N7 of 
175.9(3)°. A complementary hydrogen bond is donated by N7 via H7A to the acceptor O7 (1-
x,-y,-z) resulting in an R 22 (8) nicotinamide dimer. N7 donates a second hydrogen bond via 
H7B to the maleic acid O9. N1 also donates a hydrogen bond via H1 to O12 (1+x,y,z), as 
shown in figure 5.26. 
 
 
Figure 5.26: Packing of maleate ions and nicotinamide molecules, viewed along the a axis. 
(Unit cell shown) 
 
The combination of these hydrogen bonds forms an infinitely hydrogen bonded sheet running 
in the [001], within the sheet dimers of nicotinamide molecules are linked via maleic acid 
molecules, as shown in figure 5.27.  
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Figure 5.27: A Hydrogen bonding network running in maleate:nicotinamide. 
 
 
 
Table 5.9: Hydrogen bonds geometry in maleic acid:nicotinamide (Å and °). 
Donor-----H… Acceptor d(D-H) d(H….A) d(D…A) <(DHA) 
N(1)—H(1)…O(12)#1 0.8800(1) 1.9300(1) 2.6953(16) 144.9 
N(7)—H(7A)…O(7)#2 0.8800(1) 2.1200(1) 2.9976(17) 176.8 
N(7)—H(7B)…O(9) 0.8800(1) 2.0100(1) 2.8692(16) 165.7 
O(8)—H(8)…O(11)* 0.8400(2) 1.6000(1) 2.4288(15) 167.6 
O(11)-H(11)….O(8)* 0.8400(1) 1.6000(2) 2.4288(15) 170.4 
Symmetry transformations used to generate equivalent atoms:  (#1) x+1/2,y,-z+1/2    (#2) -x,-
y,-z.  * denotes hydrogen bonds on disordered hydrogen positions.  
 
5.13 Thermal behaviour of maleate:nicotinamide (product A) 
The thermal behaviour of maleate:nicotinamide was probed by collecting a series of powder 
diffraction data sets collected over the range 100-295 K, using the Bruker AXS D5000 high-
resolution X-ray powder diffractometer fitted with Oxford Cryostream and capillary stage 
(section 3.1.4). Lattice parameters derived from the single crystal experiment were used as a 
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starting point for a LeBail fit, starting with the data collected at 295 K. As a stable refinement 
was achieved, the resultant lattice parameters were used as a starting point for the subsequent 
fitting of the next data set at 250 K. The process was repeated until the fitting of the final data 
set at 100 K. There was no evidence of a phase change over the temperature range 
investigated. Figure 5.28 illustrates the shift of the diffraction peaks to a lower 2-theta with 
increasing temperature. 
 
Figure 5.28 X-ray powder diffraction peaks of maleate:nicotinamide over the temperature 
range investigated, 295 K (blue), 250 K (pink), 200 K (green), 150 K (sky blue) and 100 K 
(purple). 
 
The lattice parameters from these LeBail fits are given in Table 5.8, and plotted in figure 
5.29. It is clear from these that, the general trend is that of expansion. The ∆L/L0 values 
quoted in Table 5.10, indicate the fractional change in the lattice parameter (section 4.7). 
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Table 5.10: Lattice parameters from the LeBail fitting of maleate:nicotinamide product A. 
∆L/L0 are given in square brackets 
Temperature 
(K) 
a (Å) b (Å) c (Å) Volume (Å3) Rwp χ2 
100 
6.308(1) 
[0.00] 
10.678(3) 
[0.00] 
28.927(6) 
[0.00] 
1948.5(1) 
[0.00] 
10.75 8.956 
150 
6.354(1) 
[0.0073] 
10.739(3) 
[0.0057] 
28.983(5) 
[0.0019] 
1977.7(1) 
[0.0150] 
10.53 7.910 
200 
6.398(1) 
[0.0142] 
10.817(2) 
[0.0130] 
29.066(5) 
[0.0048] 
2011.4(9) 
[0.0323] 
11.34 6.99 
250 
6.4076(2) 
[0.0158] 
10.859(1) 
[0.0169] 
29.154(2) 
[0.0078] 
2028.5(4) 
[0.0411] 
4.21 2.486 
295 
6.4412(6) 
[0.0211] 
10.873(2) 
[0.0183] 
29.157(3) 
[0.0080] 
2042.1(6) 
[0.0481] 
4.76 3.839 
 
 
Figure 5.29: The fractional variation of lattice parameters obtained from the LeBail 
refinement against temperature, Unit cell volume (purple spots), a (blue line), b (pink line), c 
(orange line). 
 
In order to address the problems as previously discussed with the calculation of lattice 
parameters from LeBail pattern decomposition, Rietveld analysis was performed on each set, 
with subsequent lattice parameters acting as a starting point for the next data set (table 5.11 
and figure 5.30). 
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Table 5.11: Lattice parameters from the Rietveld fitting of maleate:nicotinamide product A. 
∆L/L0 are given in square brackets 
Temperature 
(K) 
a (Å) b (Å) c (Å) 
Volume 
(Å3) 
Rwp χ2 
100 
6.3127(8) 
[0.00] 
10.796(2) 
[0.00] 
29.148(4) 
[0.00] 
1986.6(8) 
[0.00] 
6.27 3.031 
150 
6.3385(8) 
[0.0041] 
10.812(2) 
[0.0015] 
29.143(4) 
[-0.0002] 
1997.3(8) 
[0.0054] 
6.47 3.2 
200 
6.3711(6) 
[0.0093] 
10.8357(17) 
[0.0036] 
29.147(3) 
[-0.00003] 
2012.2(6) 
[0.0129] 
6.24 2.444 
250 
6.4072(4) 
[0.0150] 
10.858(1) 
[0.0057] 
29.152(2) 
[0.0001] 
2028.1(4) 
[0.0209] 
4.26 2.907 
295 
6.442(1) 
[0.0205] 
10.876(3) 
[0.0074] 
29.160(5) 
[0.0004] 
2043.2(1) 
[0.0285] 
4.65 1.922 
 
 
 
Figure 5.30: The fractional variation of lattice parameters obtained from the Rietveld 
refinement against temperature. Unit cell volume (purple spots), a (blue line), b (pink line), c 
(orange line). 
 
As evident from figure 5.30, the c direction corresponds to the direction of the lowest thermal 
expansion and correlates with the predominant hydrogen bonding network with alternating 
nicotinamide dimers connected via maleate moieties. The b direction is privy to lower energy 
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interactions, as π-π stacking of the nicotinamide molecules exist in the (101) plane. The a 
axis is the most thermally liable. 
Thermal expansion can be described by a linear thermal expansion along its primary 
crystallographic axes, (using equation 4.1). Table 5.12, contains the linear thermal expansion 
coefficients for each lattice parameter in maleate:nicotinamide. 
 
Table 5.12: Linear thermal expansion co-efficients of maleate:nicotinamide 
  
linear thermal 
expansion 
a 1.05256x10-4 
b 3.80547x10-5 
c 2.07183x10-6 
volume 1.46224x10-4 
 
 
 
5.14 Cocrystallisation of maleic acid:isonicotinamide  
 
Within this section, maleic acid (cis-butenedioic acid), is co-crystallised with isonicotinamide 
(pyridine-4-carboxamide), (figure 5.1). As well as investigating the potential comparison in 
cocrystallisation behaviour of nicotinamide and isonicotinamide, this study should also give 
valuable insight of the two crystal structures. 
 
5.15 Characterisation of maleic acid:isonicotinamide  
Pxrd was used to confirm that the product of crystallisation was a new crystalline phase, and 
did not contain any of the starting materials (figure 5.31). 
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Figure 5.31: Powder X-ray diffraction patterns of the starting materials, maleic acid (orange) 
and isonicotinamide (red) and the maleic acid:isonicotinamide multi-component material 
(black). 
 
In parallel with traditional solvent-mediated recrystallisation, pxrd was used to confirm that 
the same bulk crystalline phase was produced by both LAG (section 1.11.4) and sonic slurry 
(section 1.11.4) methods. The diffraction patterns indicate (as previously reported) that the 
mechanochemical approach creates crystallites which are lower in quality than that of sonic 
approaches to co-crystalline preparation (figure 5.32).  
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Figure 5.32: Powder X-ray diffraction patterns of the starting materials, maleic acid (orange) 
and isonicotinamide (red). The maleic acid:isonicotinamide solvent mediated multi-
component material (black), sonic slurry (purple) and mechanochemically ground (orange). 
 
 
5.16 Maleic acid:isonicotinamide structure 
The following crystal structure description is based upon the single crystal data collected on a 
Bruker Smart 6000 diffractometer equipped with a CCD detector and a copper tube source 
(lattice parameter shown in table 5.13). The crystal selected for single crystal analysis was 
grown using an incubator (section 3.7.3), and recrystallised from ethanol to produced white 
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crystallites. This crystalline structure is also disordered, with 50% occupancy of a hydrogen 
atom across the H8 site and H11 site, in a similar way to that in maleate:nicotinamide. The 
single crystal structure also confirms the transfer of a proton from one carboxyl site on the 
maleic acid moiety to the heterocyclic nitrogen on the isonicotinamide moiety (figure 5.33) 
forming a salt. Further single crystal details can be found in appendix S. 
Table 5.13: Single crystal parameters of maleate:isonicotinamide 
Single Crystal values  
Space group P-1 
a / Ǻ 3.7240(3) 
b / Ǻ 10.8616(10) 
c / Ǻ 13.1664(10) 
α/ ˚ 99.8200(3) 
β / ˚ 97.2700(1) 
γ/ ˚ 95.9900(1) 
V / Ǻ3 2016.99 
 
 
 
Figure 5.33: The molecular structure of maleate:isonicotinamide. Showing the atom 
numbering scheme and the hard intermolecular hydrogen bonds within the asymmetric unit 
(dashed lines). Displacement ellipsoids are drawn at the 50 % probability level and H atoms 
are shown as small spheres of arbitrary radii. 
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The supramolecular structure of maleate:isonicotinamide is determined through six 
intermolecular hydrogen bonds, two N(heterocyclic)+H...O- bonds, two N-H....O bonds and 
two O-H....O (Table 5.11). The conformation of the amide group in the isonicotinamide is 
approximately planar, with a torsion angle of C5-C4-C7-O7 of 164.277(20)°.  
Table 5.14: Hydrogen bonds geometry in maleate:isonicotinamide (Å and °). 
Donor—H---Acceptor D—H H---A D----A <(DHA) 
N(1) —H(1)….O(12) 0.8800(1) 1.7400(2) 2.610(2) 170.1 
N(1)---H(1).....O(11) 0.8800(1) 2.5200(1) 3.124(2) 126.6 
N(7) —H(7A).....O(9) 0.8800(1) 2.0200(1) 2.890(2) 170.1 
N(7) —H(7B)…O(9) 0.8800(2) 2.1000(2) 2.929(2) 157.1 
O(8)—H(8)…O(11)* 0.8400(1) 1.6000(1) 2.4288(15) 167.6 
O(11)-H(11)….O(8)* 0.8400(2) 1.6000(1) 2.4288(15) 170.4 
.  
* denotes hydrogen bonds on disordered hydrogen positions. 
All strong hydrogen-bond donors and acceptors are used in the hydrogen bond network. The 
maleate ion and the isonicotinamide ion are linked via a protonated hetrocyclic N1, donating 
a hydrogen bond via H1 to the carbonyl oxygen O12. The amide N7, acts as a bifurcated 
hydrogen bond donor, firstly to O9 via H7A and secondly to O9 via H7B (figure 5.34) 
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Figure 5.34: Maleate ions and isonicotinamide molecules ribbons running in the (011) plane. 
(Unit cell shown) 
Hydrogen bonded sheets of maleate ions and isonicotinamide molecules are shown in figure 
5.35. 
 
Figure 5.35: Sheets of meleate ions and isonicotinamide molecules. (Unit cell shown) 
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Unlike in the maleate:nicotinamide structure, the favourable amide dimer synthon is not 
formed.  No pxrd solution was undertaken for the maleate:isonicotinamide. 
 
5.17 Conclusions 
All three structures discussed in this chapter had a ∆pka between 0 and 3. As discussed in 
1.11.1, in the range 0 < ∆pKa < 3 crystallisation can produce a salt, cocrystal or a disordered 
material, with the precise location of the proton highly dependent upon the packing and local 
steric environment. This is seen to be true, as in this chapter there are two salts 
(maleate:nicotinamide and maleate:isonicotinamide) and one cocrystal (fumaric 
acid:nicotinamide). The maleate:isonicotinamide was recrystallised from both methanol and 
ethanol, and unlike in the maleate:nicotinamide system the maleate ion did not undergo 
isomerisation when cocrystallised with isonicotinamide.  
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6. Polymorphism of oxamic acid  
6.1. Oxamic acid 
The title material under investigation in this chapter is oxamic acid (figure 6.1). 
 
Figure 6.1: Molecular structure of oxamic acid 
As previously discussed in section 4.1, oxamic acid is an important API, where it can 
affect the role of glycolysis in the growth of tumour cells1.  Its acts on the tumour cell 
pathway of ‘aerobic glycolysis’ which is the conversion of glucose to lactic acid under 
conditions in which oxygen is readily available. For a tumour cell to survive and 
divide, energy must be derived from its own metabolic processes, as hypothesised by 
Warburg2, 3. Oxamic acid has a similar structure to pyruvic acid and acts as an 
inhibitor to the metabolic pathways of the tumour cells.  
Oxamic acid contains both strong hydrogen bond acceptors, in form of the carbonyl 
oxygens, and donors, in the form of a hydroxyl oxygen and amide nitrogen, 
potentially lending itself as a useful building block in the design of hydrogen-bonded 
supramolecular architectures. The potential variation in intermolecular hydrogen-
bonding network can lend itself to a wide range of packing motifs and therefore in 
theory, oxamic acid has the potential ability to exhibit polymorphic behaviour.  
To date, the crystal structure of oxamic acid is still unreported. However it has been 
reported that oxamic acid is a potential impurity in various APIs4 so its 
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physiochemical characterization is as important as an understanding of its 
polymorphic behaviour. 
In terms of the determination and rationalisation of the crystal structure of the oxamic 
acid molecule from pxrd data, there are inherent difficulties associated with this 
molecule that make it a non-trivial task. The functional groups in the molecule contain 
similar electron density; and hence the direct space approach (section 2.2) may find it 
difficult to distinguish between possible packings or even syn and anti confirmations 
(figure 6.2) when limited by the data resolution obtained in a conventional pxrd 
experiment.  
 
 
Figure 6.2: Anti and syn isomers of oxamic acid 
 
Any DE solution will have to undergo further chemical and structural scrutiny before 
it is deemed to be successful. 
 
6.2 Polymorph screen 
Oxamic acid was purchased as a white powder (≥ 96 % purity) and the possibility of 
polymorphic behaviour investigated by conducting a solvent screen by traditional 
solvent mediated crystallisations (section 3.10.1) of oxamic acid from a number of 
solvents. The solvent screen identified two possible forms of oxamic acid, as shown 
by table 6.1. 
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Table 6.1: Solvent screen of oxamic acid 
Solvent Form I Form II 
Ethyl Acetate   
Acetonitrile   
Methanol   
Butanol   
Ethanol   
Propanol   
D2O   
Ethanol-d6   
 
Table 6.1 clearly demonstrates that Form I is obtained by recrystallisation from 
aprotic solvents, i.e. ethyl acetate and acetonitrile, whereas Form II is recrystallised 
from protic solvents and their deuterated analogs. This suggests that there may be a 
strong link between the solvent behaviour and the consequential interactions with the 
molecules in the solid state. The presence of acidic hydrogens and the potential for 
strong hydrogen bonding between the solute and solvent molecules during 
recrystallisation in the presence of a protic solvent will affect the overall structural 
outcome. Aprotic solvents are still polar in nature, but unlike protic solvents contain 
no acidic protons and the solvent does not display the same degree of hydrogen 
bonding with the solute. The formation of strong hydrogen bonding in a protic 
solvent, may affect the intermolecular energy profile of the system and explain the 
occurrence of a second possibly metastable form of oxamic acid (form II) which may 
be disordered or closely related to form I, as the energy for the nucleation of this 
crystalline form is lowered.   
The powder diffraction pattern of form I matches that of the commercial sample, 
(figure 6.3), and differs (but not significantly) from that of form II (figure 6.3). At first 
glance both diffraction patterns are similar, and could conceivably arise from a 
purification process by recrystallisation (from form I to form II). The most distinct 
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difference between the two patterns is the first peak at 2θ = 19.2° which is present in 
form I but not in form II. There are further low intensity peaks which again are 
present in form I but not form II (i.e. 2θ = 21.69, 23.10, 25.20, 29.87, 30.95, 32.84, 
34.00) 
The generation of form II from a number of different solvents in the solvent screen 
(table 6.1) suggests that it is a new polymorphic form rather than a solvate. 
Figure 6.3: The powder diffraction pattern of oxamic acid Form I (red) and Form II 
(blue) 
 
Consideration of the powder diffraction pattern alone shows that the structure of form 
II is similar to that of form I, just with some peaks missing. This suggests that form II 
is possibly of higher symmetry than form I, (hence fewer unique reflections in the 
diffraction pattern) raising the possibility that form II may have a metastable 
disordered structure. 
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6.3 Liquid assisted grinding 
Liquid assisted grinding (or solvent drop grinding) was then investigated as a possible 
method of inducing a polymorphic transition between the two forms, as a complement 
to the traditional solvent based approach to polymorph screening. Figure 6.4, shows 
the result of oxamic acid grinding for 10 minutes, in both a protic and aprotic solvent. 
 
Figure 6.4: Diffraction pattern of oxamic acid ground for 10 minutes in ethyl acetate 
(pink) and methanol (blue) 
 
From these patterns it is clear that both mechanochemically treated samples of oxamic 
acid, (from grinding with both protic and aprotic solvents), resemble the pattern of 
form II. However, the sample obtained from grinding in ethyl acetate does contain a 
peak ‘shoulder’ at ~19° which may be indicative of form I. In addition, the grinding 
process often results in a reduction in crystallinity and hence the other small peaks 
also indicative of form I may not be apparent. Hence it is difficult to be sure whether 
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or not the results of this experiment reproduce those from solvent-based 
recrystallisation. 
 
6.4 DSC results 
DSC was then used to investigate any phase transition between the two possible 
forms. Low temperature runs on both forms showed no significant thermal event, 
suggesting that there is no phase transition in the range 20.00 °C to –180 °C. However 
the high temperature trace of form II showed a small but significant thermal event at 
the onset temperature 179.2 °C, before sublimation at 208 °C. No thermal events were 
observed in the high temperature trace for form I. 
Figure 6.5: High temperature DSC trace of oxamic acid form II 
 
The small endotherm in figure 6.5, represents a phase transition possibly from form II 
to form I. The small intensity of this peak suggests that the forms are similar in 
energy; this could be the case if the crystal packing in both structures is similar, as 
supported by the significant similarity of the diffraction patterns of both forms. 
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6.5 Solution 
1
H NMR results 
In order to facilitate further characterisation of both forms and confirm the purity of 
the commercial form, solution 1H NMR spectra were recorded of both forms of 
oxamic acid (appendix T). Other than removal of an impurity, the 1H NMR of the 
recrystallised form I is the same as that of the commercial form. 
 
6.6 Solid-state NMR results 
Solid-state 13C MAS NMR spectroscopy was used to provide information about the 
possible contents of the asymmetric unit in both forms (see appendix U) for solid-state 
NMR spectra). Both spectra show only one centred signal at 163 ppm with a pair of 
(unlabelled) spinning sidebands indicating that the chemical shifts of the two carbons 
are unresolved. There is no clear difference between the spectra of the forms and no 
sign of additional lines that might indicate more than one molecule in the asymmetric 
unit. However, the relaxation properties of the samples are different, but this 
unfortunately does not distinguish between possible polymorphic forms, it gives an 
insight into the crystal size of the sample investigated5. 
15N MAS NMR was also used to probe the samples but the long recycle delay in 15N 
NMR impacts on the quality of the final spectra, (see appendix U). These results, 
indicate that both forms have only one molecule in the asymmetric unit but that solid-
state 15N NMR cannot distinguish between the two polymorphic forms.  
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The results from the solid-state NMR experiments are consistent with those from both 
PXRD and DSC in that it is clear that both forms are similar. All these results are 
consistent with the possibility that the two forms may be related by disorder. Disorder 
introduces a distinct difference in the contents of the asymmetric unit of a crystal 
structure. There are two types of disorder; dynamic disorder where each atom is 
vibrating with large amplitudes of vibration, and static disorder which consists of 
alternate positions for atoms or groups of atoms. X-ray diffraction gives us a ‘time 
averaged’ crystal structure and the absence/presence of disorder between the forms 
may give rise to an increase or decrease in crystal symmetry, giving rise to the 
presence or absence of a small number of diffraction peaks. 
 
6.7 Structure prediction results 
As discussed in section 1.9, crystal structure prediction remains a challenge even 
when used to study small molecular materials from first principles. In this section we 
endeavour to use powder diffraction analysis to compare experimental patterns and 
those simulated from predicted structures using the PolySNAP6 program.  
PolySNAP6 is a ‘pattern-matching’ program designed to compare an extensive 
number of patterns by generation of an (n x n) correlation matrix (using Pearson and 
Spearman correlation coefficients) to match the full profile of each of the n diffraction 
patterns with every other pattern in the group. The predicted structures of oxamic acid 
and their powder diffraction patterns were generated by collaborators at University 
College London. The structures were calculated by producing a set of densely packed 
crystal structures generated in common crystal types using MOLPAK7. The 
intermolecular lattice energy is contributed from a distributed multipole analysis8 of 
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the ab intio molecular charge density in the molecule under consideration. PolySNAP 
was then used to compare all the powder diffraction patterns produced. 
 
Figure 6.6: A dendogram produced by a PolySNAP, comparing simulated and 
experimental powder diffraction patterns for oxamic acid. Codes 1 and 2 represent 
forms I and II of oxamic acid, 3 (ciscis_ai50), 4 (ciscis_ak61), 5 (transcis_ai48), 6 
(transcis_aj74), 7 (transcis_ak35), 8 (transcis_am52), 9 (transtrans_de50), 10 
(transcis_fc58), 11 (transtrans_am58), 12 (transtrans_am62), 13 (transtrans_da59), 14 
(transtrans_am56), 15 (transtrans_af42). 
 
The numbers along the bottom of the dendrogram in figure 6.6, correspond to 
different experimental and simulated diffraction powder data sets; 1 and 2 represent 
the experimentally isolated forms I & II respectively, the other codes represent 
simulated patterns produced from the theoretical structures calculated by our 
collaborators at UCL. It is clear from the dendrogram, that the experimental and 
predicted patterns do not compare well, suggesting that the predicted crystal structures 
are not similar to those from the experimental screen in this study. For a visual 
comparison of these diffraction patterns and the energy landscape of the predicted 
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oxamic acid structures see appendix V. There are a number of different molecular 
conformations to be considered theoretically and hence further work is needed to 
enable better prediction and to facilitate unambiguous characterisation of the 
experimental forms from a theoretical basis. 
 
6.8 Structure solution of oxamic acid form I from pxrd 
The X-ray powder diffraction data set used for structural analysis was collected over a 
period of 1 hour, and range of 10˚ ≤ 2θ ≤ 50˚.  The data were indexed on the basis of 
the first 20 observable reflections using the indexing program CRYSFIRE9 and the Cc 
space group assigned to each material by consideration of systematic absences. The 
profile parameters were refined by whole-profile-fitting LeBail10 method in the 
program GSAS11 to improve the fit of the lattice, zero point and profile parameters. 
Structure solution was carried out using DE; this was implemented using the program 
POSSUM12. 
 
Figure 6.7: Molecular structure used in the DE structure, torsion angles are indicated 
by arrows. Hydrogen atoms excluded from the calculation are shown in brackets. 
 
The structural model of oxamic acid used in the DE calculation comprised the 
molecule constructed using standard bond lengths13 and angles, excluding hydroxyl 
and amide hydrogens. The molecular structure is defined by 7 elements: 3 parameters 
(θ,Φ,Ψ) to define the orientation of the molecule (bounds 0 - 360˚), 3 parameters 
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(x,y,z) to define the position of the molecule and one freely rotating torsion angle (0-
360˚). 
Out of the 25 epochs calculated, 24 adopted the syn confirmation. The solution that 
adopted the anti conformation the lowest Rwp = 6.02 %. The lowest syn conformation 
had an Rwp = 6.12 %. The following description of the successful DE calculation and 
resulting structure description is that of this anti conformation.  
The optimum DE calculation had a population of 210 and the maximum number of 
generations was set to 2000. The calculation had a K = 0.99 and F = 0.3. The progress 
plot for the anti DE solution of oxamic acid (figure 6.8) shows the progression of the 
DE calculation in terms of % Rwp with generation. 
 
Figure 6.8: Differential evolution progress plot for the solution of oxamic acid 
showing the best % Rwp (blue) and the mean % Rwp (pink). 
 
Figure 6.8 demonstrates the efficiency of the DE calculation for a 7 parameter 
problem, when compared to the 14 and 15 multi-component parameter problems 
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presented in previous chapters (4, 5, 6 and 7). The progress plots of the multi-
component crystals display a large plateau region in where there is no decline in either 
best or mean % Rwp, whereas in this single molecule problem, there is a step decline 
to convergence at generation 224.   
 
6.9 Rietveld refinement 
 
The anti structure obtained from the DE structure solution was used as a starting point 
for Rietveld refinement using the GSAS program package14. The positions of all 
atoms were refined subject to soft restraints (weighing factor of 0.001 for bond 
distances and 0.005 for geminal non-bonded distances) on standard geometry. No 
preferred orientation correction was applied. Hydrogen atoms that were not included 
in the DE calculation were placed in calculated positions according to the expected 
hydrogen bonding network. For the non-Hatoms, isotropic atomic displacement 
parameters were refined constrained according to atom type or environment. The final 
Rietveld plot can be found in figure 6.9. 
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Figure 6.9: The final Rietveld profile for oxamic acid form I. Experimental diffraction 
data is shown by red circles, the calculated pattern is shown by a solid green line and 
the difference in pink. Reflection positions are marked as black dots. 
 
 
                                            6. Polymorphism of oxamic acid 
                                                                                                                                    199 
 
 
 
Table 6.2 Initial lattice parameters, DE structure solution parameters, refined lattice 
parameters from Rietveld refinement and single crystal determination and Rietveld 
agreement factors 
Compound Oxamic acid  
Crystal data  
Chemical formula H2NC(=O)C(=O)OH 
Mr 89.05 
Dx / mg m-3 
 
1.250 
  
Indexing  
Space group Cc 
Initial a / Ǻ 9.471(1) 
Initial b / Ǻ 5.590(2) 
Initial c / Ǻ 6.824(1) 
Initial β / ˚ 107.250(2) 
Initial V / Ǻ3 338.350(2) 
  
Structure solution  
LeBail Rwp / % 5.36 
LeBail Rp / % 3.54 
LeBail χ2 14.64 
  
DE elements  
K 0.99 
F 0.3 
Np 210 
Best Rwp / % 6.02 
Refinement  
Rwp / % 5.50 
Rp / %  3.60 
R2F / % 5.78 
χ2 15.50 
  
 
  Single Crystal 
parameters 
Final a / Ǻ 9.4949(8) 9.530(5) 
Final b / Ǻ 5.4351(3) 5.424(3) 
Final c / Ǻ 6.8598(4) 6.866(4) 
Final β / ˚ 107.15(0) 107.18(4) 
Final V / Ǻ3 338.27(3) 339.3(2) 
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6.10 Structure of Oxamic acid form I from powder 
diffraction data  
Oxamic acid crystallises in the monoclinic space group Cc. The structure consists of 
infinitely hydrogen bonded sheets running in the [101] direction (figure 6.10). The 
sheets run along the axes at (½, y, ½). The oxamic acid molecule acquires the anti 
orientation in the powder solution of form I. 
 
Figure 6.10: Projection down the a axis showing the infinitely hydrogen bonded sheet 
of oxamic acid form I. (Unit cell shown) 
 
Within an individual hydrogen sheet, there are three types of hydrogen bond that 
exist, table 6.3. Chains of oxamic acid molecules run along the [010] direction, held 
together by )8(22R dimmer linkages. N5 donates a hydrogen bond via H7 to O2 (x, 
1+y, Z) and O6 accepts a hydrogen bond to complete the )8(22R dimer. The chains of 
oxamic acid are bonded together via N5 (0.85560, 0.37460, 0.40480) donating a 
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hydrogen bond via H8 to O6 (-0.5x, -0.5y, -0.5z). The combination of the dimer 
hydrogen bonds and the inter-chain hydrogen bond results in a higher motif of 1433R . 
 
Figure 6.11: A view along the b axis of oxamic acid. Infinitely hydrogen sheets 
running along the b axis. (Unit cell shown). 
 
 
 
Table 6.3: Hydrogen bond geometry in oxamic acid, Å and °. 
Donor-----H… Acceptor D-H H….A D…A <(DHA) 
N(5)---H(7)….O(2) 1.008 1.788 2.7967 178.3 
O(3)---H(9)…O(6) 1.1 1.529 2.6284 180 
N(5)---H(8)…O(6) 1.025 2.0438 3.0331 165 
 
 
6.11 Single crystal vs. Powder structure of oxamic acid form I  
Single crystal data were collected on a Bruker smart 6000 diffractometer equipped 
with a CCD detector and a copper tube source. The structure was solved and refined 
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using SHELXL. Please see appendix W for further details of the single crystal 
refinement of oxamic acid. The single crystal structure adopted the syn confirmation, 
a single crystal structure would normally warrant unequivocal structural confidence in 
the conformation in the molecule but due to the poor quality of the single crystal and 
the resultant poor quality refinement (see appendix W), reasonable doubt remains 
over this structure.  
 
Figure 6.12: Overlay of single crystal structure and syn DE solution of oxamic acid 
 
Figure 6.12 illustrates the inherent problems of solving a small molecular material like 
oxamic acid from laboratory powder X-ray data. Both single crystal and powder 
structures are in accord, in terms of packing, as the oxamic acid molecules form 
chains running in the b direction. Differences between the two crystal structures are 
highlighted by overlaying the asymmetric group of the single crystal over that of the 
powder structure. Both have adopted the syn conformation, but the difference lies in 
the position of the syn carbonyl oxygens, as in the single crystal the carbonyl carbons 
lie below the carbon backbone of the molecule where the converse is true in the 
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powder structure. This is also occurs when comparing the anti (Rwp = 6.02 %) DE 
solution to the single crystal structure. As alluded to before, functional groups 
containing similar electron density can be hard to differentiate between, due to the 
resolution possessed in a powder X-ray experiment. 
Many positives can be taken from the powder structure solution of oxamic acid, as the 
packing of the molecules in the b direction is in agreement with the single crystal 
structure. In the powder DE solutions, 24 out of the 25 epoch’s that were run were 
also in agreement with single crystal solution in adopting the syn conformation. 
Neither the powder, nor single crystal experiment, provided high enough resolution to 
place hydrogen atoms. Unfortunately, even with the combination of single crystal and 
powder X-ray diffraction, the final crystal structure of oxamic acid remains unclear 
and perplexing.  
One approach in order to rationalise the orientation of the oxamic acid molecule is to 
look into the hydrogen bonding networks afforded by either syn or anti conformers. 
Within the syn conformer, the hydroxyl hydrogen atom possesses flexibility and can 
either take up an anti position (as shown by figure 6.13) or a syn (shown in figure 
6.14). The position of the hydroxyl hydrogen has a profound effect upon the hydrogen 
bonding networks present in the final crystalline structure. As shown in figure 6.10, 
the anti conformer gives rise to chains of oxamic acid molecules running along the 
[010] direction, held together by )8(22R dimer linkages, whereas in the both forms of 
the syn conformers no dimer linkage is former, only a C(5) chain in the syn(anti) 
conformer and merely the inter-chain hydrogen bond C(4) running in the (101) plane. 
The syn(syn) conformer in particular would give rise to unfavourable steric 
interactions due to proximity of the hydrogen atoms. In terms of hydrogen bonding 
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networks, all 3 conformers are possible but the anti-oxamic acid is afforded more 
lattice stability by its hydrogen bonding network and is favourable over both syn 
conformers. 
 
Figure 6.13: Hydrogen bonding network in syn(anti)-oxamic acid conformer. 
 
Figure 6.14: Hydrogen bonding network in syn(syn)-oxamic acid conformer 
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Higher resolution data collected at a synchrotron source or neutron diffraction data 
would allow for higher certainty in the placement of the functional groups in oxamic 
acid. 
 
6.12 The attempted structure solution of oxamic acid from II pxrd 
Pxrd data was collected on a Siemens D5000 over a period of 1 hour, and a range of 
10˚ ≤ 2θ ≤ 50˚.  The data set was indexed on the basis of the first 20 observable 
reflections using the indexing program CRYSFIRE9 and a space group of P1 was 
assigned on the basis of the lack of systematic absences. The profile parameters were 
refined by whole-profile-fitting LeBail10 method in the program GSAS11 to improve 
the fit of the lattice and profile parameters. Structure solution was carried out using 
differential evolution (section 1.7.5); this was implemented using the program 
POSSUM12. 
Table 6.4: Indexed lattice parameters of oxamic acid form II 
Lattice parameter  
a  4.773(1) Å 
b  5.324(2) Å 
c 3.679(1) Å 
α 108.359(1) ° 
β 106.074(3) ° 
γ 78.888(1) ° 
Unit cell volume 84.728(1)Å3 
Space group P1 
LeBail parameters  
LeBail Rwp / % 7.48 
LeBail Rp / % 5.80 
LeBail χ2 1.421 
 
The volume of the indexed unit cell indicates an error has occurred in the indexing 
process, as the unit cell volume was indexed to 84.728 Å3. From the unit cell the 
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number of non-hydrogen atoms per unit cell can be estimated, and hence the number 
of molecules in the asymmetric unit. A general rule is that each non-hydrogen atom 
requires an average volume of 18 Å3, which equates to this case to, 6 X 18 = 108 Å3, 
which is larger than the indexed unit cell, 84.728 Å3.  
 
6.13 Neutron diffraction data 
The nature of scattering from neutrons by atomic species, offers a higher degree of 
precision in comparison to that X-ray diffraction. The same level of precision is 
afforded for each atom in the structure due to the fact the neutrons are scattered by the 
atomic nucleus and not the electron cloud surrounding the atom, and hence the 
scattering power is not directly linked to the electron density. Scattering power does 
not significantly fall off with a higher diffraction angle as experienced with X-ray 
diffraction, due to the nature of the neutron and nucleus interaction. Neutrons interact 
with both hydrogen and deuterium, and therefore neutron diffraction acts as vital tool 
in molecular crystallography, as X-rays scarcely interact with hydrogen atoms. This 
interaction allows confidence in classifying oxamic acid in either the syn or anti 
conformation. Good quality neutron data will yield high precision atomic and 
vibrational parameters, including higher thermal effects.  
Data was collected on both a hydrogenated sample of oxamic acid and a deuterated 
sample. Neutron scattering techniques particularly profit from the availability of 
deuterated samples, as the scattering noise is greatly reduced.  
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6.14 Hydrogenated neutron data 
The profile parameters were refined by whole-profile-fitting LeBail10 method in the 
program GSAS11 to improve the fit of the lattice and profile parameters. Structure 
solution was carried out using differential evolution (section 1.7.5); this was 
implemented using the program POSSUM12. Three input model, models A, B and C, 
were employed in separate structure solution searches. Model A contains full 
structural rotation, model B is fixed in anti conformation and model C is fixed in the 
syn conformation. All the models, A-C, encompass all possible conformations for the 
oxamic acid molecule in the solid state (figure 6.15).   
 
OH
H2N
O
O
O
H2N
O
OH
OH
H2N
O
O
 
Figure 6.15: Model A, B and C, of oxamic acid 
 
All solutions retrieved from the DE calculations packed oxamic acid molecules in the 
(101) plane, which is in agreement with both the powder and single crystal X-ray 
solutions. 
 
 
 
6.14.1 Model A Results 
 
In table 6.5, information on each run is presented along with generation of 
convergence and whether the solution adopted the syn or the anti conformation, as 
model A contained full structural rotation. 
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Table 6.5: The results from a number of DE calculations with variation in F (mutation 
rate) and NP (population size). For each epoch the final Rwp (in %) is given and 
figures within brackets indicate at which generation convergence was achieved. Each 
run has been classed as either syn or anti.  
 
Run F Np Epoch 1 Epoch 2 Epoch 3 Epoch 4 Epoch 5 
1 0.3 180 
4.63(374)-
syn 
4.46(307)-
syn 
4.73(892)-
syn 
4.52(317)-
syn 
4.46(280)-
syn 
2 0.4 180 
4.68(2000)-
anti 
4.41(599)-
anti 
4.94(704)-
anti 
4.26(606)-
syn 
4.27(766)-
syn 
3 0.5 180 
4.46(1180)-
syn 
4.26(980)-
syn 
4.29(1180)-
syn 
4.26(976)-
syn 
4.69(1062)-
syn 
4 0.3 270 
4.53(414)-
syn 
4.26(385)-
syn 
4.49(334)-
anti 
4.71(389)-
anti 
4.46(2000)-
anti 
 
As illustrated in table 6.5, the neutron data serves up a mixture of both syn and anti 
solutions, with the syn conformation being more favoured, in terms of regularity, with 
13 out of 20 solutions adopting a syn conformation, also the solution with the lowest 
% Rwp was in the syn conformation, with a  Rwp = 4.26%. The lowest anti Rwp = 4.41 
%. 
Even though the data is strongly suggesting that the oxamic acid molecule has 
adopted the syn conformation, as in agreement with the single and powder crystal 
structure solutions, there remains uncertainty over the final confirmation of oxamic 
acid, even with the introduction of neutron data.  
 
 
 
6.14.2 Model B results 
In table 6.6, information on each run is presented along with generation of 
convergence, as previously mentioned in section 6.14, model B is fixed in the syn 
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confirmation, in order to explore whether the conformation and rigidity of the input 
model can locate minima on the hypersurface lower than that found using model A. 
 
Table 6.6: The results from a number of DE calculations with variation in F (mutation 
rate) and NP (population size). For each epoch the final Rwp (in %) is given and 
figures within brackets indicate at which generation convergence was achieved. 
Run F Np Epoch 1 Epoch 2 Epoch 3 Epoch 4 Epoch 5 
1 0.5 60 4.51(160) 4.51(236) 4.51(2000) 4.51(2000) 4.51(243) 
2 0.5 90 4.51(2000) 4.51(181) 4.51(2000) 4.51(88) 4.51(138) 
3 0.4 90 4.51(151) 4.51(2000) 4.51(174) 4.51(113) 4.51(89) 
4 0.3 90 4.51(84) 4.51(74) 4.6(261) 4.51(489) 4.59(49) 
5 0.3 180 4.51(115) 4.51(71) 4.51(66) 4.51(2000) 4.51(282) 
6 0.4 180 4.51(157) 4.51(104) 4.51(2000) 4.51(167) 4.51(315) 
7 0.5 180 4.51(342) 4.51(210) 4.51(117) 4.51(2000) 4.51(482) 
 
As illustrated by table 6.6, all epochs in every run find a minimum  Rwp = 4.51 %. 
This is higher than the % Rwp achieved for model A.  
 
6.14.3 Model C results  
In table 6.7, information on each run is presented along with generation of 
convergence, as previously mentioned in section 8.91, model B is fixed in the anti 
confirmation. As shown in table 6.7, the bulk of epochs reach an Rwp = 4.8%, which 
is 0.29 higher than the Rwp achieved for the syn model.  
 
Table 6.7: The results from a number of DE calculations with variation in F (mutation 
rate) and NP (population size). For each epoch the final Rwp (in %) is given and 
figures within brackets indicate at which generation convergence was achieved. 
Run F Np epoch 1 epoch 2 epoch 3 epoch 4 epoch 5 
1 0.3 60 5.14(60) 4.81(53) 4.82(62) 4.95(73) 4.8(64) 
2 0.3 120 4.8(95) 4.8(101) 4.8(142) 4.8(105) 4.8(90) 
3 0.5 120 4.8(269) 4.8(171) 4.8(236) 4.8(121) 4.8(150) 
4 0.4 120 4.8(233) 4.8(97) 4.8(96) 4.8(102) 4.8(2000) 
5 0.3 180 4.8(136) 4.8(113) 4.8(523) 4.8(93) 4.8(81) 
6 0.4 180 4.8(125) 4.8(2000) 4.8(125)  /  / 
7 0.5 180 4.8(109) 4.8(1143) 4.8(249) 4.8(136) 4.8(334) 
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6.14.4 Neutron data conclusion 
As mentioned in section 6.13, neutron diffraction data offers a higher degree of 
precision in comparison to that offered by X-ray diffraction. The three input models 
A, B and C has allowed all possible conformations of the oxamic acid molecule to be 
investigated equally. The DE, in combination with the neutron data points to the syn 
conformer being the most likely. This is confirmed by the propensity of the syn 
conformer when using input model A, combined with the lowest Rwp of 4.26.  
6.15 Thermal behaviour of oxamic acid  
As discussed in section 4.7, thermal expansion co-efficients give us an extraordinary 
insight into the molecular crystal structure of oxamic acid, in particular the hydrogen 
bonding networks present within the crystal. The variable temperature data was 
collected on a Siemens D5005, in the reflection transition mode, over a 2θ range of 
10˚ ≤ 85˚. The variable temperature data confirms that there was no phase 
transformations over the temperature range investigated (50-295 K). Figure 6.16 
contains the variation of the lattice parameters over the temperature range 
investigated, as determined by the LeBail10 method. 
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Figure 6.16: The fractional variation of lattice parameters obtained from LeBail 
refinement, plotted against temperature. Unit cell volume (purple dashes), a (blue), b 
(pink), c (orange) and β (green). 
 
As evident from both figure 6.16 and table 6.8, the c axis is the most thermally liable, 
followed by a and finally the b axis which experiences negative thermal expansion. If 
we relate the thermal information back to the proposed crystal structure, as discussed 
in section 6.10, the negative expansion in the b direction is not unexpected as the 
chains of oxamic acid molecules run the (101) plane. 
Table 6.8: Linear thermal expansion co-efficients of the lattice parameters of oxamic 
acid 
Lattice parameter Linear thermal expansion 
co-efficient (K-1) 
a 6.23986x10-5 
b -2.26067x10-5 
c 9.8254x10-5 
Unit cell volume 1.0075x10-4 
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6.16 Conclusions  
 
Within this chapter, the structure solution of oxamic acid has been pursued by a 
combination of pxrd, sxrd and powder neutron diffraction. The packing of the oxamic 
acid molecule, with infinitely hydrogen bonded hydrogen sheets running in the [010] 
direction has been confirmed by the different diffraction methods. The conformation 
of the oxamic acid molecule within the hydrogen bonded sheets has been harder to 
confirm, due to the similarities in electron density surrounding the functional groups. 
Both single crystal and neutron diffraction allude to the syn conformation, whereas the 
pxrd refinement points to an anti conformation. Due to the nature of the refinements 
in this chapter, further crystallographic work would need to be carried out to confirm 
the conformation of the molecule.  
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7.0 Conclusion 
 
The research presented in this thesis is based on three main areas of small organic molecular 
crystallography; synthesis, crystal structure determination and the thermal behaviour of 
crystalline systems. 
The DE has been successfully implemented for the structure solution of three unknown 
binary multi-component materials (oxamate:nicotinamide, oxamate:isonicotinamide and 
fumaric acid:nicotinamide). The use of this technique to solve binary molecular crystal 
structures directly from powder X-ray diffraction has become a robust option. The 
comparison of pxrd structures vs. single crystal structures has illustrated both the strengths 
and the potential pitfalls of solving binary materials from powder methods. The orientation of 
an amide group, as seen in the oxamate:nicotinamide structure, needs careful attention from 
the crystallographer, with bond restraints acting as a strong indicator to whether the correct 
orientation has been assigned. As seen in all of the successful structure solutions the profile 
of the DE calculation is one of a small initial decline in Rwp followed by a prolonged plateau 
and finally a steep decline in Rwp as the calculation approaches the global minimum. As this 
profile is typical of many deterministic problems, an area of future work could include the 
development of the DE algorithm. Work has already begun within the group to improve the 
DE efficiency, through the use of eugenics to cut down population size throughout the 
calculation. A systematic analysis of the DE control parameters would also aid in improving 
the efficiency of the DE when tackling multi-component materials.   
The successful implementation of the DE is vitally important in the method development of 
solvent free or solvent reduced synthetic routes. Reduced solvent methods have obvious 
environmental and economic advantages but are not conducive to producing crystals of 
sufficient size and quality to warrant a single crystal experiment, therefore, the development 
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of structure solution from pxrd is significant. The reduced solvent synthetic methods were 
successful in producing the same phase as the traditional solvent mediated route. Reduced 
solvent synthetic methods circumvent the issue of both starting materials having similar 
solubilities in the chosen solvent and allow a wider range of materials to be used in the design 
of cocrystalline material. The next step in the continuation of the method development of the 
solvent reduced synthetic process is to move from using the pxrd data from a LAG crystallite, 
and placing into the DE. This will present inherent problems associated with solvent reduced 
synthetic methods, as often, peaks associated with starting materials will be present in the 
diffraction pattern. This mix of starting materials and the new multi-component material 
could be tackled by searching for separate phases in the DE. This will obviously impact upon 
the complexity of the problem and work would need to be employed to improve the 
efficiency of the algorithm. The simplicity of the DE algorithm offers scope for strategies to 
improve the convergence rate of the search. 
Within the systems presented in this thesis there has been a display of robust preferential 
synthons, i.e. amide dimers. As discussed in chapter 5, from a cocrystal design aspect it was 
interesting to observe an absence of an amide dimer in the maleate:iconicotinamide structure, 
unlike in the maleate:nicotinamide structure. The cocrystallisation of maleic acid with 
nicotinamide produced an unexpected isomerisation to its conformer fumaric acid. As 
mentioned in section 5.9, the isomerisation of maleic acid to fumaric acid is normally induced 
by either thermal or via photochemical routes. The isomerisation is interesting in the terms of 
a salt isomerising to form a cocrystalline material. 
The thermal analysis of structures has given extra insight to the crystal structures of the new 
binary materials. The expansion and contraction of lattice parameters from 100 to 295 K has 
allowed for both quantitative and qualitative structural analysis to be performed. To take this 
work further, the data collected could be used to aid future crystal structure prediction.  
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A combined use of powder X-ray, neutron and single crystal diffraction has been used to 
explain the crystal structure of oxamic acid. It is clear that the oxamic acid molecules line up 
in a regular fashion in the [010] direction, but due to conformational (syn or anti) flexibility, 
it becomes hard to place electron density within the unit cell. In the analysis performed thus 
far the syn conformation is the most predominate, as the majority of the powder structures 
adopted the syn conformation, as did the single crystal structure, along with the neutron data. 
Only one DE solution adopted the anti conformer, but that did relate to the lowest % Rwp 
structure. A anti-oxamic acid molecule would give rise to a more favourable hydrogen bond 
network over the syn conformer. The structure solution of oxamic acid portrays the problem 
of structural analysis of small molecular materials with functional groups of similar electron 
density, even with the aid of multiple diffraction techniques, only further analysis would 
prevent discussion on the final structure solution. 
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Appendix A: The HPLC analysis of oxamic 
acid:isonicotinamide and oxamic acid:nicotinamide 
 
 
Figure A1: HPLC spectra of isonicotinamide 
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Figure A2: HPLC spectra of oxamic acid 
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Figure A3: The HPLC spectra of oxamic acid:isonicotinamide 
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Figure A4: HPLC spectra of nicotinamide 
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Figure A5: HPLC spectra of oxamic acid:nicotinamide 
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Appendix B: The DSC trace of oxamic 
acid:isonicotinamide 
 
 
 
 
Figure B1: DSC trace of oxamic acid and isonicotinamide 
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Appendix C:  Stoichiometric diversity of oxamic 
acid:isonicotinamide 
 
 
Figure C1 : The pxrd patterns of oxamic acid (orange), isonicotinamide (aqua), oxamic acid 
1:1 isonicotinamide(blue), oxamic acid 1:2 isonicotinamide(red). 
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Appendix D: DSC trace of oxamic acid:nicotinamide 
 
Figure D1: DSC trace of oxamic acid:nicotinamdie 
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Appendix E: Stoichiometric diversity of fumaric 
acid:nicotinamide 
 
 
 
Figure E1: Diffraction patterns of fumaric acid and nicotinamide in 1:1 (from solution) in 
blue and 1:2 ratios (ground in pink and sonic slurry in green). 
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Appendix F: DSC trace of maleic acid:nicotinamide 
product A 
 
Figure F1: DSC trace of maleic acid:nicotinamide product A 
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Appendix G: DSC trace of maleic acid:nicotinamide 
product B 
 
 
Figure G1: DSC trace of maleic acid:nicotinamide product B 
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Appendix H: Cocrystallisation of succinic 
acid:nicotinamide 
 
Figure H1: Powder X-ray diffraction patterns of the starting materials, nicotinamide(red), 
succinic acid (blue) and succinic acid:nicotinamide (green) 
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Appendix I: Cocrystallisation of adipic 
acid:nicotinamide 
 
 
Figure I1: Powder X-ray diffraction pattern of starting materials, nicotinamide(blue), adipic 
acid(red) and adipic acid:nicotinamide (green) 
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Appendix J: Indexing oxamic acid:isonicotinamide 
 
 
Figure 1: Indexing output from CRYSFIRE for oxamic acid:isonicotinamide 
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Appendix K: Structure determination of 
oxamate:isonicotinamide  
 
K1: Single crystal determination of oxamate:isonicotinamide 
 
Figure K1: Atomic numbering scheme for oxamate:isonicotinamide single crystal 
solution 
 
Selected intramolecular geometric parameters in oxamate:isonicotinamide (Ǻ and °) 
 
 
C1-O1 1.234(4)  C1-N1 1.325(4)  C1-C2 1.554(5) 
C2-O3 1.263(4)  C3-N2 1.331(5)  C3-C4 1.383(5) 
C3-H3 0.9300   C4-C5 1.386(5)  C4-H4 0.9300 
C5-C6 1.388(5)  C5-C8 1.524(5)  C6-C7 1.374(5) 
C6-H6 0.9300   C7-N2 1.342(5)  C7-H7 0.9300 
C8-O8 1.235(4)  C8-N8 1.325(5)  N1-H1A 0.8600 
N1-H1B 0.8600  N2-H2 0.8600   N8-H8A 0.8600 
N8-H8B 0.8600 
 
O1-C1-N1 123.8(4)  O1-C1-C2 120.2(3)  N1-C1-C2 116.0(3) 
O3-C2-O2 127.1(4)  O3-C2-C1 118.9(3)  O2-C2-C1 114.0(3) 
N2-C3-C4 120.0(4)  N2-C3-H3 120.0  C4-C3-H3 120.0 
C3-C4-C5 119.2(4)  C3-C4-H4 120.4  C5-C4-H4 120.4 
C4-C5-C6 119.1(3)  C4-C5-C8 123.1(3)  C6-C5-C8 117.7(3)  
C7-C6-C5 119.5(4)  C7-C6-H6 120.3  C5-C6-H6 120.3 
N2-C7-C6 119.9(4)  N2-C7-H7 120.0  C6-C7-H7 120.0 
O8-C8-N8 124.0(4)  O8-C8-C5 118.9(4)  N8-C8-C5 117.1(3) 
C1-N1-H1A 120.0  C1-N1-H1B 120.0  H1A-N1-H1B 120.0 
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C3-N2-C7 122.2(3) 
 
Table K1 : Final refined atomic positions and isotropic displacement factors for 
oxamate:isonicotinamide 
Atom x y z Uiso/Ǻ2 
C1 0.4322(12) 0.3097(5) 0.21109(11) 0.0310(11) 
C2 0.5427(12) 0.4571(5) 0.17934(12) 0.0316(11) 
C3 0.9173(12) -0.0804(6) 0.14158(13) 0.0394(12) 
H3 0.83230 -0.10480 0.16970 0.047 
C4 1.0518(12) -0.2115(5) 0.11562(11) 0.0322(11) 
H4 1.0565 -0.3241 0.1260 0.039 
C5 1.1794(11) -0.1731(5) 0.07395(11) 0.0272(10) 
C6 1.1697(12) -0.0039(5) 0.05934(13) 0.0341(12) 
H6 1.2551 0.0242 0.0315 0.041 
C7 1.0330(14) 0.1217(5) 0.08629(13) 0.389 
H7 1.0260 0.2355 0.0768 0.047 
C8 1.3144(12) -0.3097(5) 0.04206(13) 0.0337(11) 
N1 0.2662(10) 0.3575(4) 0.24758(10) 0.0443(11) 
H1A 0.1947 0.2812 0.2661 0.053 
H1B 0.2299 0.4649 0.2528 0.053 
N2 0.9096(9) 0.0801(4) 0.12636(10) 0.0366(10) 
H2 0.8226 0.1600 0.1428 0.044 
N8 1.4348(10) -0.4553(4) 0.05931(10) 0.0403(10) 
H8A 1.5119 -0.5359 0.0424 0.048 
H8B 1.4359 -0.4691 0.0874 0.048 
O1 0.4941(8) 0.1584(3) 0.20132(8) 0.0415(8) 
O2 0.6705(8) 0.4054(3) 0.14323(8) 0.0437(9) 
O3 0.4975(9) 0.6072(3) 0.19098(8) 0.0437(9) 
O8 1.3038(8) -0.2797(3) 0.00216(8) 0.0480(9) 
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Table K2: Experimental details – single-crystal data for oxamate:isonicotinamide 
Crystal data  
Chemical formula C6H7N2O, C2H2NO3 
 
Mr 211.8 
Space group, cell setting P21/n, Monoclinic 
a , b, c 3.7386(18), 7.771(3), 30.372(13) 
Beta (˚) 90.15(2) 
V (Å3) 882.4(7) 
Z 4 
Dx (Mg m-3) 1.590 
Radiation type Cu Kα 
µ (mm-1) 1.115 
Specimen form, colour Plate, colourless 
Specimen size (mm) 0.30 x 0.24 x 0.05 
  
Data Collection  
Diffractometer Bruker Smart 6000 CCD 
Data Collection method CCD slices 
Absorption correction Empirical (using intensity measurements) 
Tmin 0.7308 
Tmax 0.9463 
No. Of measured, independent and 
observed reflections 
4376, 1080, 898 
Criterion for observed reflections I>2σ(I) 
Rint 0.0543 
Rmax 55.95 
  
Refinement  
Refinement on F2 
R[F2>2σ(F2)], wR(F2), S 0.0600, 0.0971, 1.046 
Reflection/profile data 1080 reflections 
H-atom treatment Constrained to parent site 
Weighting Scheme W = 1/[σ2(F20) + (0.0112P)2 + 0.6383P], 
where P = (F20 + F2C)/3 
(∆/σ) max < 0.0001 
∆ρmax, ∆ρmin(e Å-3) 0.213, -0.201 
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K2: Powder crystal determination of oxamic acid:isonicotinamide 
 
 
Figure K2: Atomic numbering scheme for oxamate:isonicotinamide  
 
Selected intramolecular geometric parameters in oxamate:isonicotinamide (Ǻ and °) 
 
C1—C2 1.39(1)  C6 –C7 1.51(1)  C17—O18 1.25(1) 
C2—N3 1.37(1)  C7—O8 1.24(1)  C17—N19 1.32(1)  
N3—C4 1.38(1)  C7—N9 1.02(1)  C4—C5 1.39(1) 
C17—C14 1.55(1)  C5—C6 1.40(1)  C14—O16 1.34(1)  
C6—C1 1.40(1)  C14—O15 1.25(1) 
 
C1-C2-N3 118(1)  C6-C7-O8 118(1)  N19-C17-C14 120(1) 
C2-N3-C4 122(1)  C6-C7-N9 119(1)  O18-C17-C14 120(1) 
N3-C4-C5 119(1)  O8-C7-N9 120(1)  C4-C5-C6 118(1) 
O15-C14-O16 118(1)  C5-C6-C1 119(1)  C6-C1-C2 119(1) 
O15-C14-C17 118(1)  O16-C14-C17 120(1)  O18-C17-N19 119(1) 
 
 
 
 
 
 
 
Appendix K 
  234 
 
 
 
 
 
 
 
Table K3: Final refined atomic positions for oxamic acid:isonicotinamide 
Atom x y z 
C1 0.115(5) 0.784(1) 0.3846(3) 
C2 -0.035(4) 0.906(1) 0.3561(3) 
N3 -0.112(4) 1.0687(8) 0.3718(2) 
C4 -0.017(4) 1.119(1) 0.4140(3) 
C5 0.117(4) 0.996(1) 0.4436(3) 
C6 0.151(5) 0.824(1) 0.4296(3) 
C7 0.337(5) 0.697(1) 0.4690(1) 
O8 0.297(3) 0.7141(14) 0.5004(3) 
N9 0.467(4) 0.5487(8) 0.44301(7) 
H10 0.234(18) 0.668(4) 0.3714(5) 
H11 -0.045(14) 0.880(3) 0.3209(4) 
H12 -0.086(15) 1.247(2) 0.4257(7) 
H13 0.143(15) 1.027(2) 0.4783(4) 
C14 0.557(4) 0.4532(5) 0.3200(2) 
O15 0.475(4) 0.608(14) 0.3119(5) 
O16 0.643(3) 0.409(2) 0.3617(4) 
C17 0.4345(6) 0.3128(12) 0.2866(4) 
O18 0.481(5) 0.156(1) 0.2951(5) 
N19 0.308(4) 0.357(2) 0.2473(4) 
H20 -0.24(3) 1.162(6) 0.350(14) 
H21 0.58(4) 0.451(8) 0.4647(4) 
H22 0.49(4) 0.525(8) 0.4078(6) 
H23 0.31(4) 0.281(8) 0.2379(6) 
H24 0.27(4) 0.464(8) 0.2472(6) 
 
 
 
 
 
 
 
 
 
 
7. Appendix L 
  235 
 
Appendix L Structure determination of 
oxamate:nicotinamide  
 
L1: Single crystal determination of oxamate:nicotinamide 
 
 
 
Figure L1: Atomic numbering scheme for oxamate:nicotinamide 
 
 
Selected intramolecular distances (Ǻ) and angles (°) 
 
C1—O1 1.235(3)  C1—N1 1.318(4)  C1—C2 1.545(4) 
C2—O3 1.240(3)  C2—O2 1.256(3)  C3—N2 1.330(4) 
C3—C4 1.374(5)  C3—H3 0.9300  C4—C5 1.384(4) 
C4—H4 0.9300  C6—H7 1.381(4)  C6—C8 1.503(4)  
C7—N2 1.336(4)  C7—H7 0.9300  C8—O8 1.233(3) 
C8—N8 1.321(4)  N1—H1A 0.8600  N1—H1B 0.8600 
N2—H2 0.8600  N2—N8A 0.8600  N8—H8B 0.8600 
 
O1-C1-N1 124.6(3)  O1-C1-C2 119.6(2)  N1-C1-C2 115.8(2) 
O3-C2-O2 126.6(3)  O3-C2-C1 117.8(3)  O2-C2-C1 115.5(2) 
N2-C3-C3 119.8(3)  N2-C3-H3 120.1  C4-C3-H3 120.1 
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C3-C4-C5 118.6(3)  C3-C4-H4 120.7  C5-C4-H4 120.7 
C6-C5-C4 120.8(3)  C6-C5-H5 119.6  C4-C5-H5 119.6 
C7-C6-C5 117.8(3)  C7-C6-C8 123.0(2)  C5-C6-C8 119.2(2) 
N2-C7-C6 120.2(3)  N2-C7-H7 119.9  C6-C7-H7 119.9 
O8-C8-N8 123.2(3)  O8-C8-C6 118.3(3)  N8-C8-C6 118.5(2) 
C1-N1-H1A 120  C1-N1-H1B 120  H1A-N1-H1B 120 
C3-N2-C7 122.7(3)  C3-N2-H2 118.7  C7-N2-H2 118.7 
C8-N8-H8A 120.0  C8-N8-H8B 120.0  H8A-N8-H8B 120.0 
 
 
O1-C1-C2 119.6(2)  O1-C1-N1 124.6  C1-C2-O3 117.9 
C1-C2-O2 115.5  O2-C2-C3 126.6  H1A-N1-H1B 120.0 
N2-C3-C4 119.8  C3-C4-C5 118.6  C4-C5-C6 120.8 
C5-C6-C7 117.8  C6-C7-N2 120.2  C7-N2-C3 122.7 
C6-C8-O8 118.3  C6-C8-N8 118.4  O8-C8-N8 123.2 
 
Table L1: Final refined atomic positions and isotropic displacement factors for 
oxamate:nicotinamide – single crystal structure 
Atom x y z Uiso/Ǻ2 
C1 0.5012(4) 0.1450(3) -0.1106(2) 0.0333(7) 
C2 0.4988(4) 0.2488(3) -0.1954(2) 0.0351(7) 
C3 0.7856(5) 0.4051(3) 0.1090(2) 0.0426(8) 
H3 0.7501 0.3190 0.1257 0.051 
C4 0.9014(6) 0.4862(3) 0.1814(2) 0.0483(6) 
H4 0.9467 0.4553 0.2472 0.058 
C5 0.9492(5) 0.6147(3) 0.1544(2) 0.0420(8) 
H5 1.0280 0.6705 0.2025 0.050 
C6 0.8814(4) 0.6611(3) 0.0569(2) 0.0318(7) 
C7 0.7676(4) 0.5742(3) -0.0127(2) 0.0336(7) 
H7 0.7208 0.6021 -0.0790 0.040 
C8 0.9347(4) 0.8018(3) 0.0309(2) 0.0348(7) 
N1 0.4564(4) 0.0194(2) -0.14010(18) 0.0429(7) 
H1A 0.4541 -0.0426 -0.0963 0.051 
H1B 0.4294 -0.0004 -0.2031 0.051 
N2 0.7247(3) 0.4503(2) 0.01590(18) 0.0357(6) 
H2 0.65470 0.39770 -0.02960 0.043 
N8 0.8659(4) 0.8454(3) -0.06221(19) 0.0442(7) 
H8A 0.8975 0.9247 -0.0792 0.053 
H8B 0.7894 0.7946 -0.1058 0.053 
O1 0.5420(3) 0.1830(2) -0.02199(14) 0.0444(6) 
O2 0.5585(4) 0.3655(2) -0.16670(15) 0.0458(6) 
O3 0.4369(4) 0.2105(2) -0.28373(16) 0.0558(7) 
O8 1.0448(3) 0.8696(2) 0.09696(16) 0.0473(6) 
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Table L2: Experimental details – single-crystal data for oxamate:nicotinamide 
Crystal data  
Chemical formula C6H7N2O2, C2H2NO3 
 
Mr 211.8 
Space group, cell setting P21/c, Monoclinic 
a , b, c 6.9742(14), 9.8751(16), 13.676(2) 
Beta 103.86(1) 
V (Å3) 914.5(3) 
Z 4 
Dx (Mg m-3) 1.590 
Radiation type Cu Kα 
µ (mm-1) 1.076 
Specimen form, colour block, colourless 
Specimen size (mm) 0.12 x 0.10 x 0.08 
  
Data Collection  
Diffractometer Bruker Smart 6000 CCD 
Data Collection method CCD slices 
Absorption correction Empirical (using intensity measurements) 
Tmin 0.8817 
Tmax 0.9189 
No. Of measured, independent and 
observed reflections 
1530 
Criterion for observed reflections I>2σ(I) 
Rint 0.0398 
Rmax 65.80 
  
Refinement  
Refinement on F2 
R[F2>2σ(F2)], wR(F2), S 0.0605, 0.0719, 1.168 
Reflection/profile data  
H-atom treatment Constrained to parent site 
Weighting Scheme W = 1/[σ2(F20) + (0.1016P)2 + 0.3815P], 
where P = (F20 + F2C)/3 
(∆/σ) max < 0.0001 
∆ρmax, ∆ρmin(e Å-3) 0.213, -0.201 
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L2: Powder determination of oxamate:nicotinamide 
 
 
Figure L2: Atomic numbering scheme for oxamate:nicotinamide 
 
 
Selected intramolecular geometric parameters in oxamate:nicotinamide (Ǻ and °) 
 
C1—C2 1.39(1)  C5—C6 1.34(1)  C6—C1 1.37(1)  
C2—N3 1.37(1)  C5—C7 1.51(1)  C7—O9 1.21(1) 
N3—C4 1.38(1)  C7—N8 1.37(1)  N8—H230.84(1) 
C4—C5 1.40(1)  N8—H24 0.87(1)  C1—H10 1.08(1) 
N3—H11 1.08(1)  C4—H12 1.08(1)  C6—H13 1.08(1) 
N16—H21 0.89(1)  N16—H22 0.82(1) 
 
 
C1-C2-N3 120(1)  N16-C14-O15 122(1)  C2-N3-C4 120(1) 
N16-C14-C17 116(1)  N3-C4-C5 120(1)  O15-C14-C17 120(1) 
C4-C5-C6 120(1)  O19-C17-O18 120(1)  C5-C6-C1 119(1) 
O19-C17-C14 120(1)  C6-C1-C2 119(1)  O18-C17-C14 118(1) 
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C5-C7-O9 119(1)  C5-C7-N8 118(1) 
 
 
 
 
 
 
 
 
Table L3: Final refined atomic positions in the powder solution of 
oxamate:nicotinamide 
Atom x y z 
C1 0.105(6) 0.514(2) 0.821(5) 
C2 0.222(5) 0.594(3) 0.8962(4) 
N3 0.279(4) 0.545(2) 0.993(6) 
C4 0.229(6) 0.420(2) 1.0142(6) 
C5 0.217(6) 0.336(2) 0.9368(4) 
C6 0.50(5) 0.386(2) 0.8448(4) 
C7 0.062(5) 0.198(2) 0.965(4) 
N8 0.131(4) 0.154(2) 1.0623(4) 
O9 -0.037(5) 0.126(2) 0.9007(6) 
H10 0.03(2) 0.560(5) 0.750(8) 
H11 0.25(2) 0.699(5) 0.8815(5) 
H12 0.27(2) 0.384(3) 1.090(1) 
H13 -0.06(2) 0.329(3) 0.790(6) 
C14 0.489(5) 0.646(2) 0.607(5) 
O15 0.455(6) 0.682(2) 0.519(5) 
N16 0.535(4) 0.515(2) 0.6354(4) 
C17 0.506(7) 0.747(1) 0.6910(5) 
O18 0.554(5) 0.706(2) 0.7809(5) 
N19 0.444(5) 0.869(2) 0.6723(5) 
H20 0.37(2) 0.609(5) 1.053(1) 
H21 0.54(4) 0.45(1) 0.5887(10) 
H22 0.57(4) 0.49(1) 0.6956(10) 
H23 0.10(4) 0.08(1) 1.0792(10) 
H24 0.21(4) 0.21(1) 1.1058(10) 
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Appendix M: Thermal expansion of monoclinic systems 
In order to be able to compare the thermal expansion from one monoclinic system to the 
other, anisotropic nature of thermal expansion is best described in a Cartesian axis. The 
thermal expansion tensors of oxamic acid: nicotinamide were evaluated by the following 
procedure used for monoclinic systems
50
. The non-zero thermal expansivity coefficients of 
the tensor are first determined by evaluating the following expressions that describe the 
lengths of the crystallographic axes a,b and c, and the angle β as a function of temperature. 
The elements of the tensor are shown in Figure M.1; 
 
α11 0 α13 
 
0 α22 0 
 
α31 0 α33 
Figure M1: Non-zero thermal co-efficient tensor 
The tensor elements are evaluated from the following; 
 
]./)(}/)[ln(/)][ln(){[cot(2/1
/)][ln(
/)][ln(
/)cot(/)][ln(
3113
33
22
11
dtddTcddTad
dTcd
dTbd
dTddTad
ββαα
α
α
ββα
−−==
=
=
+=
 
 
Equations M.2-M.6: Tensor elements for a monoclinic system 
 
The tensor is not diagonal when described in the monoclinic crystal axis frame, but can be 
made so by using the Cartesian axes c,b and a* as an orthogonal basis set and by rotating the 
principal axis of the tensor x by an angle φ from the a* axis in the anticlockwise sense when 
looking down the crystallographic b axis, where the rotation of the principal axis is shown by 
equation 5.7. 
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)./(22tan 113313 αααϕ −=                                                                    [Equation M.7]
 
 
Figure M2: The anti-clockwise rotation of principal axis to Cartesian axis frame 
 
 
 
Therefore, in this notation we have; 
 
ϕαϕαϕα
α
ϕαϕαϕα
2sincossin
2sinsincos
13
2
33
2
1133
2222
13
2
33
2
1111
++=
=
−+=
S
S
S
 
 
Equations M.8-10: Diagonal elements of the thermal expansion tensor in its principal 
diagonalised form 
 
All values of the derivatives were taken from the gradients of relevant graphs and the 
reference value of β in the cot (β) terms was taken to the measurement at 100 K. 
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Table M1: The thermal expansion coefficients and tensor elements of oxamic acid and 
nicotinamide salt 
 
Thermal expansion coefficient (x 10
-5
K
-1
) 
 
α11= 1.99249 
 
α22= -0.0003 
 
α33= 0.0007 
 
α13= α31= 1.117604 
 
Diagonalised thermal expansion tensor elements (x 10
-5
K
-1
) 
 
S11=2.33137 
S22=0.0003 
S33=0.0944 
 
 
The diagonalised thermal expansion tensor confirms the anisotropic nature of the salt.   
 
 Appendix N 
  243 
 
Appendix N: Indexing oxamic acid:nicotinamide 
 
 
Figure N1: Indexing output of oxamic acid:nicotinamide 
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Appendix O: Indexing fumaric acid:nicotinamide 
Table O1: Indexing output for fumaric acid:nicotinamide 
Merit Volume IndexProg Date a b c alpha beta gamma 
26.43 1102.851 KOHLv7.01b 
18-Jun-
08 14.3889 13.8156 5.5583 90 93.517 90 
25.5 1102.98 DICVOL91/log 
18-Jun-
08 18.716 13.8163 5.5578 90 129.873 90 
25.5 1102.98 DICVOL91/log 
18-Jun-
08 17.6359 13.8163 5.5578 90 125.465 90 
25.5 1102.972 DICVOL91/log 
18-Jun-
08 15.7418 13.8163 5.5578 90 114.152 90 
25.5 1102.971 DICVOL91/log 
18-Jun-
08 15.1054 13.8163 5.5578 90 108.028 90 
25.4 1103.06 DICVOL91/log 
18-Jun-
08 14.3916 13.8159 5.5581 90 93.51 90 
6.6 5085.308 DICVOL91/log 
18-Jun-
08 35.6472 31.166 4.5773 90 90 90 
5.7 5214.102 DICVOL91/log 
18-Jun-
08 41.4572 14.3605 8.7581 90 90 90 
5.6 4967.622 DICVOL91/log 
18-Jun-
08 74.5999 11.3849 5.849 90 90 90 
9 3468.679 TREOR90/log 
18-Jun-
08 17.4869 14.3593 13.814 90 90 90 
4.6 2521.75 ITO12/log 
18-Jun-
08 13.687 14.8747 13.4363 112.282 94.008 85.777 
6.6 2576.12 ITO12/log 
18-Jun-
08 13.959 14.925 13.0914 106.581 99.77 87.224 
17 1736.525 TREOR90/log 
18-Jun-
08 14.3612 13.8119 8.7546 90 90 90 
10.09 3400.429 KOHLv7.01b 
18-Jun-
08 13.5723 22.5875 12.0058 90 112.498 90 
9.8 2356.96 ITO12/log 
18-Jun-
08 14.8317 17.1405 10.4053 103.7 105.128 69.232 
9.49 1083.336 KOHLv7.01b 
18-Jun-
08 10.4415 13.5506 8.6847 101.848 108.006 103.588 
4.4 5748.25 ITO12/log 
18-Jun-
08 18.9336 21.9922 13.8049 90 90 90 
15.8 996.253 KOHLv7.01b 
18-Jun-
08 12.9207 13.6946 6.4967 84.039 105.189 116.091 
11.34 1065.486 KOHLv7.01b 
18-Jun-
08 13.2538 13.2086 6.6413 97.771 105.912 72.661 
9.14 1014.063 KOHLv7.01b 
18-Jun-
08 7.8242 20.2495 6.4634 92.86 97.281 91.354 
6.3 3011.75 ITO12/log 
18-Jun-
08 17.2691 22.142 7.8765 90 90 90 
4.8 5742.57 ITO12/log 
18-Jun-
08 18.7379 22.2255 13.789 90 90 90 
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Appendix P: Structure determination of fumaric 
acid:nicotinamide 
 
P1: Single crystal determination of fumaric acid:nicotinamide 
 
 
Figure P1: Atomic numbering scheme for fumaric acid:nicotinamide  
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Table P1 : Final refined atomic positions and isotropic displacement factors for fumaric 
acid:nicotinamide 
Atom x y z Uiso/Ǻ2 
C2 0.8233(3) 0.55975(11) 0.34373(11) 0.0352(4) 
H2 0.9595 0.5832 0.3799 0.042 
C3 0.6744(3) 0.62561(11) 0.29686(12) 0.0377(4) 
H3 0.7079 0.6931 0.3005 0.045 
C4 0.4754(3) 0.59181(11) 0.24443(11) 0.0350(4) 
H4 0.3697 0.6359 0.2119 0.042 
C5 0.4317(3) 0.49223(10) 0.23987(10) 0.0298(4) 
C6 0.5914(3) 0.43120(10) 0.28925(11) 0.0314(4) 
H6 0.5633 0.3632 0.2867 0.038 
C7 0.2207(3) 0.44850(10) 0.18527(10) 0.0301(4) 
N1 0.7833(2) 0.46395(9) 0.34024(9) 0.0344(3) 
N7 0.0770(2) 0.50649(9) 0.13449(10) 0.0374(4) 
H7A -0.0494 0.4826 0.1027 0.045 
H7B 0.1077 0.5691 0.1324 0.045 
O7 0.1852(2) 0.35946(7) 0.19058(8) 0.0379(3) 
C8 0.6744(3) 0.31135(11) 0.05629(11) 0.0323(4) 
C9 0.4874(3) 0.24989(11) 0.00716(11) 0.0325(4) 
H9 0.5047 0.1813 0.0080 0.039 
C10 0.2985(3) 0.28909(11) -0.03748(11) 0.0346(4) 
H10 0.2888 0.3579 -0.0394 0.042 
C11 0.0994(3) 0.23304(11) -0.08514(10) 0.0313(4) 
O8 0.8317(2) 0.26044(8) 0.10824(9) 0.0411(3) 
H8 0.9376 0.2977 0.1322 0.062 
O9 0.6779(2) 0.39909(8) 0.04933(9) 0.0425(3) 
O11 0.1195(2) 0.13910(7) -0.07607(8) 0.0386(3) 
H11 0.003 0.1119 -0.1053 0.058 
O12 -0.0689(2) 0.27372(8) -0.12767(8) 0.0393(3) 
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Bond lengths [Å] and angles [°] for Fumaric acid:nicotinamide 
C(2)-N(1)  1.340(2) 
C(2)-C(3)  1.377(2) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.383(2) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.395(2) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.388(2) 
C(5)-C(7)  1.499(2) 
C(6)-N(1)  1.337(2) 
C(6)-H(6)  0.9500 
C(7)-O(7)  1.2459(18) 
C(7)-N(7)  1.320(2) 
N(7)-H(7A)  0.8800 
N(7)-H(7B)  0.8800 
C(8)-O(9)  1.2138(19) 
C(8)-O(8)  1.3182(19) 
C(8)-C(9)  1.487(2) 
C(9)-C(10)  1.315(2) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.485(2) 
C(10)-H(10)  0.9500 
C(11)-O(12)  1.2238(19) 
C(11)-O(11)  1.3056(19) 
O(8)-H(8)  0.8400 
O(11)-H(11)  0.8400 
 
N(1)-C(2)-C(3) 122.51(15) 
N(1)-C(2)-H(2) 118.7 
C(3)-C(2)-H(2) 118.7 
C(2)-C(3)-C(4) 118.91(14) 
C(2)-C(3)-H(3) 120.5 
C(4)-C(3)-H(3) 120.5 
C(3)-C(4)-C(5) 119.28(14) 
C(3)-C(4)-H(4) 120.4 
C(5)-C(4)-H(4) 120.4 
C(6)-C(5)-C(4) 117.86(14) 
C(6)-C(5)-C(7) 118.81(13) 
C(4)-C(5)-C(7) 123.32(13) 
N(1)-C(6)-C(5) 122.82(13) 
N(1)-C(6)-H(6) 118.6 
C(5)-C(6)-H(6) 118.6 
O(7)-C(7)-N(7) 122.48(14) 
O(7)-C(7)-C(5) 119.09(13) 
N(7)-C(7)-C(5) 118.43(12) 
C(6)-N(1)-C(2) 118.61(13) 
C(7)-N(7)-H(7A) 120.0 
C(7)-N(7)-H(7B) 120.0 
H(7A)-N(7)-H(7B) 120.0 
O(9)-C(8)-O(8) 124.31(14) 
O(9)-C(8)-C(9) 122.86(14) 
O(8)-C(8)-C(9) 112.83(13) 
C(10)-C(9)-C(8) 120.96(14) 
C(10)-C(9)-H(9) 119.5 
C(8)-C(9)-H(9) 119.5 
C(9)-C(10)-C(11) 124.38(14) 
C(9)-C(10)-H(10) 117.8 
C(11)-C(10)-H(10) 117.8 
O(12)-C(11)-O(11) 124.26(14) 
O(12)-C(11)-C(10) 121.35(14) 
O(11)-C(11)-C(10) 114.38(13) 
C(8)-O(8)-H(8) 109.5 
C(11)-O(11)-H(11) 109.5
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Table P2: Experimental details – single-crystal data for fumaric acid:nicotinamide 
Crystal data  
Chemical formula C6H6N2O, C4H4O4 
Mr 238.20 
Space group, cell setting P21/c, Monoclinic 
a , b, c 5.5376(4), 13.7850(10), 14.2006(11) 
Beta (˚) 92.54(1) 
V (Å3) 1082.95(14) 
Z 4 
Dx (Mg m-3) 1.461 
Radiation type Cu Kα 
µ (mm-1) 1.115 
Specimen form, colour Slab, colourless 
Specimen size (mm) 0.34 x 0.15 x 0.06 
  
Data Collection  
Diffractometer Bruker Smart 6000 CCD 
Data Collection method Omega Scan 
Absorption correction Empirical (using intensity measurements) 
Tmin 0.7222 
Tmax 0.9411 
No. Of measured, independent and 
observed reflections 
6418, 1835, 1639 
Criterion for observed reflections I>2σ(I) 
Rint 0.0543 
Rmax  
  
Refinement  
Refinement on F2 
R[F2>2σ(F2)], wR(F2), S 0.0471, 0.1222, 1.037 
Reflection/profile data 1835 reflections 
H-atom treatment Constrained to parent site 
Weighting Scheme W = 1/[σ2(F20) + (0.0812P)2 + 0.1751P], 
where P = (F20 + F2C)/3 
(∆/σ) max < 0.0001 
∆ρmax, ∆ρmin(e Å-3) 0.213, -0.201 
Extinction method None 
Extinction coefficient  N/A 
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Powder crystal determination of fumaric acid:nicotinamide 
 
 
 
Figure P2: Atomic numbering scheme for fumaric acid:nicotinamide 
 
 
N1---C2 1.33553(17)  N1---C6 1.34522(7)  C2---N11.33553(17)    
C2---C3 1.39193(9)  C2---H10 1.07992(6)  C3---C2 1.39193(9)   
C3---C4 1.35195(7)  C3---H23 1.08303(14)          C4---C3 1.35195(7)        
C4---C51.35509(19)          C4---H11 1.07986(7)           C5---C4 1.35509(19)           
C5---C6 1.38734(9)       C5---C7 1.50027(8)          C6---N1 1.34522(7)          
C6---C5 1.38734(9)           C6---H12 1.08001(13)   C7---C5 1.50027(8)          
C7---O8 1.23432(8)         C7---N9 1.29935(13)          O8---C71.23432(8)           
N9---C7 1.29935(13)           H10---C2 1.07992(6)         H11---C4 1.07986(7)          
H12---C6 1.08001(13)           O13---O14 1.23964(7)     C14---O13 1.23964(7)           
C14---C15 1.48856(9)     C14---O18 1.32027(18)          C15---C14 1.48856(9)   
C15---C16 1.28011(7)           C15---H21 1.05273(11)     C15---H22 2.02125(14)    
C16---C15 1.28011(7)           C16---C17 1.49483(9)       C16---H21 2.02303(15)          
C16---H22 1.05149(10)          C17---C16 1.49483(9)     C17---O19 1.30833(16)    
C17---O20 1.21760(7)        O18---O14 1.32027(18)          O19---C17 1.30833(16)          
O20---C17 1.21760(7)      H21---C15 1.05273(11)   H21---C16 2.02303(15)          
H22---C15 2.02125(14)          H22---C161.05149(10)          H23---C3 1.08303(14)         
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Table P4: Final powder X-ray diffraction refined atomic positions and isotropic 
displacement factors for fumaric acid:nicotinamide 
Atom x y z Uiso/Ǻ2 
N1 0.16087 0.53418 0.22849       0.025 
C2 0.17678       0.44215       0.16935       0.025 
C3   0.22366       0.38106       0.33513       0.025 
C4    0.26228       0.41818       0.54316       0.025 
C5   0.26245       0.51543       0.57628       0.025 
C6 0.20638 0.57339 0.42367 0.025 
C7 0.31079       0.55827       0.79846       0.025          
O8 0.37284       0.51224       0.91126       0.025          
N9 0.27951       0.63794       0.88823       0.025          
H10 0.16007       0.41747      -0.01263      0.05 
H11 0.28129       0.37069       0.69262       0.05           
H12 0.19218       0.64724       0.47398       0.05           
C13 0.58435       0.25375       0.8442        0.025          
C14 0.5402        0.29567       0.67614       0.025          
C15 0.48935       0.23778       0.48408       0.025          
C16 0.47664       0.27282       0.27128       0.025          
C17   0.41636       0.22058       0.08476       0.025          
O18 0.55064       0.38984       0.64633       0.025          
O19 0.43642       0.13136       0.02782       0.025          
O20 0.35956       0.26588      -0.04192      0.025          
H21 0.45718       0.17214       0.52793       0.05           
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Appendix Q: Indexing of maleic acid:nicotinamide 
product A 
 
Table Q1: Index output for maleic acid:nicotinamide product A 
Merit Volume V/V1 IndexProg a b c alpha beta gamma 
22.27 2040.138 1 TAUPv3.3a 6.4374 10.8654 29.1677 90 90 90 
22.25 2040.078 1 KOHLv7.01b 10.8665 29.1648 6.4372 90 90 90 
17.83 2038.151 1 TAUPv3.3a 6.4377 10.872 29.1201 90 90 90 
15.4 2037.75 1 DICVOL91/log 29.1186 10.8685 6.4389 90 90 90 
15.4 2037.75 1 DICVOL91/log 29.1186 10.8685 6.4389 90 90 90 
7.2 1357.687 0.67 DICVOL91/log 19.7333 6.4397 10.8609 90 100.355 90 
7.2 1357.687 0.67 DICVOL91/log 19.7333 6.4397 10.8609 90 100.355 90 
7.1 1358.472 0.67 DICVOL91/log 20.7397 6.4399 10.8654 90 110.593 90 
7.1 1358.472 0.67 DICVOL91/log 20.7397 6.4399 10.8654 90 110.593 90 
6.8 1357.346 0.67 DICVOL91/log 24.1712 6.4403 10.8548 90 126.556 90 
6.8 1357.346 0.67 DICVOL91/log 24.1712 6.4403 10.8548 90 126.556 90 
12 950.223 0.47 TREOR90/log 14.4895 6.4385 10.5369 90 104.836 90 
10.41 1735.598 0.85 KOHLv7.01b 10.9535 29.109 5.5018 90 98.354 90 
7 1577.445 0.77 TREOR90/log 10.8345 17.0146 9.3993 90 114.44 90 
5 2274.03 1.11 ITO12/log 12.0879 17.9924 11.8978 111.66 105.831 74.597 
4.9 1782.78 0.87 ITO12/log 11.0106 20.8687 7.9291 94.96 100.076 93.041 
4.9 1782.78 0.87 ITO12/log 11.0106 20.8687 7.9291 94.96 100.076 93.041 
11.6 1025.69 0.5 ITO12/log 11.8144 11.9324 8.4614 101.007 109.084 65.763 
8.5 822.36 0.4 ITO12/log 11.3126 11.8808 6.7632 98.973 98.969 109.942 
8 909.069 0.45 TREOR90/log 15.3876 5.925 11.1664 90 116.755 90 
6.5 2144.52 1.05 ITO12/log 19.4612 20.791 5.8238 95.079 94.412 113.001 
6 1475.808 0.72 TREOR90/log 22.5702 10.15 6.4751 90 95.789 90 
10 907.606 0.44 TREOR90/log 14.3505 5.9314 11.1468 90 106.945 90 
9 1311.082 0.64 TREOR90/log 12.5031 11.6857 10.8228 90 123.991 90 
7 1165.687 0.57 TREOR90/log 16.6255 6.4331 10.9365 90 94.746 90 
6.6 1369.94 0.67 ITO12/log 10.495 19.581 6.8515 97.39 89.3 101.127 
6 1426.306 0.7 TREOR90/log 12.6442 10.3618 11.04 90 99.568 90 
6 1426.306 0.7 TREOR90/log 12.6442 10.3618 11.04 90 99.568 90 
6 1298.104 0.64 TREOR90/log 20.3385 9.7748 6.5432 90 93.703 90 
5 5925.499 2.9 TREOR90/log 16.9261 16.9261 20.6828 90 90 90 
6.4 1464.86 0.72 ITO12/log 13.9531 18.1271 5.9686 93.08 97.995 100.541 
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Appendix R: Structure determination of maleic acid:nicotinamide product A 
 
 
 
 
Figure R1: Atomic numbering scheme for maleate:nicotinamide product A 
 
 
Selected intramolecular distances (Ǻ) and angles (°)
C(2)-N(1)  1.341(2) 
C(2)-C(3)  1.376(2) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.381(2) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.392(2) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.3782(19) 
C(5)-C(7)  1.506(2) 
C(6)-N(1)  1.339(2) 
C(6)-H(6)  0.9500 
C(7)-O(7)  1.2369(17) 
C(7)-N(7)  1.3277(19) 
N(1)-H(1)  0.8800 
N(7)-H(7A)  0.8800 
N(7)-H(7B)  0.8800 
C(8)-O(9)  1.2412(18) 
C(8)-O(8)  1.2860(18) 
C(8)-C(9)  1.4926(19) 
C(9)-C(10)  1.335(2) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.4947(19) 
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C(10)-H(10)  0.9500 
C(11)-O(12)  1.2379(17) 
C(11)-O(11)  1.2847(18) 
O(8)-H(8)  0.8400 
O(11)-H(11)  0.8400 
 
N(1)-C(2)-C(3) 118.91(14) 
N(1)-C(2)-H(2) 120.5 
C(3)-C(2)-H(2) 120.5 
C(2)-C(3)-C(4) 119.60(14) 
C(2)-C(3)-H(3) 120.2 
C(4)-C(3)-H(3) 120.2 
C(3)-C(4)-C(5) 120.39(13) 
C(3)-C(4)-H(4) 119.8 
C(5)-C(4)-H(4) 119.8 
C(6)-C(5)-C(4) 117.81(14) 
C(6)-C(5)-C(7) 122.66(13) 
C(4)-C(5)-C(7) 119.53(12) 
N(1)-C(6)-C(5) 120.43(14) 
N(1)-C(6)-H(6) 119.8 
C(5)-C(6)-H(6) 119.8 
O(7)-C(7)-N(7) 123.00(14) 
O(7)-C(7)-C(5) 118.84(13) 
N(7)-C(7)-C(5) 118.15(12) 
C(6)-N(1)-C(2) 122.86(13) 
C(6)-N(1)-H(1) 118.6 
C(2)-N(1)-H(1) 118.6 
C(7)-N(7)-H(7A) 120.0 
C(7)-N(7)-H(7B) 120.0 
H(7A)-N(7)-H(7B) 120.0 
O(9)-C(8)-O(8) 122.69(13) 
O(9)-C(8)-C(9) 117.02(13) 
O(8)-C(8)-C(9) 120.28(13) 
C(10)-C(9)-C(8) 130.25(13) 
C(10)-C(9)-H(9) 114.9 
C(8)-C(9)-H(9) 114.9 
C(9)-C(10)-C(11) 130.14(13) 
C(9)-C(10)-H(10) 114.9 
C(11)-C(10)-H(10) 114.9 
O(12)-C(11)-O(11) 122.03(13) 
O(12)-C(11)-C(10) 117.61(13) 
O(11)-C(11)-C(10) 120.35(12) 
C(8)-O(8)-H(8) 109.5 
C(11)-O(11)-H(11) 109.5 
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Table R1: Final refined atomic positions and istropic displacement factors for 
maleate:nicotinamide 
Atom x y z Uiso/Å2 
C2 0.8400(3) 0.10591(14) 0.11242(5) 0.0311(4) 
H2 0.9651 -0.1204 0.1293 0.037 
C3 0.7921(3) 0.17669(13) 0.07472(5) 0.0309(4) 
H3 0.8841 -0.2407 0.0653 0.037 
C4 0.6094(3) 0.15407(13) 0.05065(5) 0.0273(3) 
H4 0.576 -0.2027 0.0246 0.033 
C5 0.4739(2) 0.06052(12) 0.06440(4) 0.0236(3) 
C6 0.5286(2) 0.00756(13) 0.10245(5) 0.0257(3) 
H6 0.4389 0.0717 0.1128 0.031 
C7 0.2761(2) 0.03699(12) 0.03755(5) 0.0256(3) 
N1 0.7073(2) 0.01612(11) 0.12494(4) 0.0283(3) 
H1 0.739 0.0292 0.149 0.034 
N7 0.1565(2) 0.05764(11) 0.04977(4) 0.0301(3) 
H7A 0.0414 0.0744 0.0343 0.036 
H7B 0.1924 0.1037 0.0733 0.036 
O7 0.23401(18) 0.10497(10) 0.00477(3) 0.0340(3) 
C8 0.1643(2) 0.19101(13) 0.16467(5) 0.0262(3) 
C9 0.1581(2) 0.28759(12) 0.20107(5) 0.0245(3) 
H9 0.1567 0.37 0.1901 0.029 
C10 0.1540(2) 0.27659(12) 0.24663(5) 0.0240(3) 
H10 0.1516 0.3523 0.2629 0.029 
C11 0.1528(2) 0.16378(13) 0.27603(5) 0.0252(3) 
O8 0.13510(18) 0.07712(9) 0.17502(4) 0.0338(3) 
H8 0.1143 0.0707 0.2034 0.051 
O9 0.20188(18) 0.22591(10) 0.12499(3) 0.0358(3) 
O11 0.12887(18) 0.05679(9) 0.25793(4) 0.0342(3) 
H11 0.1166 0.0641 0.2294 0.051 
O12 0.17355(18) 0.17796(10) 0.31789(3) 0.0347(3) 
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Appendix S: Structure determination of maleate:isonicotinamide  
 
S1: Single crystal determination of maleate:isonicotinamide 
 
 
 
Figure S1: The atomic numbering scheme of maleate:isonicotinamide. Displacement 
ellipsoids are drawn at the 50 % probability level and H atoms are shown as small spheres of 
arbitrary radii. 
Selected intramolecular distances (Ǻ) and angles (°) 
 
C8-O9 1.235(3)  C8-O8 1.294(3)  C8-C9 1.485(3) 
C9-C10 1.338(3)  C9-H9 0.9500   C10-C11 1.499(3) 
C10-H10 0.9500  C11-O12 1.246(3)  C11-O11 1.271(3) 
O8-H8 0.8400   O11-H11 0.8400  C2-N1 1.334(3) 
C2-C3 1.379(3)  C2-H2 0.9500   C3-H3 0.9500 
C4-C5 1.388(3)  C4-C7 1.521(3)  C5-C6 1.377(3) 
C5-H5 0.9500   C6-N1 1.332(3)  C6-H6 0.9500 
C6-O7 1.232(3)  C7-N7 1.324(3)  N1-H1 0.8800 
N7-H7A 0.8800  N7-H7B 0.8800 
 
O9-C8-O8 121.2(2)  O9-C8-C9 118.2(2)  O8-C8-C9 120.57(19) 
C10-C9-C8 130.7(2)  C10-C9-H9 114.6  C8-C9-H9 114.6 
C9-C10-C11 129.1(2)  C9-C10-H10 115.5  C11-C10-H10 115.5 
O12-C11-O11 121.87(19) O12-C11-C10 116.7(2) O11-C11-C10 121.45(19) 
C8-O8-H8 109.5  C11-O11-H11 109.5  N1-C2-C3 119.9(2) 
N1-C2-H2 120.1  C3-C2-H2 120.1  C4-C3-C2 119.7(2) 
C4-C3-H3 120.2  C2-C3-H3 120.2  C3-C4-C5 118.97(19) 
C3-C4-C7 117.96(18)  C5-C4-C7 123.26(19)  C6-C5-H5 120.4 
C4-C5-H5 120.4  N1-C6-C5 120.24(19)  N1-C6-H6 119.9 
C5-C6-H6 119.9  O7-C7-N7 124.37(19) O7-C7-C4 118.51(19) 
N7-C7-C4 117.13(18)  C6-N1-C2 122.00(18)  C6-N1-H1 119.0 
C2-N1-H1 119.0  C7-N7-H7A 120.0  C7-N7-H7B 120.0 
H7A-N7-H7B 120.0 
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Table S1: Final refined atomic positions and isotropic displacement factors for 
maleate:isonicotinamide - Single crystal structure. 
Atom x y z Uiso/Ǻ2 
N1 0.6298(5) 0.66710(17) 0.78234(13) 0.0249(4) 
H1 0.5456 0.6497 0.8385 0.03 
C2 0.6352(6) 0.5733(2) 0.70288(16) 0.0257(5) 
H2 0.5523 0.4891 0.7078 0.031 
C3 0.7613(6) 0.5988(2) 0.61361(17) 0.0256(5) 
H3 0.7684 0.5321 0.5572 0.031 
C4 0.8768(5) 0.7214(2) 0.60671(15) 0.0220(5) 
C5 0.8748(6) 0.8165(2) 0.69162(16) 0.0255(5) 
H5 0.96 0.9014 0.6893 0.031 
C6 0.7479(6) 0.7863(2) 0.77926(16) 0.0260(5) 
H6 0.7446 0.8507 0.8377 0.031 
C7 0.9930(5) 0.7457(2) 0.50446(16) 0.0230(5) 
N7 1.1759(5) 0.85725(17) 0.50537(14) 0.0267(5) 
H7A 1.2481 0.8751 0.4478 0.032 
H7B 1.2254 0.9135 0.5635 0.032 
O7 0.9120(4) 0.66154(15) 0.42683(12) 0.0313(4) 
C8 0.4825(6) 0.8785(2) 1.23913(17) 0.0265(5) 
C9 0.2897(6) 0.7486(2) 1.20344(17) 0.0265(5) 
H9 0.1821 0.7136 1.2555 0.032 
C10 0.2422(6) 0.6727(2) 1.11010(16) 0.0260(5) 
H10 0.1054 0.5926 1.1058 0.031 
C11 0.3746(6) 0.6963(2) 1.01142(16) 0.0253(5) 
O8 0.6318(5) 0.93794(15) 1.17473(12) 0.0347(4) 
H8 0.5842 0.8941 1.1145 0.052 
O9 0.4964(4) 0.92784(14) 1.33153(11) 0.0304(4) 
O11 0.5467(5) 0.80175(15) 1.00597(12) 0.0334(4) 
H11 0.5808 0.8489 1.0649 0.05 
O12 0.3081(4) 0.60743(15) 0.93542(11) 0.0307(4) 
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Appendix T: 
1
H NMR of forms I & II oxamic acid 
 
 
 
Figure T1: 
1
H NMR of oxamic acid form I (0-10.5 ppm) in DMSO 
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Figure T2: 
1
H NMR of oxamic acid form I (11.5-16 ppm) in DMSO 
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Figure T3: 
1
H NMR of oxamic acid form II (0-8.5 ppm) in DMSO 
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Figure T4: 
1
H NMR of oxamic acid form II (11-16 ppm) in DMSO 
In figures (T1-T4), two singlet peaks are seen for the amine protons instead of a doublet due 
to free rotation in the bond being hindered. This hindrance occurs as the π-system stabilizes 
the molecule and hence the protons are in a different environment. There is little coupling 
between the two hydrogens on the nitrogen as they are nearly equivalent. There is also an 
impurity present within the commercial sample which is seen at 7.2 ppm; this impurity is not 
seen in the 
1
H NMR of oxamic acid recrystallised from ethyl acetate 
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Appendix U: Solid state NMR of oxamic acid (forms I and II) 
 
Figure U1: Solid state 
13
C NMR of oxamic acid form I 
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Figure U2: Solid state 
13
C NMR of oxamic acid form II 
 
Figure U3: Solid state 
15
N NMR of oxamic acid form I 
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Figure U4: Solid state 
15
N NMR of oxamic acid form II 
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Appendix V: The polymorphism of oxamic acid 
 
Figure V1: Powder diffraction patterns of predicted crystal structures of oxamic acid. 
 
Figure V2: Diffraction pattern of oxamic acid form I (red) and form II (blue) 
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Figure V3:  Energy landscape of Oxamic acid. 
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Appendix W: Single crystal structure of oxamic acid 
Data was recorded at room temperature on a Bruker smart 6000 diffractometer equipped with 
a CCD detector and a Cu tube source. The structure was solved and refined using SHELXL. 
Formula    C2H3N3O 
Formula weight   85.07 
Temperature    293(2) K 
Wavelength    1.54178 Å 
Crystal system, space group  Monoclinic, Cc 
a     9.530(5)Å 
b     5.424(3)Å 
c     6.866(4)Å 
β     107.18(4)° 
Volume    339.1(3) Å3  
Z, calculated density   3, 1.250 Mg/cm3 
Crystal size    0.20 x 0.12 x 0.08 mm 
Final R indicies [I >2θ(I)] 
R1     0.2160  
wR2     0.4178 
 
 
Table W1: Atomic positions of oxamic acid 
Atom x y z Ueq/ Å
2 
O(3) 0.4527(7) 0.8718(10) 0.7305(9) 0.021(2) 
O(4) 0.6696(9) 0.8769(17) 0.9767(12) 0.034(3) 
O(1) 0.6856(10) 1.3607(19) 0.9763(15) 0.052(3) 
O(2) 0.4573(8) 1.3766(18) 0.7417(11) 0.027(2) 
C(2) 0.5520(20) 0.9803(18) 0.8390(40) 0.028(3) 
C(1) 0.5540(20) 1.2669(18) 0.8390(40) 0.029(3) 
  
 
